0001062993-14-003005.txt : 20140515 0001062993-14-003005.hdr.sgml : 20140515 20140515125644 ACCESSION NUMBER: 0001062993-14-003005 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20140331 FILED AS OF DATE: 20140515 DATE AS OF CHANGE: 20140515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cybrdi, Inc. CENTRAL INDEX KEY: 0000019002 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 952461404 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-09081 FILM NUMBER: 14845435 BUSINESS ADDRESS: STREET 1: 401 ROSEMONT AVENUE STREET 2: - CITY: FREDERICK STATE: MD ZIP: 21701 BUSINESS PHONE: 301-644-3901 MAIL ADDRESS: STREET 1: 401 ROSEMONT AVENUE STREET 2: - CITY: FREDERICK STATE: MD ZIP: 21701 FORMER COMPANY: FORMER CONFORMED NAME: CERTRON CORP DATE OF NAME CHANGE: 19920703 10-Q 1 form10q.htm FORM 10-Q Cybrdi, Inc.: Form 10-Q - Filed by newsfilecorp.com

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2014 OR

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File No: 09081

CYBRDI, INC.
(Exact name of registrant as specified in its charter)

CALIFORNIA
(State or other jurisdiction of incorporation or organization)

95-2461404
(I.R.S. Employer ID No)

No 29 Chang'An South Road Xi'an Shaanxi P.R. China 710061
(Address of principal executive office) (Zip Code) Registrant's telephone number: (011) 86-29-8237-3068

N/A
Former name, former address and former fiscal year, (if changed since last report)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [X]                                 No [    ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes [    ]                                 No [X]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of "large accelerated filer", "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer [   ] Accelerated filer [   ] Non-accelerated filer [   ] Smaller reporting company [X]
    (Do not check if a smaller  
    reporting company)  

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes [    ]                                 No [X]

The number of shares of common stock, no par value per share, outstanding as of May 9, 2014 was 120,225,323.

1


FORM 10-Q
QUARTERLY PERIOD ENDED March 31, 2014
INDEX
TABLE OF CONTENTS

    Page
PART I – FINANCIAL INFORMATION  
Item 1: Financial Statements F-1
Item 2: Management’s Discussion and Analysis of Financial Condition and Results of Operations 3
Item 3: Quantitative and Qualitative Disclosures About Market Risk 10
Item 4T: Controls and Procedures 10
PART II – OTHER INFORMATION  
Item 1: Legal Proceedings 11
Item 1A: Risk Factors 11
Item 2: Unregistered Sales of Equity Securities and Use of Proceeds 12
Item 3: Defaults Upon Senior Securities 12
Item 4: Mine Safety Disclosures 12
Item 5: Other Information 12
Item 6: Exhibits 13

2


Item 1 Financial Statements

CYBRDI, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS

    March 31,     December  
          31,  
    2014     2013  
ASSETS   (Unaudited)     (Audited)  
CURRENT ASSETS            
       Cash and equivalents $  886,570   $  203,921  
       Accounts receivable, net   50,235     6,409  
       Inventories   797,775     848,525  
       Other receivables, net and prepaid expenses   127,343     906,459  
       Advance to suppliers   3     4,536  
TOTAL CURRENT ASSETS   1,861,926     1,969,850  

PROPERTY, PLANT AND EQUIPMENT, NET

  1,090,546     1,144,781  

CONSTRUCTION IN PROGRESS

  6,535,811     6,609,918  

INTANGIBLE ASSETS, NET

  616,382     628,193  

 

           

TOTAL ASSETS

$  10,104,665   $  10,352,742  

 

           

LIABILITIES AND EQUITY

           

 

           

CURRENT LIABILITIES

           

       Short-term loan

$  1,447,783   $  1,308,858  

       Accounts payable

  31,402     11,903  

       Accrued expenses

  865,286     810,331  

       Deferred revenue

  130,575     126,128  

       Customers deposits

  157,971     165,066  

       Due to related parties

  3,015,609     2,963,494  

       Deferred tax liabilities

  10,421     10,598  

       Other payables

  441,075     591,613  

TOTAL CURRENT LIABILITIES

  6,100,122     5,987,991  

CONSTRUCTION PAYABLE

  369,989     376,297  

TOTAL LIABILITIES

  6,470,111     6,364,288  

 

           

EQUITY

           

 

           

Preferred Stock, $1.00 per value, 500,000 shares authorized, no shares issued and outstanding

  -     -  

Common Stock, no par value, 150,000,000 shares authorized, and 120,225,323 shares issued and outstanding as of March 31, 2014 and December 31, 2013, respectively

  4,313,614     4,313,614  

Additional paid-in capital

  172,308     172,308  

Reserve funds

  336,885     336,885  

Accumulated deficit

  (3,758,942 )   (3,525,809 )

Accumulated other comprehensive income

  1,586,167     1,656,723  

TOTAL STOCKHOLDERS’ EQUITY

  2,650,032     2,953,721  

NONCONTROLLING INTEREST

  984,522     1,034,733  

TOTAL EQUITY

  3,634,554     3,988,454  

 

           

TOTAL LIABILITIES AND EQUITY

$  10,104,665   $  10,352,742  

See notes to consolidated financial statements.

F-1


CYBRDI, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME
(Unaudited)

    Three Months Ended March 31,  
                 2014                  2013  

Revenue

           

                                   Housing

$  80,650   $  -  

                                   Commercial rental

  -     -  

                                   Tissue array products

  68,136     151,152  

Total revenue

  148,786     151,152  

Cost of Sales

           

                                   Housing

  47,145     -  

                                   Commercial rental - related party

  26,299     16,696  

                                   Tissue array products

  68,070     98,520  

                                                                                             Total cost of sales

  141,514     115,216  

 

           

Gross Profit

  7,272     35,936  

 

           

Operating Expenses:

           

                                   Salaries and wages

  50,988     53,913  

                                   Depreciation and amortization

  11,422     33,445  

                                   Bad debt expense

  -     6,630  

                                   Professional fees

  38,575     40,107  

                                   Selling and distribution expenses

  2,861     4,186  

                                   Other general and administrative expenses

  123,538     27,592  

Total Operating Expenses

  227,384     165,873  

 

           

Loss from Operations

  (220,112 )   (129,937 )

 

           

Other Expense

           

                                   Interest expenses, net

  (47,472 )   (46,188 )

                                   Other expense, net

  (767 )   (2,048 )

Total Other Expense, Net

  (48,239 )   (48,236 )

 

           

Loss before Income Taxes

  (268,351 )   (178,173 )

Less: Income Tax (Benefit) Expense

  (1,738 )   142  

Net loss

  (266,613 )   (178,315 )

Less: Net loss attributable to the non-controlling interests

  (33,480 )   (31,493 )

Net loss attributable to CYBRDI, INC.

  (233,133 )   (146,822 )

Foreign currency translation loss

  (70,556 )   (37,094 )

Comprehensive loss

$  (303,689 ) $  (183,916 )

 

           

Net Loss Per Common Share

           

                                   Basic and Diluted

$  (0.00 ) $  (0.00 )

 

           

Weighted Average Number of Shares Outstanding

           

                                   Basic and Diluted

  120,225,323     120,225,323  

See notes to consolidated financial statements.

F-2


CYBRDI INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)

    Three Months Ended March 31,  

CASH FLOWS FROM OPERATING ACTIVITIES

  2014     2013  

                           Net loss attributable to Cybrdi Inc.

$  (233,133 ) $  (146,822 )

                             Adjustments to Reconcile Net Loss to Cash Provided by operating activities:

           

                                               Depreciation and amortization

  44,707     55,881  

                                               Bad debt expense

  -     6,630  

                                               Minority interest

  (33,480 )   (31,493 )

                             Changes in Operating Assets and Liabilities:

           

                                               Accounts receivable

  (44,753 )   (15,067 )

                                               Inventories

  37,206     4,262  

                                               Other receivable and prepaid expenses

  782,725     6,552  

                                               Accounts payable and other current liabilities

  96,421     92,845  

                                               Deferred revenue

  6,683     -  

                                               Advance to suppliers

  (4,409 )   24,307  

                             Net Cash used in Operating Activities

  651,967     (2,905 )

 

           

CASH FLOWS FROM INVESTING ACTIVITIES

           

                                       Advance for loan to affiliated companies

  (4,249 )   -  

                                       Purchase of property, plant, and equipment

  (7,702 )   (7,601 )

                                               Payments for construction in progress

  (37,970 )   (279 )

                             Net Cash used in Investing Activities

  (49,921 )   (7,880 )

 

           

CASH FLOWS FROM FINANCING ACTIVITIES

           

                                       Proceeds from loans from related companies

  78,950     10,668  

                                       Loan from shareholders/officers

  17,877     8,998  

                             Net cash provided by Financing Activities

  96,827     19,666  

NET INCREASE IN CASH & CASH EQUIVALENTS

  698,873     8,881  

EFFECT OF EXCHANGE RATE CHANGE ON CASH & CASH EQUIVALENTS

  (16,224 )   15,074  

CASH & CASH EQUIVALENTS, BEGINNING BALANCE

  203,921     956,235  

 

           

CASH & CASH EQUIVALENTS, ENDING BALANCE

$  886,570   $  980,190  

 

           

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION

           

                                               Interest paid

$  39,328   $  45,799  

                                               Income taxes paid

$  113   $  153  

See notes to consolidated financial statements.

F-3


CYBRDI, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

NOTE A - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 1. Interim Financial Statements

The unaudited consolidated financial statements of Cybrdi Inc. and subsidiaries have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and pursuant to the requirements for reporting on Form 10-Q. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. However, the information included in these interim financial statements reflects all adjustments (consisting solely of normal recurring adjustments) which are, in the opinion of management, necessary for the fair presentation of the consolidated financial position and the consolidated results of operations. Results shown for interim periods are not necessarily indicative of the results to be obtained for a full year. The consolidated balance sheet information as of December 31, 2013 was derived from the audited consolidated financial statements included in the Company’s Annual Report on Form 10-K. These interim financial statements should be read in conjunction with that report. Certain comparative amounts have been reclassified to conform to the current period's presentation.

The consolidated financial statements include the accounts of Cybrdi, Inc. and its wholly-owned subsidiaries and joint ventures. All material intercompany balances and transactions have been eliminated.

2. Description of Business

Cybrdi, Inc. was incorporated on August 1, 1966, under the laws of the State of California. From then to approximately June 2004, we conducted business in the distribution of magnetic media products, primarily blank audio and video cassettes. Due to continuing intense price competition and technological changes in the marketplace for its products, the Company lost its remaining significant customers and disposed of or wrote off its remaining inventory. As a result of these occurrences, the Company concluded that its audio and videotape businesses were no longer viable and some of its product lines were obsolete.

In November 2004, we acquired all of the ownership interests in Cybrdi, Inc., a privately held company incorporated in the State of Maryland ("Cybrdi Maryland"). For financial statement reporting purposes, the transaction was treated as a reverse acquisition, with Cybrdi Maryland deemed the accounting acquirer and Certron Corporation deemed the accounting acquiree. Historical information of the surviving company is that of Cybrdi Maryland.

Cybrdi Maryland was established in 2001 to acquire an interest in biogenetic products commercialization and related services entities in Asia. On March 5, 2003, Cybrdi Maryland acquired an 80% interest in Shaanxi Chao Ying Biotechnology Co., Ltd. (“Chaoying Biotech”), a sino-foreign equity joint venture established in July 2000 in the People's Republic of China (“PRC”), through the exchange of 99% of shares to the existing shareholders of Chaoying Biotech. For financial statement reporting purposes, the merger was treated as a reverse acquisition, with Chaoying Biotech deemed the accounting acquirer and Cybrdi Maryland deemed the accounting acquiree.

F-4


Chaoying Biotech is a sino-foreign equity joint venture between Shaanxi Chaoying Beauty & Cosmetics Group Co., Ltd. (the “Chinese Partner”, a PRC corporation) and Immuno-Onco Genomics Inc. (the “Foreign Partner”, a USA corporation). The joint venture agreement has a 15 year operating period starting from its formation in July 2000 and it may be extended upon mutual consent. The principal activities of Chaoying Biotech are research, manufacture and sale of various high-quality tissue arrays and the related services in the PRC.

Most of the Company’s activities are conducted through Chaoying Biotech, of which it owns an 80% interest. Chaoying Biotech, with its principal operations located in China, aims to take advantage of China's abundant scientific talent, low wage rates, less stringent biogenetic regulation, and the huge genetic population as it introduces its growing list of tissue micro array products.

On February 10, 2005, the Company completed the merger with Cybrdi Maryland and changed its name to Cybrdi, Inc.

On July 26, 2007, Chaoying Biotech entered into an acquisition agreement with the Chinese partner to acquire 83.33% equity ownership of Shandong Chaoying Culture and Entertainment Co., Ltd (“SD Chaoying”) from the Chinese partner for RMB 15 million. The Chinese partner is a principal shareholder of the Company and Mr. Bai, the Company’s chief executive officer, chairman and a principal shareholder, is also a principal of the Chinese partner. SD Chaoying is a corporation organized in the Shandong province of P.R.China. On September 5, 2007, Shandong MOFCOM approved this acquisition and ownership of SD Chaoying was transferred to Chaoying Biotech from the Chinese Partner.

The business of SD Chaoying will primarily focus on culture and entertainment, including make-up, personal care, health club, gambling, saunas for massage and bath, karaoke, catering, and lodging. The Company plans for SD Chaoying to have a specific emphasis on casino gambling, but such operations have not been approved by Shandong Administration for Civil Affairs. At the end of 2010, SD Chaoying had substantially completed the construction of two residential buildings and had recognized revenue from sales of housing units from these buildings for 2010. The main structure of the commercial entertainment center has also been completed, with the exterior, rooftop, the surrounding supporting projects and the community landscaping yet to be completed, but which are expected to be completed in 2014 prior to the commencement of operations by merchant tenants if we can obtain an estimated $3.0 million to complete construction. In January 2011, SD Chaoying engaged Dongshan Victoria Spring Hotel (“Victoria”), which is controlled by the wife of the General Manager of SD Chaoying, to manage and operate the SPA business at the completed section of the cultural and entertainment facility. SD Chaoying has not charged any fees from Victoria and no written agreement was signed. As of March 31, 2014, the Company has not commenced collecting rental and management fee revenue for the culture and entertainment center.

On April 29, 2011, Chaoying Biotech invested $154,732 (equivalent to RMB 1 million) to restore the operation of the Institute of Shaanxi Chaoying Clinical Pathology (“IOSCCP”), a wholly-owned subsidiary established on July 31, 2003, whose main business includes pathology research and consulting, diagnostic clinical pathology and pathology-related research and development of new technologies, and basic training in pathology. Chaoying Biotech has been its sole shareholder.

F-5


3. Going Concern

The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred significant losses and has not demonstrated the ability to generate sufficient cash flows from operations to satisfy its liabilities and sustain operations. The Company had an accumulated deficit of $3,758,942 and $3,525,809 as of March 31, 2014 and December 31, 2013, including net losses of $266,613 and $178,315 for the three months ended March 31, 2014 and 2013, respectively. In addition, current liabilities exceeded current assets by $4,238,196 and $4,018,141 at March 31, 2014 and December 31, 2013, respectively. These matters raise substantial doubt about the Company’s ability to continue as a going concern.

The Company finances its operations primarily through short-term bank borrowings and advances from related parties and/or officers/shareholders. In order to complete the construction of SD Chaoying cultural and entertainment center, approximately $3.0 million (equivalent to RMB 19 million) of capital is needed. The Company, taking into accounts the available banking facilities, internal financial resource, and support from related companies, believes it has sufficient working capital to meet its present obligation for at least the next twelve months. Management is taking actions to address the company's financial condition and deteriorating liquidity position. The following sets forth management’s plans for dealing with the adverse effects of the conditions:

(a) Sale of housing inventories: Proceeds to be received from the sale of the remaining housing of the two completed residential buildings are expected to amount to approximately $0.3 million. However, there is no assurance when such sales will occur.
   
(b) Rental and management fee revenue from the cultural and entertainment center: Annual rental revenue is estimated to be approximately $0.68 million per year. Management fee revenue will be charged to commercial tenants at 3% of annual gross revenue. As of March 31, 2014, the Company has not commenced collecting rental and management fee revenue for the culture and entertainment center.

The Company may require additional funds and may seek to raise such funds through public and private financings or from other sources. There is no assurance that the above management’s plans will be realized or the additional financing will be available or that, if available, such financing will be obtainable on terms favorable to the Company or that any additional financing will not be dilutive. The consolidated financial statements do not include any adjustments that might result from the outcome of those uncertainties.

F-6


4. Use of Estimates:

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.

5. Revenue Recognition

Revenue represents the invoiced value of goods sold recognized upon the delivery of goods to customers and service income is recognized when services are provided. Deferred revenue represents the undelivered portion of invoiced value of goods sold to customers. Sales transactions not meeting all the conditions of the full accrual method are accounted for using the deposit method of accounting. Under the deposit method, all costs are capitalized as incurred, and payments received from the buyer are recorded as customer deposits.

6. Reverse Merger

On February 10, 2005, (the "Closing Date") the Company closed on an Agreement and Plan of Merger (the "Agreement") among Certron Corporation (“Certron”), a California corporation, Certron Acquisition Corp., a Maryland corporation and a wholly-owned subsidiary of Certron ("Acquisition Sub"), and Cybrdi, Inc., a Maryland corporation (“Cybrdi – Maryland”) relating to the acquisition by Certron of all of the issued and outstanding capital stock of Cybrdi -Maryland in exchange for shares of common stock of Certron that will aggregate approximately 93.8% of the issued and outstanding common stock of Certron. Pursuant to the terms of the Agreement, at the Closing Date (a) Acquisition Sub has been merged with and into Cybrdi - Maryland, with Cybrdi -Maryland being the surviving corporation, (b) the common stock of Cybrdi-Maryland has been cancelled and converted into the right to receive shares of the common stock of Certron at an exchange ratio of 1.566641609 per share. This resulted in the issuance of 47,328,263 shares of the Carton’s common stock, and (c) each share of the common stock of Acquisition Sub has been converted in to and become one share of the common stock of Cybrdi-Maryland. The share exchange has been accounted for as a reverse merger under the purchase method of accounting. Accordingly, Cybrdi, Inc. will be treated as the continuing entity for accounting purposes and the historical financial statements presented will be those of Cybrdi, Inc.

In connection with the Agreement, on February 10, 2005, the Company amended its articles of incorporation to authorize the issuance of 150 million shares of common stock no par value and 500,000 shares of preferred stock, $1.00 par value per share, none of which are issued or outstanding.

Concurrent with the filing of the Articles of Merger, all of the Company then existing officers and directors tendered their resignation and Yanbiao Bai was appointed as its Chairman of the Board of Directors. Mr. Bai then nominated the balance of the Board of Directors.

F-7


7. Income Taxes

Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due plus deferred taxes related primarily to the differences between the basis of assets and liabilities for financial and income tax reporting. The deferred tax assets and liabilities represent the future tax return consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes also are recognized for operating losses that are available to offset future income taxes.

8. Recent Accounting Pronouncements

The Company has adopted all recently issued accounting pronouncements. The adoption of the accounting pronouncements, including those not yet effective, is not anticipated to have a material effect on the financial position or results of operations of the Company.

F-8


NOTE B – ASSETS

The March 31, 2014 consolidated balance sheet included total current assets of $1,861,926 and non-current assets of $8,242,739. Of these amounts, $886,570 in cash and equivalents is planned for funding current operations and for future business expansion.

Current assets also included accounts receivable, inventories, other receivables and prepaid expenses, and advance to suppliers. Inventories are mainly finished goods. Other components of inventories include raw materials and housing inventories. Inventories are stated at the lower of cost or market. Cost of raw materials is determined on the basis of first in first out method (“FIFO”). Finished goods are determined on the weighted average basis and are comprised of direct materials, direct labor, and an appropriate proportion of overhead.

Included in non-current assets are property, plant and equipment, construction-in-progress and intangible assets. Property, plant and equipment mainly consist of building, office equipment, motor vehicles, leasehold improvement and machinery used for product manufacturing located in the People’s Republic of China (“PRC”). Depreciation on property, plant and equipment is computed using the straight-line method over the estimated useful life of the assets. The majority of the assets have estimated useful lives of 10 years. Building and office equipment have estimated useful lives of 20 and 5 years, respectively. The “construction in progress” in the amount of $6,535,811 mainly consisted of land under development and construction of the entertainment, culture, and casino facility in Shandong Province, which will be transferred to fixed assets in SD Chaoying when construction is completed. For the $3.22 million land use rights, $2.5 million was classified under construction-in-progress for the commercial property and the remaining $0.62 million was classified under intangible assets subject to amortization. Intangible assets included a tissue chip patent at Chaoying Biotech and $0.62 million of land use rights being put in operation for the partial completed commercial property at SD Chaoying. Effective January 1, 2002, with the adoption of the accounting guidance for Goodwill and Other Intangible Assets, intangible assets with a definite life are amortized on a straight-line basis. The patent expired on April 30, 2013, which was amortized over its estimated life of 10 years. The land use rights classified in intangible asset is being amortized over its estimated life of 36.9 years through the maturity of the land use rights for commercial use on November 6, 2047.

F-9


NOTE C – LIABILITIES

As of March 31, 2014, the balance sheet included total liabilities of $6,470,111, which consisted of current liabilities of $6,100,122 and construction payable of $369,989. Included in the current liabilities was a short-term loan of $160,865 (equivalent to RMB 1.0 million) from Mr. Fengguo Liu, an unrelated party. The short-term loan is due on January 15, 2015 with an interest rate at 2% per month. Also included in the current liabilities was $3,015,609 of loans from related companies, including Xi’an Yanfeng Biotechnology Co., Ltd., Shaanxi Yanfeng Real Estate Co. Ltd, Shaanxi Chaoying Beauty & Cosmetics Group Co., Ltd and the stockholders who are also the Company’s officers. These entities were related to the Company through common ownership and principal officers. These loans are non-interest bearing and have no set repayment terms.

NOTE D – STOCKHOLDERS’ EQUITY

As a result of the reverse merger (see Note A item 6), the common stock of Cybrdi-Maryland has been cancelled and converted into shares of common stock of Certron at an exchange ratio of 1.566641609 per share. This resulted in the issuance of 47,328,263 shares of Carton’s common stock to the Cybrdi shareholders. As of March 31, 2014 and December 31, 2013, the Company had 120,225,323 shares issued and outstanding, respectively.

As of March 31, 2014, the balance sheet included total equity of $3,634,554, of which $984,522 was for non-controlling interest, representing 20% minority interest in Chaoying Biotech and 16.67% minority interest in SD Chaoying.

As of March 31, 2013, the balance sheet included total equity of $3,988,454, of which $1,034,733 was for non-controlling interest, representing 20% minority interest in Chaoying Biotech and 16.67% minority interest in SD Chaoying.

F-10


NOTE E – INCOME TAXES

Under the Enterprise Income Tax (“EIT”) of the PRC, prior to 2007, Chinese enterprises are generally subject to an income tax at an effective rate of 33% (30% statutory income taxes plus 3% local income taxes) on income reported in the statutory financial statements after appropriate tax adjustments, unless the enterprise is located in a specially designated region for which more favorable effective tax rates are applicable. Beginning on January 1, 2008, the new EIT law has replaced the existing laws for Domestic Enterprises (“DEs”) and Foreign Invested Enterprises (“FIEs”). The new standard EIT rate of 25% will replace the 33% rate previously applicable to both DES and FIEs. The two year tax exemption, six year 50% tax reduction and tax holiday for production-oriented FIEs will be eliminated. According to the Western Developing Plan implemented by the PRC Government, Chaoying Biotech is entitled to a 50% reduction in EIT of preferential policy, but not less than 15%. As a result, Chaoying Biotech’s effective EIT tax rate has been 15% since 2008.

The Company’s income tax expense includes U.S. and PRC income taxes. There were no U.S. current taxes for the three months ended March 31, 2014 according to net loss incurred in the U.S. entity, which will not be anticipated to have any tax benefit in the future since no revenue is expected to be generated in the U.S as a result of discontinuing the U.S. operating company in Maryland in October 2007. There were $116 and $0 of PRC current income taxes accrued for the three months ended March 31, 2014 in SD Chaoying and Chaoying Biotech, respectively.

NOTE F – CONTINGENCIES AND LITIGATION LIABILITIES

During the three months ended March 31, 2014, there were no material developments in any previously reported litigation.

F-11


Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operation

The following discussion and analysis should be read in conjunction with the company’s Financial Statements and Notes thereto appearing elsewhere in this Report on Form 10-Q as well as the company’s other SEC filings, including our annual report on Form 10-K for the year ended December 31, 2013.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Certain statements in this quarterly report on Form 10-Q contain or may contain forward-looking statements that are subject to known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements were based on various factors and were derived utilizing numerous assumptions and other factors that could cause its actual results to differ materially from those in the forward-looking statements. These factors include, but are not limited to, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk, U.S. and global competition, and other factors. Most of these factors are difficult to predict accurately and are generally beyond its control. You should consider the areas of risk described in connection with any forward-looking statements that may be made herein. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. Readers should carefully review this quarterly report in its entirety, including but not limited to its financial statements and the notes thereto. Except for its ongoing obligations to disclose material information under the Federal securities laws, the Company undertakes no obligation to release publicly any revisions to any forward-looking statements, to report events or to report the occurrence of unanticipated events. For any forward-looking statements contained in any document, the Company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. This report on Form 10-Q contains forward-looking statements within the meaning of the federal securities laws. These include statements about our expectations, beliefs, intentions or strategies for the future, which we indicate by words or phrases such as "anticipate," "expect," "intend," "plan," "will," "we believe," "Cybrdi believes," "management believes" and similar language. The forward-looking statements are based on the current expectations of Cybrdi and are subject to certain risks, uncertainties and assumptions, including those set forth in the discussion under "Description of Business" and "Management's Discussion and Analysis." The actual results may differ materially from results anticipated in these forward-looking statements. We base the forward-looking statements on information currently available to us, and we assume no obligation to update them.

3


PLAN OF OPERATIONS

Cybrdi is a holding company incorporated with 80% equity in Chaoying Biotech, which is engaged in biotechnology manufacturing, and research and development. Through Chaoying Biotech, Cybrdi controls SD Chaoying, a cultural and Entertainment Company, which is also developing a casino.

Biotechnology Manufacturing, R&D Business

Chaoying Biotech is actively seeking to expand its biotechnology manufacturing business. Tissue chips, also called micro-tissue arrays, represent a newly developed technology which is intended to provide high-throughput molecular profiling and parallel analysis of biological and molecular characteristics for hundreds of pathologically controlled tissue specimens. Tissue arrays can, at times, provide rapid and cost-effective localization and evaluation of proteins, RNA, or DNA molecules, which is particularly useful for functioning genomic studies. Cybrdi manufactures both human and animal tissue micro-array for a wide variety of scientific uses, including drug discovery and development.

We supply US BioMax, Inc., a United States research and development subcontractor for Pfizer, and, through US BioMax, Inc. we provide our products and services to other major biotechnology companies in the U.S. and Europe such as America Nanoarray. We are also a supplier for the China’s National Biomedical Center, Shanghai Biochip Center, a research partner with Peking University Academy of Military Medical Sciences, and perform dermatological research and development for Lancome and Estee Lauder. Since 2010, our sole domestic sales representative in China was Xi’an AiLiNa Biotechnology Co., Ltd., and the only overseas sales representative was US BioMax, Inc. We mainly distribute our products through these two sales representatives, which are controlled by the same individual, an unrelated party.

We are the patent holder and producer of Tissue Microarrays (TMAs) which are a powerful tool to examine disease pathology across a variety of patients and disease conditions. We also hold three patents in antibody detection.

Our manufacturing facility and a pathology and molecule laboratory is located at an approximately 18,000 square foot facility that we own in Shaanxi province. At this facility, we have established the standard tissue chip production, processing procedure and a quality control system. We have also established an electronic management system to effectively manage biologic information databank.

Specifically, our products and services include:

TISSUE MICROARRAYS (“TMA”): TMA technology can survey hundreds or even thousands of clinical specimens in a single experiment utilizing common probes, including DNA, RNA, peptide, protein and antibody probes. This is an efficient, in vivo approach for the validation of gene discoveries and identification of potential molecules for diagnosis and therapy. TMA chips can be broadly applied in both basic and clinical research conducted by the academic, medical, pharmaceutical and biogenetic research communities. We currently offer a wide variety of tissue array products and services on the commercial market, including approximately (at present) 234 different disease and 98 different organ types of both human and animal varieties. These tissues are prepared in a variety of array panels of differing formats and tissue densities to service the full range of scientific research interests. New products are being added on a monthly basis per customer demands.

TECHNICAL SERVICES: Complimenting the production and marketing of tissue chips, we have launched an in-house technical services platform to perform customized research according to customer specifications. By outsourcing experimentation to us, international research labs, (particularly those in high labor and material cost markets) can incur substantial cost savings.

Frequently requested services include the standard immunohisto chemistry (IHC) and in-situ-hybridization (ISH) services needed to locate proteins or genes of interest using customer-supplied probes. These probes are applied to select normal, diseased and marginal tissue from our tissue array bank. The results are presented as publishable, detailed pathology reports including high resolution digital photographs. Through virtual cybernetic bio-services (vCBS), these results can be sent via the Internet to the customer the day after the probe is received by our labs. Our technical services currently serve our Chinese customers.

Our business strategies and focus in the near future include: enhancing R&D in TMAs and technical service; expanding our product portfolio and virtual tissue array data bank (vTMAB); and launching the health diagnosis kit for obesity and skin disease.

4


Culture, Entertainment, and Real Estate Business

Chaoying Biotech owns 83.33% of SD Chaoying, a culture and entertainment company. SD Chaoying is developing a Culture and Entertainment Square in Changle City of Shandong Province on the 33,333 square meter land it owns the right to use. The usage areas of the Square will be approximately 19,145 square meters. With the entertainment facilities of restaurants spas, hotel rooms, movie theaters, cosmetic and personal care salons, body buildup gyms, the Square will become local cultural and entertainment center. The project includes four multi-family residential buildings (about 14,188 square meters), and two of them had been completed. Of 74 total units, 68 units had been sold as of March 30, 2014.

The total cost for the construction is estimated to be $10 million. At present, SD Chaoying has invested approximately $7 million in the construction. We are planning to include a casino but the casino has not yet been completed and we intend to engage another party to operate the casino. We have not yet reached agreement with any operator. Operation of the casino has not yet been approved by the Shandong Administration for Civil Affairs and such approval is required in order to operate the casino, and there can be no assurance we will receive such approval. We believe that the casino will attract patrons from surrounding areas and that the potential for a cultural and entertainment business is enhanced as living standards rise in the region. We anticipate financing the balance of the construction in part from the sale of the residential units. However, there is no assurance that sufficient proceeds will be generated from the sale of the residential units. We believe that the balance of any funding will need to be obtained from affiliated companies or from banks and affiliates. Two units were sold during the three months ended March 31, 2014.

We will also explore other business development opportunities that can leverage our sales platform and relationship with affiliated companies. Until such time as we can identify attractive marketing opportunities, we will loan available cash on a short term unsecured basis to non-affiliated third parties in order to generate interest income.

5


RESULTS OF OPERATIONS

THREE MONTHS ENDED MARCH 31, 2014 AND 2013

Net Revenue

Cybrdi now mainly generates two categories of revenues, including sales of tissue chip & kits products and residential housing. The net sales decreased by $2,366 to $148,786 for the three months ended March 31, 2014 from $151,152 for the three months ended March 31, 2013, a decrease of 2%.

Tissue Chip & Kit Products: Net sales decreased by $83,016 to $68,136 for the three months ended March 31, 2014 as compared to $151,152 for the three months ended March 31, 2013, a decrease of 55%. The decrease in net sales of tissue chip & kit product was primarily due to no export sales during the three months ended March 31, 2014. The sales revenues generated from export sales now are subject to the value added tax (“VAT”) pursuant to PRC tax regulations, which was exempt for export sales in the past. The VAT imposed by PRC tax bureau on export sales is absorbed by the Company without charging to the customers. Currently, our sole domestic sales representative in China is Xi’an AiLiNa Biotechnology Co., Ltd., and the only overseas sales representative is US BioMax, Ltd., a reseller located in the US. We mainly distribute our products through these two sales representatives, which are under common control by a non-affiliated person.

Housing: SD Chaoying completed the construction of the two six-story multi-family residential buildings with a total of 74 housing units in 2009. There were two housing units sold during the three months ended March 31, 2014, and we recognized sales revenue aggregating $80,650; compared to no housing unit sold during the quarter ended March 31, 2013. Since SD Chaoying is required to continue its involvement with the property after the sale, including installations of utility systems, improvements and amenities, and community landscaping, profit from the sale was recognized using the percentage of completion method as required by ASC Topic 360-20, “Property, Plant, and Equipment – Real Estate Sales”.

Commercial rental: In January 2011, SD Chaoying engaged Dongshan Victoria Spring Hotel (“Victoria”), which is controlled by the wife of the General Manager of SD Chaoying, to manage and operate the SPA business at the completed section of the cultural and entertainment facility. SD Chaoying has not charged any fees from Victoria and no written agreement was signed. As a result, no revenue was recognized for the three months ended March 31, 2014 and 2013, respectively. Costs related to operating commercial rentals amounted to $26,299 and $16,696 for the three months ended March 31, 2014 and 2013, respectively.

6


Gross Margin

Gross margin as a percentage of sales are 5% and 24% for the three months ended March 31, 2014 and the three months ended March 31, 2013.

Gross margin of tissue chip & kit products segment decreased from 35% to 0.1% from first quarter of 2013 to first quarter of 2014; because no export sale with higher gross margin during this quarter. Gross margin of housing segment was 42% for the first quarter of 2014; there was no sale and cost incurred for housing segment in first quarter of 2013.

The commercial rental segment has not generated revenue since its commencement, but incurred costs directly associated with the business. As a result, a loss of $26,299 and $16,696 was recorded at the commercial rental segment for the three months ended March 31, 2014 and 2013, respectively.

Operating Expenses

The Company’s operating expenses increased by $61,511 to $227,384 for the three months ended March 31, 2014 from $165,873 for the three months ended March 31, 2013, and increase of 37%. Such increase was mainly attributable to the increase of heating fees incurred in winter and marketing espense.

Other Expense

Net other expenses increased by $3 to $48,239 for the three months ended March 31, 2014, a 0.01% increase, from $48,236 for the three months ended March 31, 2013.

Income Taxes

The Company did not record any U.S. and PRC current income tax for the three months ended March 31, 2014, and 2013, since there was no taxable income during these periods. There was $116 of PRC current income taxes accrued for the three months ended March 31, 2014 in SD Chaoying.

Net Loss

As a result of the above factors, our net loss excluding minority interests increased by $88,298, or 50%, from $178,315 for the three months ended March 31, 2014 to $266,613 for the three months ended March 31, 2013.

7


LIQUIDITY AND CAPITAL RESOURCES

Operating working capital deficit (total current asset deduct total current liabilities) increased by $220,055 from $(4,018,141) as of December 31, 2013 to $(4,238,196) as of March 31, 2014. The Company's cash and cash equivalents increased to $886,570 as of March 31, 2014 from $203,921 as of December 31, 2013, primarily as a result of a decline in other receivables to $127,343 as of March 31, 2014 from $906,450 as of December 31, 2013. The decline in other receivable was attributable to the construction material purchase deposit of $756,065 that was returned to the Company in January, 2014.

For investing activities, the Company incurred net cash outflow during the three months ended March 31, 2014. The primary reason was due to $7,702 used in purchasing property, plant, and equipment and there were payments for construction in progress amounting to $37,970 during the first quarter of 2014.

For financing activities, the Company obtained net proceeds of $96,827, from related parties and shareholders/officers of the Company.

The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred significant losses and has not demonstrated the ability to generate sufficient cash flows from operations to satisfy its liabilities and sustain operations. The Company had an accumulated deficit of $3,758,942 and $3,525,809 as of March 31, 2014 and December 31, 2013, including net losses of $266,613 and $178,315 for the three months ended March 31, 2014 and 2013, respectively. In addition, current liabilities exceeded current assets by $4,238,196 and $4,018,141 as of March 31, 2014 and December 31, 2013, respectively. These matters raise substantial doubt about the Company’s ability to continue as a going concern.

8


The Company finances its operations primarily through short-term bank borrowings and advances from related parties and/or officers/shareholders. In order to complete the construction of SD Chaoying cultural and entertainment center, approximately $3.0 million (equivalent to RMB 19 million) of capital is expected to be needed. The Company, taking into accounts the available banking facilities, internal financial resource, and supports from related companies and affiliates, believes it has sufficient working capital to meet its present obligation for at least the next twelve months. Management is taking actions to address the company's financial condition and deteriorating liquidity position. The following sets forth management’s plans for dealing with the adverse effects of its financial conditions:

(a)

Sale of housing inventories: Proceeds to be received from the sale of the remaining housing of the two completed residential buildings are expected to amount to approximately $0.3 million. However, there is no assurance when such sales will occur.

   
(b)

Rental and management fee revenue from the cultural and entertainment center: Annual rental revenue is estimated to be approximately $0.68 million per year. Management fee revenue will be charged to commercial tenants at 3% of annual gross revenue. As of March 31, 2014, the Company has not commenced collecting rental and management fee revenue for the culture and entertainment center.

The Company will likely require additional funds and may seek to raise such funds through public and private financings or from other sources. There is no assurance that the above management’s plans will be realized or the additional financing will be available at all or that, if available, such financing will be obtainable on terms favorable to the Company or that any additional financing will not be dilutive. The consolidated financial statements do not include any adjustments that might result from the outcome of those uncertainties.

INFLATION

Inflation has not had a material impact on our business.

9


Item 3. Quantitative and Qualitative Disclosures about Market Risk

A smaller reporting company is not required to provide the information required by this Item.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures. Under the supervision and with the participation of our management, including our Chief Executive Officer, Yanbiao Bai, and Principal Financial Officer, Yonghong Ren, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the "Exchange Act")) as of the end of the period covered by this report. Based upon that evaluation, our Chief Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures as of the end of the period covered by this report were effective such that the information required to be disclosed by us in reports filed under the Securities Exchange Act of 1934 is (i) recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms and (ii) accumulated and communicated to our management to allow timely decisions regarding disclosure. A controls system cannot provide absolute assurance, however, that the objectives of the controls system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.

Changes in Internal Control Over Financial Reporting. During the most recent quarter ended March 31, 2014, there has been no change in our internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) under the Exchange Act) ) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

10


PART II. OTHER INFORMATION

Item 1. Legal Proceedings

On June 6, 2000, we received a notice to inform us that we may have a potential liability from waste disposal in the Casmalia Disposal Site at Santa Barbara County, California. We were given a choice of either signing an agreement that would toll the statute of limitations for eighteen (18) months in order to allow us to resolve any liability with the government without incurring costs associated with being named a defendant in a lawsuit, or becoming an immediate defendant in a lawsuit. We signed the tolling agreement. On November 20, 2001, the tolling agreement was extended for an additional 18 months. On May 20, 2003 the tolling agreement was again extended for an additional 18 months and on November 24, 2004 the tolling agreement was again extended for additional 18 months. On June 29, 2004, we received a proposed settlement from the EPA in the amount of $21,131, which had been accrued as other payable. We are waiting for communication from the government concerning payment of the final settlement. As of March 31, 2014, the Company had not received further correspondences from the EPA regarding this matter.

Other than stated above, there are no material pending legal proceedings to which the Registrant is a party or as to which any of its property is subject, and no such proceedings are known to the Registrant to be threatened or contemplated against it.

Item 1A. Risk Factors

A smaller reporting company is not required to provide the information required by this Item.

11


Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures

Not Applicable

Item 5. Other Information

None

12


Item 6. Exhibits

Exhibit Description
Number  
31.1 Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2 Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1 Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2 Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

XBRL Exhibit

101.INS† XBRL Instance Document.
101.SCH† XBRL Taxonomy Extension Schema Document.
101.CAL† XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF† XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB† XBRL Taxonomy Extension Label Linkbase Document.
101.PRE† XBRL Taxonomy Extension Presentation Linkbase Document.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

CYBRDI, INC.

DATE: May    , 2014 By /s/ Yanbiao Bai                                                
  Yanbiao Bai, Chief Executive Officer and president
   
  By /s/ Yonghong Ren                               
  Yonghong Ren, Principal Financial Officer

13


EX-31.1 2 exhibit31-1.htm EXHIBIT 31.1 Cybrdi, Inc.: Exhibit 31.1 - Filed by newsfilecorp.com

     EXHIBIT 31.1

OFFICER'S CERTIFICATION PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT

I, YanBiao Bai, certify that:

1. I have reviewed this quarterly report on Form 10-Q for the quarter ended March 31, 2014 of Cybrdi, Inc.

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this report.

4. The issuer' s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the issuer and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the issuer's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the issuer's internal control over financial reporting that occurred during the issuer's most recent fiscal quarter (the issuer's fourth fiscal quarter in the case of an annual report)that has materially affected, or is reasonably likely to materially affect, the issuer's internal control over financial reporting; and

5. The issuer's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the issuer's auditors and the audit committee of the issuer's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the issuer's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the issuer's internal control over financial reporting.

Date: May , 2014

By: /s/ YanBiao Bai               
YanBiao Bai
Chief Executive Officer


EX-31.2 3 exhibit31-2.htm EXHIBIT 31.2 Cybrdi, Inc.: Exhibit 31.2 - Filed by newsfilecorp.com

EXHIBIT 31.2

OFFICER'S CERTIFICATION PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT

I, Yongong Ren, certify that:

1. I have reviewed this quarterly report on Form 10-Q for the quarter ended March 31, 2014 of Cybrdi, Inc.

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this report.

4. The issuer' s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the issuer and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the issuer's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the issuer's internal control over financial reporting that occurred during the issuer's most recent fiscal quarter (the issuer's fourth fiscal quarter in the case of an annual report)that has materially affected, or is reasonably likely to materially affect, the issuer's internal control over financial reporting; and

5. The issuer's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the issuer's auditors and the audit committee of the issuer's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the issuer's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the issuer's internal control over financial reporting.

Date: May , 2014

By: /s/ Yongong Ren           
Yongong Ren
Treasurer and COO


EX-32.1 4 exhibit32-1.htm EXHIBIT 32.1 Cybrdi, Inc.: Exhibit 32.1 - Filed by newsfilecorp.com

     EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Cybrdi, Inc. (the "Company") on Form 10-Q for the period ended March 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906of the Sarbanes-Oxley Act of 2002, that to his knowledge:

1. The Report fully complies with the requirements of Section 13(a) or15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company for the three months and nine months ended March 31, 2014.

3. A signed original of this written statement required by Section 906has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

Date: May , 2014

By: /s/ YANBIAO BAI                    
YanBiao Bai
Chief Executive Officer


EX-32.2 5 exhibit32-2.htm EXHIBIT 32.2 Cybrdi, Inc.: Exhibit 32.2 - Filed by newsfilecorp.com

     EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Cybrdi, Inc. (the "Company") on Form 10-Q for the period ended March 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906of the Sarbanes-Oxley Act of 2002, that to his knowledge:

1. The Report fully complies with the requirements of Section 13(a) or15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company for the three months and nine months ended March 31, 2014.

3. A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

Date: May , 2014
  By: /s/ Yongong Ren                                   
  Yongong Ren
  Treasurer and COO


EX-101.INS 6 cydi-20140331.xml XBRL INSTANCE FILE --12-31 cydi Cybrdi, Inc. 2014-03-31 0000019002 No Smaller Reporting Company No 10-Q false 120225323 Yes 2014 Q1 0000019002 2014-05-09 0000019002 2014-01-01 2014-03-31 0000019002 2014-03-31 0000019002 2013-12-31 0000019002 2013-01-01 2013-03-31 0000019002 2012-12-31 0000019002 2013-03-31 shares iso4217:USD iso4217:USD shares pure utr:Y iso4217:CNY 886570 203921 50235 6409 797775 848525 127343 906459 3 4536 1861926 1969850 1090546 1144781 6535811 6609918 616382 628193 10104665 10352742 1447783 1308858 31402 11903 865286 810331 130575 126128 157971 165066 3015609 2963494 10421 10598 441075 591613 6100122 5987991 369989 376297 6470111 6364288 0 0 4313614 4313614 172308 172308 336885 336885 -3758942 -3525809 1586167 1656723 2650032 2953721 984522 1034733 3634554 3988454 10104665 10352742 1.00 1.00 500000 500000 0 0 0 0 150000000 150000000 120225323 120225323 120225323 120225323 80650 0 0 0 68136 151152 148786 151152 47145 0 26299 16696 68070 98520 141514 115216 7272 35936 50988 53913 11422 33445 0 6630 38575 40107 2861 4186 123538 27592 227384 165873 -220112 -129937 -47472 -46188 -767 -2048 -48239 -48236 -268351 -178173 -1738 142 -266613 -178315 -33480 -31493 -233133 -146822 -70556 -37094 -303689 -183916 0.00 0.00 120225323 120225323 44707 55881 44753 15067 -37206 -4262 -782725 -6552 96421 92845 6683 0 -4409 24307 651967 -2905 4249 0 7702 7601 37970 279 -49921 -7880 78950 10668 17877 8998 96827 19666 698873 8881 -16224 15074 956235 980190 39328 45799 113 153 <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <strong>NOTE A - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <strong>1. Interim Financial Statements</strong></p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> The unaudited consolidated financial statements of Cybrdi Inc. and subsidiaries have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and pursuant to the requirements for reporting on Form 10-Q. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. However, the information included in these interim financial statements reflects all adjustments (consisting solely of normal recurring adjustments) which are, in the opinion of management, necessary for the fair presentation of the consolidated financial position and the consolidated results of operations. Results shown for interim periods are not necessarily indicative of the results to be obtained for a full year. The consolidated balance sheet information as of December 31, 2013 was derived from the audited consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K. These interim financial statements should be read in conjunction with that report. Certain comparative amounts have been reclassified to conform to the current period's presentation.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> The consolidated financial statements include the accounts of Cybrdi, Inc. and its wholly-owned subsidiaries and joint ventures. All material intercompany balances and transactions have been eliminated.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <strong>2. Description of Business</strong></p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> Cybrdi, Inc. was incorporated on August 1, 1966, under the laws of the State of California. From then to approximately June 2004, we conducted business in the distribution of magnetic media products, primarily blank audio and video cassettes. Due to continuing intense price competition and technological changes in the marketplace for its products, the Company lost its remaining significant customers and disposed of or wrote off its remaining inventory. As a result of these occurrences, the Company concluded that its audio and videotape businesses were no longer viable and some of its product lines were obsolete.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> In November 2004, we acquired all of the ownership interests in Cybrdi, Inc., a privately held company incorporated in the State of Maryland (&quot;Cybrdi Maryland&quot;). For financial statement reporting purposes, the transaction was treated as a reverse acquisition, with Cybrdi Maryland deemed the accounting acquirer and Certron Corporation deemed the accounting acquiree. Historical information of the surviving company is that of Cybrdi Maryland.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> Cybrdi Maryland was established in 2001 to acquire an interest in biogenetic products commercialization and related services entities in Asia. On March 5, 2003, Cybrdi Maryland acquired an 80% interest in Shaanxi Chao Ying Biotechnology Co., Ltd. (&#8220;Chaoying Biotech&#8221;), a sino-foreign equity joint venture established in July 2000 in the People's Republic of China (&#8220;PRC&#8221;), through the exchange of 99% of shares to the existing shareholders of Chaoying Biotech. For financial statement reporting purposes, the merger was treated as a reverse acquisition, with Chaoying Biotech deemed the accounting acquirer and Cybrdi Maryland deemed the accounting acquiree.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> Chaoying Biotech is a sino-foreign equity joint venture between Shaanxi Chaoying Beauty &amp; Cosmetics Group Co., Ltd. (the &#8220;Chinese Partner&#8221;, a PRC corporation) and Immuno-Onco Genomics Inc. (the &#8220;Foreign Partner&#8221;, a USA corporation). The joint venture agreement has a 15 year operating period starting from its formation in July 2000 and it may be extended upon mutual consent. The principal activities of Chaoying Biotech are research, manufacture and sale of various high-quality tissue arrays and the related services in the PRC.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> Most of the Company&#8217;s activities are conducted through Chaoying Biotech, of which it owns 80% interest.&nbsp; Chaoying Biotech, with its principal operations located in China, aims to take advantage of China's abundant scientific talent, low wage rates, less stringent biogenetic regulation, and the huge genetic population as it introduces its growing list of tissue micro array products.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> On February 10, 2005, the Company completed the merger with Cybrdi Maryland and changed its name to Cybrdi, Inc.On July 26, 2007, Chaoying Biotech entered into an acquisition agreement with the Chinese partner to acquire 83.33% equity ownership of Shandong Chaoying Culture and Entertainment Co., Ltd (&#8220;SD Chaoying&#8221;) from the Chinese partner for RMB15 million. The Chinese partner is a principal shareholder of the Company and Mr. Bai, the Company&#8217;s chief executive officer, chairman and a principal shareholder, is also a principal of the Chinese partner. SD Chaoying is a corporation organized in the Shandong province of P.R.China. On September 5, 2007, Shandong MOFCOM approved this acquisition and ownership of SD Chaoying was transferred to Chaoying Biotech from the Chinese Partner.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> The business of SD Chaoying will primarily focus on culture and entertainment, including make-up, personal care, health club, gambling, saunas for massage and bath, karaoke, catering, and lodging. The Company plans for SD Chaoying to have a specific emphasis on casino gambling, but such operations have not been approved by Shandong Administration for Civil Affairs. At the end of 2010, SD Chaoying had substantially completed the construction of two residential buildings and had recognized revenue from sales of housing units from these buildings for 2010. The main structure of the commercial entertainment center has also been completed, with the exterior, rooftop, the surrounding supporting projects and the community landscaping yet to be completed, but which are expected to be completed in 2014 prior to the commencement of operations by merchant tenants if we can obtain an estimated $3.0 million to complete construction. In January 2011, SD Chaoying engaged Dongshan Victoria Spring Hotel (&#8220;Victoria&#8221;), which is controlled by the wife of the General Manager of SD Chaoying, to manage and operate the SPA business at the completed section of the cultural and entertainment facility. SD Chaoying has not charged any fees from Victoria and no written agreement was signed. As of March 31, 2014, the Company has not commenced collecting rental and management fee revenue for the culture and entertainment center.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> On April 29, 2011, Chaoying Biotech invested $154,732 (equivalent to RMB1 million) to restore the operation of the Institute of Shaanxi Chaoying Clinical Pathology (&#8220;IOSCCP&#8221;), a wholly-owned subsidiary established on July 31, 2003, whose main business includes pathology research and consulting, diagnostic clinical pathology and pathology-related research and development of new technologies, and basic training in pathology. Chaoying Biotech has been its sole shareholder.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <strong>3. Going Concern</strong></p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred significant losses and has not demonstrated the ability to generate sufficient cash flows from operations to satisfy its liabilities and sustain operations. The Company had an accumulated deficit of $3,758,942 and $3,525,809 as of March 31, 2014 and December 31, 2013, including net losses of $266,613 and $178,315 for the three months ended March 31, 2014 and 2013, respectively. In addition, current liabilities exceeded current assets by $4,238,196 and $4,018,141 at March 31, 2014 and December 31, 2013, respectively. These matters raise substantial doubt about the Company&#8217;s ability to continue as a going concern.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> The Company finances its operations primarily through short-term bank borrowings and advances from related parties and/or officers/shareholders. In order to complete the construction of SD Chaoying cultural and entertainment center, approximately $3.0 million (equivalent to RMB19 million) of capital is needed. The Company, taking into account the available banking facilities, internal financial resource, and support from related companies, believes it has sufficient working capital to meet its present obligation for at least the next twelve months. Management is taking actions to address the company's financial condition and deteriorating liquidity position. The following sets forth management&#8217;s plans for dealing with the adverse effects of the conditions:</p> <table border="0" cellpadding="0" cellspacing="0" style="font-family: times new roman,times,serif; font-size: 10pt;" width="100%"> <tr> <td valign="top" width="5%"> <font style="font-size: 10pt;"><font style="font-family: times new roman,times,serif;">(a)</font> </font></td> <td> <font style="font-size: 10pt;"><font style="font-family: times new roman,times,serif;">Sale of housing inventories: Proceeds to be received from the sale of the remaining housing of the two completed residential buildings are expected to amount to approximately $0.3 million. However, there is no assurance when such sales will occur. </font> </font></td> </tr> <tr> <td width="5%"> &nbsp;</td> <td> &nbsp;</td> </tr> <tr> <td valign="top" width="5%"> <font style="font-size: 10pt;"><font style="font-family: times new roman,times,serif;">(b)</font> </font></td> <td> <font style="font-size: 10pt;"><font style="font-family: times new roman,times,serif;">Rental and management fee revenue from the cultural and entertainment center: Annual rental revenue is estimated to be approximately $0.68 million per year. Management fee revenue will be charged to commercial tenants at 3% of annual gross revenue. As of March 31, 2014, the Company has not commenced collecting rental and management fee revenue for the culture and entertainment center. </font> </font></td> </tr> </table> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> As of March 31, 2014, the Company has not commenced collecting rental and management fee revenue for the culture and entertainment center.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> The Company may require additional funds and may seek to raise such funds through public and private financings or from other sources. There is no assurance that the above management&#8217;s plans will be realized or the additional financing will be available or that, if available, such financing will be obtainable on terms favorable to the Company or that any additional financing will not be dilutive. The consolidated financial statements do not include any adjustments that might result from the outcome of those uncertainties.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <strong>4. Use of Estimates:</strong></p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <strong>5. Revenue Recognition</strong></p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> Revenue represents the invoiced value of goods sold recognized upon the delivery of goods to customers and service income is recognized when services are provided. Deferred revenue represents the undelivered portion of invoiced value of goods sold to customers. Sales transactions not meeting all the conditions of the full accrual method are accounted for using the deposit method of accounting. Under the deposit method, all costs are capitalized as incurred, and payments received from the buyer are recorded as customer deposits.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <strong>6. Reverse Merger</strong></p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> On February 10, 2005, (the &quot;Closing Date&quot;) the Company closed on an Agreement and Plan of Merger (the &quot;Agreement&quot;) among Certron Corporation (&#8220;Certron&#8221;), a California corporation, Certron Acquisition Corp., a Maryland corporation and a wholly-owned subsidiary of Certron (&quot;Acquisition Sub&quot;), and Cybrdi, Inc., a Maryland corporation (&#8220;Cybrdi &#8211; Maryland&#8221;) relating to the acquisition by Certron of all of the issued and outstanding capital stock of Cybrdi -Maryland in exchange for shares of common stock of Certron that will aggregate approximately 93.8% of the issued and outstanding common stock of Certron. Pursuant to the terms of the Agreement, at the Closing Date (a) Acquisition Sub has been merged with and into Cybrdi - Maryland, with Cybrdi -Maryland being the surviving corporation, (b) the common stock of Cybrdi-Maryland has been cancelled and converted into the right to receive shares of the common stock of Certron at an exchange ratio of 1.566641609 per share. This resulted in the issuance of 47,328,263 shares of the Carton&#8217;s common stock, and (c) each share of the common stock of Acquisition Sub has been converted in to and become one share of the common stock of Cybrdi-Maryland. The share exchange has been accounted for as a reverse merger under the purchase method of accounting. Accordingly, Cybrdi, Inc. will be treated as the continuing entity for accounting purposes and the historical financial statements presented will be those of Cybrdi, Inc.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> In connection with the Agreement, on February 10, 2005, the Company amended its articles of incorporation to authorize the issuance of 150 million shares of common stock no par value and 500,000 shares of preferred stock, $1.00 par value per share, none of which are issued or outstanding.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> Concurrent with the filing of the Articles of Merger, all of the Company then existing officers and directors tendered their resignation and Yanbiao Bai was appointed as its Chairman of the Board of Directors. Mr. Bai then nominated the balance of the Board of Directors.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <strong>7. Income Taxes</strong></p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due plus deferred taxes related primarily to the differences between the basis of assets and liabilities for financial and income tax reporting. The deferred tax assets and liabilities represent the future tax return consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes also are recognized for operating losses that are available to offset future income taxes.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <strong>8. Recent Accounting Pronouncements</strong></p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> The Company has adopted all recently issued accounting pronouncements. The adoption of the accounting pronouncements, including those not yet effective, is not anticipated to have a material effect on the financial position or results of operations of the Company.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <strong>1. Interim Financial Statements</strong> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">The unaudited consolidated financial statements of Cybrdi Inc. and subsidiaries have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and pursuant to the requirements for reporting on Form 10-Q. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. However, the information included in these interim financial statements reflects all adjustments (consisting solely of normal recurring adjustments) which are, in the opinion of management, necessary for the fair presentation of the consolidated financial position and the consolidated results of operations. Results shown for interim periods are not necessarily indicative of the results to be obtained for a full year. The consolidated balance sheet information as of December 31, 2013 was derived from the audited consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K. These interim financial statements should be read in conjunction with that report. Certain comparative amounts have been reclassified to conform to the current period's presentation.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">The consolidated financial statements include the accounts of Cybrdi, Inc. and its wholly-owned subsidiaries and joint ventures. All material intercompany balances and transactions have been eliminated.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <strong>2. Description of Business</strong> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">Cybrdi, Inc. was incorporated on August 1, 1966, under the laws of the State of California. From then to approximately June 2004, we conducted business in the distribution of magnetic media products, primarily blank audio and video cassettes. Due to continuing intense price competition and technological changes in the marketplace for its products, the Company lost its remaining significant customers and disposed of or wrote off its remaining inventory. As a result of these occurrences, the Company concluded that its audio and videotape businesses were no longer viable and some of its product lines were obsolete.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">In November 2004, we acquired all of the ownership interests in Cybrdi, Inc., a privately held company incorporated in the State of Maryland ("Cybrdi Maryland"). For financial statement reporting purposes, the transaction was treated as a reverse acquisition, with Cybrdi Maryland deemed the accounting acquirer and Certron Corporation deemed the accounting acquiree. Historical information of the surviving company is that of Cybrdi Maryland.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> Cybrdi Maryland was established in 2001 to acquire an interest in biogenetic products commercialization and related services entities in Asia. On March 5, 2003, Cybrdi Maryland acquired an 80% interest in Shaanxi Chao Ying Biotechnology Co., Ltd. (&#8220;Chaoying Biotech&#8221;), a sino-foreign equity joint venture established in July 2000 in the People's Republic of China (&#8220;PRC&#8221;), through the exchange of 99% of shares to the existing shareholders of Chaoying Biotech. For financial statement reporting purposes, the merger was treated as a reverse acquisition, with Chaoying Biotech deemed the accounting acquirer and Cybrdi Maryland deemed the accounting acquiree. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> Chaoying Biotech is a sino-foreign equity joint venture between Shaanxi Chaoying Beauty &amp; Cosmetics Group Co., Ltd. (the &#8220;Chinese Partner&#8221;, a PRC corporation) and Immuno-Onco Genomics Inc. (the &#8220;Foreign Partner&#8221;, a USA corporation). The joint venture agreement has a 15 year operating period starting from its formation in July 2000 and it may be extended upon mutual consent. The principal activities of Chaoying Biotech are research, manufacture and sale of various high-quality tissue arrays and the related services in the PRC. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> Most of the Company&#8217;s activities are conducted through Chaoying Biotech, of which it owns 80% interest.&#160; Chaoying Biotech, with its principal operations located in China, aims to take advantage of China's abundant scientific talent, low wage rates, less stringent biogenetic regulation, and the huge genetic population as it introduces its growing list of tissue micro array products. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> On February 10, 2005, the Company completed the merger with Cybrdi Maryland and changed its name to Cybrdi, Inc.On July 26, 2007, Chaoying Biotech entered into an acquisition agreement with the Chinese partner to acquire 83.33% equity ownership of Shandong Chaoying Culture and Entertainment Co., Ltd (&#8220;SD Chaoying&#8221;) from the Chinese partner for RMB15 million. The Chinese partner is a principal shareholder of the Company and Mr. Bai, the Company&#8217;s chief executive officer, chairman and a principal shareholder, is also a principal of the Chinese partner. SD Chaoying is a corporation organized in the Shandong province of P.R.China. On September 5, 2007, Shandong MOFCOM approved this acquisition and ownership of SD Chaoying was transferred to Chaoying Biotech from the Chinese Partner. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> The business of SD Chaoying will primarily focus on culture and entertainment, including make-up, personal care, health club, gambling, saunas for massage and bath, karaoke, catering, and lodging. The Company plans for SD Chaoying to have a specific emphasis on casino gambling, but such operations have not been approved by Shandong Administration for Civil Affairs. At the end of 2010, SD Chaoying had substantially completed the construction of two residential buildings and had recognized revenue from sales of housing units from these buildings for 2010. The main structure of the commercial entertainment center has also been completed, with the exterior, rooftop, the surrounding supporting projects and the community landscaping yet to be completed, but which are expected to be completed in 2014 prior to the commencement of operations by merchant tenants if we can obtain an estimated $3.0 million to complete construction. In January 2011, SD Chaoying engaged Dongshan Victoria Spring Hotel (&#8220;Victoria&#8221;), which is controlled by the wife of the General Manager of SD Chaoying, to manage and operate the SPA business at the completed section of the cultural and entertainment facility. SD Chaoying has not charged any fees from Victoria and no written agreement was signed. As of March 31, 2014, the Company has not commenced collecting rental and management fee revenue for the culture and entertainment center. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> On April 29, 2011, Chaoying Biotech invested $154,732 (equivalent to RMB1 million) to restore the operation of the Institute of Shaanxi Chaoying Clinical Pathology (&#8220;IOSCCP&#8221;), a wholly-owned subsidiary established on July 31, 2003, whose main business includes pathology research and consulting, diagnostic clinical pathology and pathology-related research and development of new technologies, and basic training in pathology. Chaoying Biotech has been its sole shareholder. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <strong>3. Going Concern</strong> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred significant losses and has not demonstrated the ability to generate sufficient cash flows from operations to satisfy its liabilities and sustain operations. The Company had an accumulated deficit of $3,758,942 and $3,525,809 as of March 31, 2014 and December 31, 2013, including net losses of $266,613 and $178,315 for the three months ended March 31, 2014 and 2013, respectively. In addition, current liabilities exceeded current assets by $4,238,196 and $4,018,141 at March 31, 2014 and December 31, 2013, respectively. These matters raise substantial doubt about the Company&#8217;s ability to continue as a going concern. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> The Company finances its operations primarily through short-term bank borrowings and advances from related parties and/or officers/shareholders. In order to complete the construction of SD Chaoying cultural and entertainment center, approximately $3.0 million (equivalent to RMB19 million) of capital is needed. The Company, taking into account the available banking facilities, internal financial resource, and support from related companies, believes it has sufficient working capital to meet its present obligation for at least the next twelve months. Management is taking actions to address the company's financial condition and deteriorating liquidity position. The following sets forth management&#8217;s plans for dealing with the adverse effects of the conditions: </p> <table border="0" cellpadding="0" cellspacing="0" style="font-family: times new roman,times,serif; font-size: 10pt;" width="100%"> <tr> <td valign="top" width="5%"> <font style="font-size: 10pt;"> <font style="font-family: times new roman,times,serif;">(a)</font> </font> </td> <td> <font style="font-size: 10pt;"> <font style="font-family: times new roman,times,serif;"> Sale of housing inventories: Proceeds to be received from the sale of the remaining housing of the two completed residential buildings are expected to amount to approximately $0.3 million. However, there is no assurance when such sales will occur. </font> </font> </td> </tr> <tr> <td width="5%">&#160;</td> <td>&#160;</td> </tr> <tr> <td valign="top" width="5%"> <font style="font-size: 10pt;"> <font style="font-family: times new roman,times,serif;">(b)</font> </font> </td> <td> <font style="font-size: 10pt;"> <font style="font-family: times new roman,times,serif;"> Rental and management fee revenue from the cultural and entertainment center: Annual rental revenue is estimated to be approximately $0.68 million per year. Management fee revenue will be charged to commercial tenants at 3% of annual gross revenue. As of March 31, 2014, the Company has not commenced collecting rental and management fee revenue for the culture and entertainment center. </font> </font> </td> </tr> </table> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">As of March 31, 2014, the Company has not commenced collecting rental and management fee revenue for the culture and entertainment center.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">The Company may require additional funds and may seek to raise such funds through public and private financings or from other sources. There is no assurance that the above management&#8217;s plans will be realized or the additional financing will be available or that, if available, such financing will be obtainable on terms favorable to the Company or that any additional financing will not be dilutive. The consolidated financial statements do not include any adjustments that might result from the outcome of those uncertainties.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <strong>4. Use of Estimates:</strong> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <strong>5. Revenue Recognition</strong> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">Revenue represents the invoiced value of goods sold recognized upon the delivery of goods to customers and service income is recognized when services are provided. Deferred revenue represents the undelivered portion of invoiced value of goods sold to customers. Sales transactions not meeting all the conditions of the full accrual method are accounted for using the deposit method of accounting. Under the deposit method, all costs are capitalized as incurred, and payments received from the buyer are recorded as customer deposits.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <strong>6. Reverse Merger</strong> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> On February 10, 2005, (the "Closing Date") the Company closed on an Agreement and Plan of Merger (the "Agreement") among Certron Corporation (&#8220;Certron&#8221;), a California corporation, Certron Acquisition Corp., a Maryland corporation and a wholly-owned subsidiary of Certron ("Acquisition Sub"), and Cybrdi, Inc., a Maryland corporation (&#8220;Cybrdi &#8211; Maryland&#8221;) relating to the acquisition by Certron of all of the issued and outstanding capital stock of Cybrdi -Maryland in exchange for shares of common stock of Certron that will aggregate approximately 93.8% of the issued and outstanding common stock of Certron. Pursuant to the terms of the Agreement, at the Closing Date (a) Acquisition Sub has been merged with and into Cybrdi - Maryland, with Cybrdi -Maryland being the surviving corporation, (b) the common stock of Cybrdi-Maryland has been cancelled and converted into the right to receive shares of the common stock of Certron at an exchange ratio of 1.566641609 per share. This resulted in the issuance of 47,328,263 shares of the Carton&#8217;s common stock, and (c) each share of the common stock of Acquisition Sub has been converted in to and become one share of the common stock of Cybrdi-Maryland. The share exchange has been accounted for as a reverse merger under the purchase method of accounting. Accordingly, Cybrdi, Inc. will be treated as the continuing entity for accounting purposes and the historical financial statements presented will be those of Cybrdi, Inc. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> In connection with the Agreement, on February 10, 2005, the Company amended its articles of incorporation to authorize the issuance of 150 million shares of common stock no par value and 500,000 shares of preferred stock, $1.00 par value per share, none of which are issued or outstanding. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">Concurrent with the filing of the Articles of Merger, all of the Company then existing officers and directors tendered their resignation and Yanbiao Bai was appointed as its Chairman of the Board of Directors. Mr. Bai then nominated the balance of the Board of Directors.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <strong>7. Income Taxes</strong> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due plus deferred taxes related primarily to the differences between the basis of assets and liabilities for financial and income tax reporting. The deferred tax assets and liabilities represent the future tax return consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes also are recognized for operating losses that are available to offset future income taxes.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <strong>8. Recent Accounting Pronouncements</strong> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">The Company has adopted all recently issued accounting pronouncements. The adoption of the accounting pronouncements, including those not yet effective, is not anticipated to have a material effect on the financial position or results of operations of the Company.</p> 0.80 0.99 15 0.80 0.8333 15000000 3000000 154732 1000000 3758942 3525809 266613 178315 4238196 4018141 3000000 19000000 300000 680000 0.03 0.938 1.566641609 47328263 150000000 500000 1.00 <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <strong>NOTE B &#8211; ASSETS</strong> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> The March 31, 2014 consolidated balance sheet included total current assets of $1,861,926 and non-current assets of $8,242,739. Of these amounts, $886,570 in cash and equivalents is planned for funding current operations and for future business expansion. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">Current assets also included accounts receivable, inventories, other receivables and prepaid expenses, and advance to suppliers. Inventories are mainly finished goods. Other components of inventories include raw materials and housing inventories. Inventories are stated at the lower of cost or market. Cost of raw materials is determined on the basis of first in first out method (&#8220;FIFO&#8221;). Finished goods are determined on the weighted average basis and are comprised of direct materials, direct labor, and an appropriate proportion of overhead.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> Included in non-current assets are property, plant and equipment, construction-in-progress and intangible assets. Property, plant and equipment mainly consist of building, office equipment, motor vehicles, leasehold improvement and machinery used for product manufacturing located in the People&#8217;s Republic of China (&#8220;PRC&#8221;). Depreciation on property, plant and equipment is computed using the straight-line method over the estimated useful life of the assets. The majority of the assets have estimated useful lives of 10 years. Building and office equipment have estimated useful lives of 20 and 5 years, respectively. The &#8220;construction in progress&#8221; in the amount of $6,535,811 mainly consisted of land under development and construction of the entertainment, culture, and casino facility in Shandong Province, which will be transferred to fixed assets in SD Chaoying when construction is completed. For the $3.22 million land use rights, $2.5 million was classified under construction-in-progress for the commercial property and the remaining $0.62 million was classified under intangible assets subject to amortization. Intangible assets included a tissue chip patent at Chaoying Biotech and $0.62 million of land use rights being put in operation for the partial completed commercial property at SD Chaoying. Effective January 1, 2002, with the adoption of the accounting guidance for Goodwill and Other Intangible Assets, intangible assets with a definite life are amortized on a straight-line basis. The patent expired on April 30, 2013, which was amortized over its estimated life of 10 years. The land use rights classified in intangible asset is being amortized over its estimated life of 36.9 years through the maturity of the land use rights for commercial use on November 6, 2047. </p> 1861926 8242739 886570 10 20 5 6535811 3220000 2500000 620000 620000 10 36.9 <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <strong>NOTE C &#8211; LIABILITIES</strong> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> As of March 31, 2014, the balance sheet included total liabilities of $6,470,111, which consisted of current liabilities of $6,100,122 and construction payable of $369,989. Included in the current liabilities was a short-term loan of $160,865 (equivalent to RMB1.0 million) from Mr. Fengguo Liu, an unrelated party. The short-term loan is due on January 15, 2015 with an interest rate at 2% per month. Also included in the current liabilities was $3,015,609 of loans from related companies, including Xi&#8217;an Yanfeng Biotechnology Co., Ltd., Shaanxi Yanfeng Real Estate Co. Ltd, Shaanxi Chaoying Beauty &amp; Cosmetics Group Co., Ltd and the stockholders who are also the Company&amp;#8217;s officers. These entities were related to the Company through common ownership and principal officers. These loans are non-interest bearing and have no set repayment terms. </p> 6470111 6100122 369989 160865 1000000 0.02 3015609 <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <strong>NOTE D &#8211; STOCKHOLDERS&#8217; EQUITY</strong> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> As a result of the reverse merger (see Note A item 6), the common stock of Cybrdi-Maryland has been cancelled and converted into shares of common stock of Certron at an exchange ratio of 1.566641609 per share. This resulted in the issuance of 47,328,263 shares of Carton&#8217;s common stock to the Cybrdi shareholders. As of March 31, 2014 and December 31, 2013, the Company had 120,225,323 shares issued and outstanding, respectively. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> As of March 31, 2014, the balance sheet included total equity of $3,634,554, of which $984,522 was for non-controlling interest, representing 20% minority interest in Chaoying Biotech and 16.67% minority interest in SD Chaoying. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> As of March 31, 2013, the balance sheet included total equity of $3,988,454, of which $1,034,733 was for non-controlling interest, representing 20% minority interest in Chaoying Biotech and 16.67% minority interest in SD Chaoying. </p> 1.566641609 47328263 120225323 3634554 984522 0.20 0.1667 3988454 1034733 0.20 0.1667 <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <strong>NOTE E &#8211; INCOME TAXES</strong> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> Under the Enterprise Income Tax (&#8220;EIT&#8221;) of the PRC, prior to 2007, Chinese enterprises are generally subject to an income tax at an effective rate of 33% ( 30% statutory income taxes plus 3% local income taxes) on income reported in the statutory financial statements after appropriate tax adjustments, unless the enterprise is located in a specially designated region for which more favorable effective tax rates are applicable. Beginning on January 1, 2008, the new EIT law has replaced the existing laws for Domestic Enterprises (&#8220;DEs&#8221;) and Foreign Invested Enterprises (&#8220;FIEs&#8221;). The new standard EIT rate of 25% will replace the 33% rate previously applicable to both DES and FIEs. The two year tax exemption, six year 50% tax reduction and tax holiday for production-oriented FIEs will be eliminated. According to the Western Developing Plan implemented by the PRC Government, Chaoying Biotech is entitled to a 50% reduction in EIT of preferential policy, but not less than 15%. As a result, Chaoying Biotech&#8217;s effective EIT tax rate has been 15% since 2008. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> The Company&#8217;s income tax expense includes U.S. and PRC income taxes. There were no U.S. current taxes for the three months ended March 31, 2014 according to net loss incurred in the U.S. entity, which will not be anticipated to have any tax benefit in the future since no revenue is expected to be generated in the U.S as a result of discontinuing the U.S. operating company in Maryland in October 2007. There were $116 and $0 of PRC current income taxes accrued for the three months ended March 31, 2014 in SD Chaoying and Chaoying Biotech, respectively. </p> 0.33 0.30 0.03 0.25 0.33 0.50 0.50 0.15 0.15 116 0 <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <strong>NOTE F &#8211; CONTINGENCIES AND LITIGATION LIABILITIES</strong> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">During the three months ended March 31, 2014, there were no material developments in any previously reported litigation.</p> EX-101.SCH 7 cydi-20140331.xsd XBRL SCHEMA FILE 101 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 102 - Statement - CONSOLIDATED BALANCE SHEETS link:calculationLink link:presentationLink link:definitionLink 103 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 104 - Statement - CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME link:calculationLink link:presentationLink link:definitionLink 105 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:calculationLink link:presentationLink link:definitionLink 106 - Disclosure - ORGANIZATION AND PRINCIPAL ACTIVITIES link:calculationLink link:presentationLink link:definitionLink 107 - Disclosure - BASIS OF PRESENTATION link:calculationLink link:presentationLink link:definitionLink 108 - Disclosure - GOING CONCERN link:calculationLink link:presentationLink link:definitionLink 109 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:calculationLink link:presentationLink link:definitionLink 110 - Disclosure - ASSETS link:calculationLink link:presentationLink link:definitionLink 111 - Disclosure - LIABILITIES link:calculationLink link:presentationLink link:definitionLink 112 - Disclosure - STOCKHOLDERS EQUITY link:calculationLink link:presentationLink link:definitionLink 113 - Disclosure - INVENTORIES link:calculationLink link:presentationLink link:definitionLink 114 - Disclosure - OTHER RECEIVABLE, NET AND PREPAID EXPENSE link:calculationLink link:presentationLink link:definitionLink 115 - Disclosure - PROPERTY, PLANT AND EQUIPMENT link:calculationLink link:presentationLink link:definitionLink 116 - Disclosure - CONSTRUCTION IN PROGRESS link:calculationLink link:presentationLink link:definitionLink 117 - Disclosure - INTANGIBLE ASSETS, NET link:calculationLink link:presentationLink link:definitionLink 118 - Disclosure - ADVANCE FROM CUSTOMER link:calculationLink link:presentationLink link:definitionLink 119 - Disclosure - SHORT-TERM LOAN link:calculationLink link:presentationLink link:definitionLink 120 - Disclosure - RELATED PARTY TRANSACTIONS link:calculationLink link:presentationLink link:definitionLink 121 - Disclosure - COMMITMENTS, CONTINGENCIES, AND LEGAL PROCEEDINGS link:calculationLink link:presentationLink link:definitionLink 122 - Disclosure - RESERVE FUNDS link:calculationLink link:presentationLink link:definitionLink 123 - Disclosure - INCOME TAX link:calculationLink link:presentationLink link:definitionLink 124 - Disclosure - CONCENTRATIONS OF BUSINESS AND CREDIT RISK link:calculationLink link:presentationLink link:definitionLink 125 - Disclosure - SEGMENT REPORTING link:calculationLink link:presentationLink link:definitionLink 126 - Disclosure - SUBSEQUENT EVENTS link:calculationLink link:presentationLink link:definitionLink 127 - Disclosure - CONTINGENCIES AND LITIGATION LIABILITIES link:calculationLink link:presentationLink link:definitionLink 128 - Disclosure - Summary of Significant Accounting Policies (Policies) link:calculationLink link:presentationLink link:definitionLink 129 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:calculationLink link:presentationLink link:definitionLink 130 - Disclosure - INVENTORIES (Tables) link:calculationLink link:presentationLink link:definitionLink 131 - Disclosure - OTHER RECEIVABLE, NET AND PREPAID EXPENSE (Tables) link:calculationLink link:presentationLink link:definitionLink 132 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables) link:calculationLink link:presentationLink link:definitionLink 133 - Disclosure - INTANGIBLE ASSETS, NET (Tables) link:calculationLink link:presentationLink link:definitionLink 134 - Disclosure - RELATED PARTY TRANSACTIONS (Tables) link:calculationLink link:presentationLink link:definitionLink 135 - Disclosure - RESERVE FUNDS (Tables) link:calculationLink link:presentationLink link:definitionLink 136 - Disclosure - CONCENTRATIONS OF BUSINESS AND CREDIT RISK (Tables) link:calculationLink link:presentationLink link:definitionLink 137 - Disclosure - SEGMENT REPORTING (Tables) link:calculationLink link:presentationLink link:definitionLink 138 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details) link:calculationLink link:presentationLink link:definitionLink 139 - Disclosure - ASSETS (Narrative) (Details) link:calculationLink link:presentationLink link:definitionLink 140 - Disclosure - LIABILITIES (Narrative) (Details) link:calculationLink link:presentationLink link:definitionLink 141 - Disclosure - STOCKHOLDERS EQUITY (Narrative) (Details) link:calculationLink link:presentationLink link:definitionLink 142 - Disclosure - INCOME TAX (Narrative) (Details) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 8 cydi-20140331_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 cydi-20140331_def.xml XBRL DEFINITION FILE EX-101.LAB 10 cydi-20140331_lab.xml XBRL LABEL FILE Document and Entity Information [Abstract] Document and Entity Information [Abstract] Statement [Table] Legal Entity [Axis] Entity [Domain] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Period End Date Trading Symbol Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Entity Filer Category Entity Common Stock, Shares Outstanding Entity Current Reporting Status Entity Voluntary Filers Entity Well Known Seasoned Issuer Entity Public Float Document Fiscal Year Focus Document Fiscal Period Focus Statement of Financial Position [Abstract] ASSETS CURRENT ASSETS Cash and equivalents Accounts receivable, net Inventories Other receivables, net and prepaid expenses Advance to suppliers TOTAL CURRENT ASSETS PROPERTY, PLANT AND EQUIPMENT, NET CONSTRUCTION IN PROGRESS INTANGIBLE ASSETS, NET TOTAL ASSETS LIABILITIES AND EQUITY CURRENT LIABILITIES Short-term loan Accounts payable Accrued expenses Deferred revenue Customers deposits Due to related parties Deferred tax liabilities Other payables TOTAL CURRENT LIABILITIES CONSTRUCTION PAYABLE TOTAL LIABILITIES EQUITY Preferred Stock, $1.00 per value, 500,000 shares authorized, no shares issued and outstanding Common Stock, no par value, 150,000,000 shares authorized, and 120,225,323 shares issued and outstanding as of March 31, 2014 and December 31, 2013, respectively Additional paid-in capital Reserve funds Accumulated deficit Accumulated other comprehensive income TOTAL STOCKHOLDERS' EQUITY NONCONTROLLING INTEREST TOTAL EQUITY TOTAL LIABILITIES AND EQUITY Preferred Stock, Par Value Per Share Preferred Stock, Shares Authorized Preferred Stock, Shares Issued Preferred Stock, Shares Outstanding Common Stock, No Par Value Common Stock, Shares Authorized Common Stock, Shares, Issued Common Stock, Shares, Outstanding Statement of Operations [Abstract] Revenue Housing Commercial rental Commercial rental Tissue array products Tissue array products Total revenue Cost of Sales Housing Commercial rental - related party Commercial rental Tissue array products Tissue array products Total cost of sales Gross Profit Operating Expenses: Salaries and wages Depreciation and amortization Bad debt expense Professional fees Selling and distribution expenses Other general and administrative expenses Total Operating Expenses Loss from Operations Other Expense Interest expenses, net Other expense, net Total Other Expense, Net Loss before Income Taxes Less: Income Tax (Benefit) Expense Net loss Less: Net loss attributable to the non-controlling interests Net loss attributable to CYBRDI, INC. Foreign currency translation loss Comprehensive loss Net Loss Per Common Share Basic and Diluted Weighted Average Number of Shares Outstanding Basic and Diluted Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Net loss attributable to Cybrdi Inc. Adjustments to Reconcile Net Loss to Cash Provided by operating activities: Depreciation and amortization Depreciation and amortization Bad debt expense Minority interest Changes in Operating Assets and Liabilities: Accounts receivable Inventories Other receivable and prepaid expenses Accounts payable and other current liabilities Deferred revenue Advance to suppliers Net Cash used in Operating Activities CASH FLOWS FROM INVESTING ACTIVITIES Advance for loan to affiliated companies Purchase of property, plant, and equipment Payments for construction in progress Net Cash used in Investing Activities CASH FLOWS FROM FINANCING ACTIVTIES Proceeds from loans from related companies Loan from shareholders/officers Repayments of loan from shareholders/officers Net cash provided by Financing Activities NET INCREASE IN CASH & CASH EQUIVALENTS EFFECT OF EXCHANGE RATE CHANGE ON CASH & CASH EQUIVALENTS CASH & CASH EQUIVALENTS, BEGINNING BALANCE CASH & CASH EQUIVALENTS, ENDING BALANCE SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION Interest paid Income taxes paid Notes to Financial Statements [Abstract] Notes to Financial Statements [Abstract] ORGANIZATION AND PRINCIPAL ACTIVITIES [Text Block] BASIS OF PRESENTATION [Text Block] GOING CONCERN [Text Block] GOING CONCERN BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Text Block] ASSETS [Text Block] Assets LIABILITIES [Text Block] LIABILITIES STOCKHOLDERS EQUITY [Text Block] INVENTORIES [Text Block] OTHER RECEIVABLE, NET AND PREPAID EXPENSE [Text Block] OTHER RECEIVABLE, NET AND PREPAID EXPENSE PROPERTY, PLANT AND EQUIPMENT [Text Block] CONSTRUCTION IN PROGRESS [Text Block] CONSTRUCTION IN PROGRESS INTANGIBLE ASSETS, NET [Text Block] ADVANCE FROM CUSTOMER [Text Block] CUSTOMER DEPOSITS SHORT-TERM LOAN [Text Block] RELATED PARTY TRANSACTIONS [Text Block] COMMITMENTS, CONTINGENCIES, AND LEGAL PROCEEDINGS [Text Block] RESERVE FUNDS [Text Block] RESERVE FUNDS INCOME TAX [Text Block] CONCENTRATIONS OF BUSINESS AND CREDIT RISK [Text Block] SEGMENT REPORTING [Text Block] SUBSEQUENT EVENTS [Text Block] CONTINGENCIES AND LITIGATION LIABILITIES [Text Block] Interim Financial Statements [Policy Text Block] Description of Business [Policy Text Block] Going Concern [Policy Text Block] Use of estimates [Policy Text Block] Reclassifications [Policy Text Block] Cash and cash equivalents [Policy Text Block] Inventories [Policy Text Block] Property, plant and equipment [Policy Text Block] Construction in progress policy [Policy Text Block] Construction in progress policy [Policy Text Block] Accounts and other receivables [Policy Text Block] Research and development costs [Policy Text Block] Advertising costs [Policy Text Block] Fair value measurements [Policy Text Block] Revenue recognition [Policy Text Block] Foreign currency translation [Policy Text Block] Reverse Merger [Policy Text Block] Reverse Merger Income taxes [Policy Text Block] Comprehensive income (loss) [Policy Text Block] Intangible assets [Policy Text Block] Recent Accounting Pronouncements [Policy Text Block] Contingencies [Policy Text Block] Schedule of Estimated Useful Lives of the Property, Plant and Equipment [Table Text Block] Schedule of Inventory [Table Text Block] Other receivables, net and prepaid expense [Table Text Block] Other receivables, net and prepaid expense Schedule of Property, Plant and Equipment [Table Text Block] Schedule of Intangible Assets [Table Text Block] Schedule of Amortization Expenses for Intangible Assets [Table Text Block] Schedule of Due from related parties [Table Text Block] Schedule of Due from Related Parties consisted of Loans or Advances Schedule of Due to Related Parties [Table Text Block] Schedule of Due to Related Parties [Table Text Block] Schedule of Future Minimum Lease Payments Under Operating Leases [Table Text Block] Schedule of Reserve Funds Balance [Table Text Block] Schedule of Reserve Funds Balance [Table Text Block] Schedule of Credit Risk of Sales to Major Customers [Table Text Block] Schedule of Credit Risk of Sales to Major Customers Schedule of Credit Risk of Purchases of Raw Materials from Major Suppliers [Table Text Block] Schedule of Credit Risk of Purchases of Raw Materials from Major Suppliers Schedule of Segment Reporting Information, by Segment Revenues [Table Text Block] Schedule of Segment Reporting Information, by Segment Revenues Schedule of Segment Reporting Information, by Segment Loss [Table Text Block] Schedule of Segment Reporting Information, by Segment Loss [Table Text Block] Schedule of Segment Reporting Information, by Segment Total Assets [Table Text Block] Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Basis Of Presentation And Summary Of Significant Accounting Policies 1 Basis Of Presentation And Summary Of Significant Accounting Policies 1 Basis Of Presentation And Summary Of Significant Accounting Policies 2 Basis Of Presentation And Summary Of Significant Accounting Policies 2 Basis Of Presentation And Summary Of Significant Accounting Policies 3 Basis Of Presentation And Summary Of Significant Accounting Policies 3 Basis Of Presentation Andsummary Of Significant Accounting Policies 4 Basis Of Presentation Andsummary Of Significant Accounting Policies 4 Basis Of Presentation And Summary Of Significant Accounting Policies 4 Basis Of Presentation And Summary Of Significant Accounting Policies 4 Basis Of Presentation And Summary Of Significant Accounting Policies 5 Basis Of Presentation And Summary Of Significant Accounting Policies 5 Basis Of Presentation And Summary Of Significant Accounting Policies 6 Basis Of Presentation And Summary Of Significant Accounting Policies 6 Basis Of Presentation And Summary Of Significant Accounting Policies 7 Basis Of Presentation And Summary Of Significant Accounting Policies 7 Basis Of Presentation And Summary Of Significant Accounting Policies 8 Basis Of Presentation And Summary Of Significant Accounting Policies 8 Basis Of Presentation Andsummary Of Significant Accounting Policies 10 Basis Of Presentation Andsummary Of Significant Accounting Policies 10 Basis Of Presentation Andsummary Of Significant Accounting Policies 11 Basis Of Presentation Andsummary Of Significant Accounting Policies 11 Basis Of Presentation Andsummary Of Significant Accounting Policies 12 Basis Of Presentation Andsummary Of Significant Accounting Policies 12 Basis Of Presentation Andsummary Of Significant Accounting Policies 13 Basis Of Presentation Andsummary Of Significant Accounting Policies 13 Basis Of Presentation Andsummary Of Significant Accounting Policies 14 Basis Of Presentation Andsummary Of Significant Accounting Policies 14 Basis Of Presentation Andsummary Of Significant Accounting Policies 15 Basis Of Presentation Andsummary Of Significant Accounting Policies 15 Basis Of Presentation Andsummary Of Significant Accounting Policies 16 Basis Of Presentation Andsummary Of Significant Accounting Policies 16 Basis Of Presentation Andsummary Of Significant Accounting Policies 17 Basis Of Presentation Andsummary Of Significant Accounting Policies 17 Basis Of Presentation Andsummary Of Significant Accounting Policies 18 Basis Of Presentation Andsummary Of Significant Accounting Policies 18 Basis Of Presentation Andsummary Of Significant Accounting Policies 19 Basis Of Presentation Andsummary Of Significant Accounting Policies 19 Basis Of Presentation Andsummary Of Significant Accounting Policies 20 Basis Of Presentation Andsummary Of Significant Accounting Policies 20 Basis Of Presentation And Summary Of Significant Accounting Policies 22 Basis Of Presentation And Summary Of Significant Accounting Policies 22 Basis Of Presentation And Summary Of Significant Accounting Policies 23 Basis Of Presentation And Summary Of Significant Accounting Policies 23 Basis Of Presentation And Summary Of Significant Accounting Policies 24 Basis Of Presentation And Summary Of Significant Accounting Policies 24 Basis Of Presentation And Summary Of Significant Accounting Policies 25 Basis Of Presentation And Summary Of Significant Accounting Policies 25 Basis Of Presentation And Summary Of Significant Accounting Policies 26 Basis Of Presentation And Summary Of Significant Accounting Policies 26 Basis Of Presentation And Summary Of Significant Accounting Policies 27 Basis Of Presentation And Summary Of Significant Accounting Policies 27 Assets 1 Assets 1 Assets 2 Assets 2 Assets 3 Assets 3 Assets 4 Assets 4 Assets 5 Assets 5 Assets 6 Assets 6 Assets 7 Assets 7 Assets 8 Assets 8 Assets 9 Assets 9 Assets 10 Assets 10 Assets 11 Assets 11 Assets 12 Assets 12 Assets 13 Assets 13 Liabilities 1 Liabilities 1 Liabilities 2 Liabilities 2 Liabilities 3 Liabilities 3 Liabilities 4 Liabilities 4 Liabilities 5 Liabilities 5 Liabilities 6 Liabilities 6 Liabilities 7 Liabilities 7 Stockholders Equity 1 Stockholders Equity 1 Stockholders Equity 2 Stockholders Equity 2 Stockholders Equity 3 Stockholders Equity 3 Stockholders Equity 4 Stockholders Equity 4 Stockholders Equity 5 Stockholders Equity 5 Stockholders Equity 6 Stockholders Equity 6 Stockholders Equity 7 Stockholders Equity 7 Stockholders Equity 8 Stockholders Equity 8 Stockholders Equity 9 Stockholders Equity 9 Stockholders Equity 10 Stockholders Equity 10 Stockholders Equity 11 Stockholders Equity 11 Income Tax 1 Income Tax 1 Income Tax 2 Income Tax 2 Income Tax 3 Income Tax 3 Income Tax 4 Income Tax 4 Income Tax 5 Income Tax 5 Income Tax 6 Income Tax 6 Income Tax 7 Income Tax 7 Income Tax 8 Income Tax 8 Income Tax 9 Income Tax 9 Income Tax 10 Income Tax 10 Income Tax 11 Income Tax 11 TOTAL CURRENT ASSETS TOTAL ASSETS TOTAL CURRENT LIABILITIES TOTAL LIABILITIES TOTAL STOCKHOLDERS EQUITY TOTAL EQUITY TOTAL LIABILITIES AND EQUITY Commercial Rental Tissue Array Products Total revenue Housing (HomeBuildingCosts) Commercial Rental Costs Tissue Array Products Costs Total cost of sales Gross Profit Total Operating Expenses Loss from Operations Interest expenses, net Total Other Expense, Net Loss before Income Taxes Net loss Net Loss Attributable To CYBRDI, INC. Comprehensive loss Basic and Diluted (WeightedAverageNumberOfShareOutstandingBasicAndDiluted) Depreciation Andamortization Accounts receivable Inventories (IncreaseDecreaseInInventories) Other receivable and prepaid expenses Deferred revenue (IncreaseDecreaseInDeferredRevenue) Advance from Suppliers Net Cash used in Operating Activities Advance for loan to affiliated companies Purchase of property, plant, and equipment Payments for construction in progress Net Cash used in Investing Activities Repayments of loan from shareholders/officers Net cash provided by (used in) Financing Activities NET INCREASE (DECREASE) IN CASH & CASH EQUIVALENTS Customer Deposits [Text Block] Construction In Progress Policy [Text Block] Basis Of Presentation Andsummary Of Significant Accounting Policies Zero Two Two One Seven Zero J Seven N Fq T G Nn Txr Basis Of Presentation Andsummary Of Significant Accounting Policies Zero Two Two One Seven Zerolb T Four Tk C Db Z C Z Basis Of Presentation Andsummary Of Significant Accounting Policies Zero Two Two One Seven Zeroxxh Nine B Twov K St P R Basis Of Presentation Andsummary Of Significant Accounting Policies Zero Two Two One Seven Two Six Seven One Ninez T Mg Hp H Rx H Six Basis Of Presentation Andsummary Of Significant Accounting Policies Zero Two Two One Seven Zerop L P W Fivec R B Pq D W Basis Of Presentation Andsummary Of Significant Accounting Policies Zero Two Two One Seven Zero Pwkf V Mdt P L D One Basis Of Presentation Andsummary Of Significant Accounting Policies Zero Two Two One Seven Zero Z Four Grs S One Zeror Sixx D Basis Of Presentation Andsummary Of Significant Accounting Policies Zero Two Two One Seven Zero Z St Th P Q Zerox B Qx Basis Of Presentation Andsummary Of Significant Accounting Policies Zero Two Two One Seven Zerof C Qpzc Three Vtqk R Basis Of Presentation Andsummary Of Significant Accounting Policies Zero Two Two One Seven Two Six Seven One R H Wrk S D G Z Zcq Basis Of Presentation Andsummary Of Significant Accounting Policies Zero Two Two One Seven Two Six Seven Onez Fivem D Zero Mtx Tls T Basis Of Presentation Andsummary Of Significant Accounting Policies Zero Two Two One Seven Two Six Seven One Four One D Zy Znw T Nl J Basis Of Presentation Andsummary Of Significant Accounting Policies Zero Two Two One Seven Two Six Seven Onen V Twoy Vqqp M Ft J Basis Of Presentation Andsummary Of Significant Accounting Policies Zero Two Two One Seven Two Six Seven One Dgt Lf Four Twov Gf Hk Basis Of Presentation Andsummary Of Significant Accounting Policies Zero Two Two One Seven Two Six Seven Onec N L Zero Four B Jf Seven J Z C Basis Of Presentation Andsummary Of Significant Accounting Policies Zero Two Two One Seven Two Six Seven One Gd V R Lp Xyf Gb G Basis Of Presentation Andsummary Of Significant Accounting Policies Zero Two Two One Seven Two Six Seven Oned Kx Dbs Eight Hh S Cy Basis Of Presentation Andsummary Of Significant Accounting Policies Zero Two Two One Seven Two Six Seven One Eightg Oneg Prz Zeroy Hp Four Basis Of Presentation Andsummary Of Significant Accounting Policies Zero Two Two One Seven Two Six Seven Oneq Seven S Tx Ones Eighty Vdl Basis Of Presentation Andsummary Of Significant Accounting Policies Zero Two Two One Seven Two Six Seven One C R B Eight N Ninen Ll Fourdw Basis Of Presentation Andsummary Of Significant Accounting Policies Zero Two Two One Seven Zeros Fourkc S Vc Sixmnzm Basis Of Presentation Andsummary Of Significant Accounting Policies Zero Two Two One Seven Zero T F Seven Seven Jln K Vmzr Basis Of Presentation Andsummary Of Significant Accounting Policies Zero Two Two One Seven Zerod Dblt Fiveb L V Sc J Basis Of Presentation Andsummary Of Significant Accounting Policies Zero Two Two One Seven Zero K Two V S R Nn L Dkw J Basis Of Presentation Andsummary Of Significant Accounting Policies Zero Two Two One Seven Zeroyk L Six Kq X S Ninex Ph Basis Of Presentation Andsummary Of Significant Accounting Policies Zero Two Two One Seven Zero Qspt Kln R Hrz Zero Assets Zero Two Two One Seven Zerots Slxz Z P Sh Zero Three Assets Zero Two Two One Seven Zero Ps Four Mz Nb Eightg One Nm Assets Zero Two Two One Seven Zeroc G Z Fqzlk Four Four P X Assets Zero Two Two One Seven Zero Q Zero Vcc Nph N Onem H Assets Zero Two Two One Seven Zero Hhf L H Eightd T Zb Sevenh Assets Zero Two Two One Seven Zerob Grfp N Sv Xq Twon Assets Zero Two Two One Seven Zero Tbbg Five Seven Fv Sevenk Sixb Assets Zero Two Two One Seven Zerorn Onet Ninet Vd Rc H Nine Assets Zero Two Two One Seven Zero Zero Sevenhwnz Khh Five Five L Assets Zero Two Two One Seven Zero X Tp L T L Twos C M Four M Assets Zero Two Two One Seven Zerov Zsl Seveny Pwm One R K Assets Zero Two Two One Seven Zero One Six M Q Seven Qpyt Mv Z Assets Zero Two Two One Seven Zero Q Ml Fourdt Z Four Dk Jb Liabilities Zero Two Two One Seven Zeror K Zerocf B Two Fpk W Six Liabilities Zero Two Two One Seven Zero X Rsgk Two Seven Zm Rsc Liabilities Zero Two Two One Seven Zero Rp One Tnkp Zero S Two Three L Liabilities Zero Two Two One Seven Zero S Sevenqv Zero Six N Onem T Sh Liabilities Zero Two Two One Seven Zero Pk Nine B Dhz Onet Ts N Liabilities Zero Two Two One Seven Zero F Vy Twod Sixy S Z Nine F M Liabilities Zero Two Two One Seven Zero Onep Nine Pn N Two One Q G V W Stockholders Equity Zero Two Two One Seven Zerom V Five J C Z F Qqcy Eight Stockholders Equity Zero Two Two One Seven Zero Q L M T Zero T K Four P Eightzr Stockholders Equity Zero Two Two One Seven Zero Two R H Seven Cdh V Threed G Zero Stockholders Equity Zero Two Two One Seven Zero Zk Znw L T Mfxv Two Stockholders Equity Zero Two Two One Seven Zero Q G Sevengn Seven Z Eight Ch F V Stockholders Equity Zero Two Two One Seven Zeroh V W Threeq Two Onefd Sevenp Five Stockholders Equity Zero Two Two One Seven Zero Nine C Vcpq Dnb P Sixq Stockholders Equity Zero Two Two One Seven Zeroqm Kgr X V Three Nine Hh N Stockholders Equity Zero Two Two One Seven Zerow Two Fourmrld Tvgw H Stockholders Equity Zero Two Two One Seven Zerok B Fourd Z Kn Seven Bs R One Stockholders Equity Zero Two Two One Seven Zerowm C Zero Dw Nine Ninebg Dp Income Tax Zero Two Two One Seven Zero Xhx Eightw V Xrm Two Eight V Income Tax Zero Two Two One Seven Zero Jmyt T Eight L Five Twod W Seven Income Tax Zero Two Two One Seven Zero Q S Three Gk X X Jrzq H Income Tax Zero Two Two One Seven Zeroqz Vvc T Nwpgg Four Income Tax Zero Two Two One Seven Zeron Fourb Zerovp Five Four Ht Seven F Income Tax Zero Two Two One Seven Zerob One N J Tz Q B Dwf M Income Tax Zero Two Two One Seven Zerom F Fw B Eight Mdx N One H Income Tax Zero Two Two One Seven Zerot Eightm Qc S Qf K Mg Q Income Tax Zero Two Two One Seven Zerokk H Sevenrg G G V Rc Eight Income Tax Zero Two Two One Seven Zero Tr M S D G Lh S V Tb Income Tax Zero Two Two One Seven Zerovwyd Nine Nine Q Twowb Js EX-101.PRE 11 cydi-20140331_pre.xml XBRL PRESENTATION FILE EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0!1PT*[H0$``!@-```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,EUUOPB`4AN^7[#\TW"Z6 MXC;G%JL7^[C<3.9^`"NGEDB!`#K]]Z/XD<5T&C.3<5-2X)SW*4G?O`Q&RUHD M"S"6*YDCDF8H`5DHQN4T1Q^3ETX?)=91R:A0$G*T`HM&P\N+P62EP2:^6MH< M5<[I!XQM44%-;:HT2+]2*E-3YU_-%&M:S.@4<#?+>KA0TH%T'=?T0,/!$Y1T M+ESRO/33:Q(#PJ+D<;VQT2[:ET-@JIKPQ[;,6UO?(8"+%WIVBOP6<+KB7NJ&Y9S!@+=HXW&N&WP```/__`P!02P,$ M%``&``@````A`+55,"/U````3`(```L`"`)?]=J>*V? M5@^@8B)G:13'&HX<85?=WFQ?>*24FV+7^ZBRBXL:NI3\(V(T'4\4"_'L)MI<3_3_MCAQ(DN)T$C@ M\SS?BG-`Z^N!+I]HJ?B]SCSBIX3A363X8<'%#U1?````__\#`%!+`P04``8` M"````"$`T45'SVP!``"="P``&@`(`7AL+U]R96QS+W=O.4F[\U6'Y5,]J7&3/[$OL?3@-V_K^VKJJV@!==?/:@W(T6_%N;HVT`'!:5 MI@:7L6G+\O%D/4-BQF_#B'E@&C$G<;S*<1@:7,2,2SX^!0416@EI9!4XGQ5E M1B2!:41"XH26(T@[H>70;M+04:545`F.87]3SS;20/GN#`YUBX7/D^]JFZ(1 M/F&F>7L!F;;.(Y@<-Z&#(G,2P=60;I:!@UJ2MR8TC:!QO'Y2TY4E;G%,VMGX MS,JZ4X<_9I=/>UQ3_1<^V]]A8T'!>'5Q!\R&@A&AU8C)#;_ZJWHX)=_[/NG]9NU%<^"KZN/3?70>G\1,E?K^E6P M=M..>B!@W2R]B-PL8-UUW7;NCHOYPNPF`>\@?N,@G-,\+=F4MW.$0E(TE$:8 M#8WDUGVA(,+:]0@J\VQ+7PKXH:/7DD#(,2-2<_/`8$E`1I%$2TR`>4_(TG2(M'GPJ+:9I"EQ20,B^C=X%>OWL M\-1)%`RC291&(19:]U![Q/GA'I(FH_N[9#(.'PD-OS]%Z4\DS\?17QSN!5N3 M:4C3X`?>@J/VW,,]T"YI%-^&\0A4-H[4@F^W!DTP!X?M==J.K,J2Z0U5,TK$ M7`KXQ)DT-,@RM9(&8,XSI]-X?$D4X),?;D]-IOH]TT?9N4=Z>FJ8GG<8SN&TR M5F1P#=:/^AYIFL'9_0D,?@,``/__`P!02P,$%``&``@````A`%/SKYX?!@`` M`!H``!@```!X;"]W;W)K698&RC&&,!F'MZI^:4YYWEH0X=+L[%/;7N^WVR8[Y67:;*IK?H&50U67:0LOZ^.V MN=9YNN\^5)ZWTG'\;9D6%QLCW-=+8E2'0Y'EGZOLMKT^0SG_B'<-.MC=R]F MX'_8%G$#+;M7Y86<_B?M$!?;V\:$3Z-\B M?VLF?UO-J7K[K2[V?Q27'-2&/.D,/%?5BX9^W>NWX,/;V:>_=!GXL[;V^2%] M/;=_56^_Y\7QU$*Z/3B1/MC]_N?GO,E`40BSD9Z.E%5G(``_K;+0I0&*I#^Z MWV_%OCWM;.5OO,!1`N#6<]ZT7PH=TK:RUZ:MRO\0)$PH#")-$`7LS;I<&F2+ MA+KS?4[;]/&AKMXL*!K8LKFFN@3%/036!U,@#](8COK12>&(.LB3CK*S`]N" MCS>0GN^/@?>P_0Z*9@82SR&"(I(>H1,![`:*<.XIQ?DP8Q21+>,$>)VE,8M.R63]]<( M'7\-'0VF=$*V98P0OZ/CAT*--8.4INO"$\(;ZX[P@JY9+I,&,UZLC6*$("_A MAD'(B1'`#6+:O":CX7;?:3"M]G`\+U8[0J!PAH;@U7X+032+UE#38*K9K-H1 M@IJY@7`Y,5SGI40R1F"@& M`7TI/M)-3]_ENFDT2RFKHU@@!K<.9,!:)"'KRHLF0X7*IL?OF$(T= MAGDU&".>#%3()R]!"-\+@S$&);?*%N3<%B*V=6PP2.Y.2D<(IFU"(0+\5GU0 M>'*5,71H^FP4<6,PF%OC]R:$JJ=G^>*6E3CY24BDWHQ$3I90/$*#TEM\HY MA)R[A'"X31B0X0<[,W43`\"\"W=L9RK<*I.0V)J8 M9(I0@3-Q':Y':O'J(<@O*"Y4X[R0SY;3!P#$2$\%(\GH/Q6&89" M,X`>'OZ=$,X8V?!#$/P<0.P(B8GS/H3R6^49:NX9TT=(PP]!*`X;/8F)P!N..%=)G7QSS)S^?&RJI7?9DNX6YM>'>XZ'^2^G*7O1_#%P#=;?EV M6(#[]VMZS+^E];&X--8Y/T!(9Q-`XFN\P<<7;77MKL&?JQ9NWKL_3_!-2PZ7 MQ\X&P(>J:OL7^FIZ^.[F\7\```#__P,`4$L#!!0`!@`(````(0``/.8S'`,` M`'8)```9````>&PO=V]R:W-H965TTT[;_?,4YH<=..Y(*`>7G]G'-L M#JOKI[KR'IE47#0)(CY&'FLRD?-FEZ#?O^ZN%LA3FC8YK43#$O3,%+I>?_ZT M.@CYH$K&M`<.C4I0J76[#`*5E:RFRA/51708AQ M%-24-\@Z+.48#U$4/&.W(MO7K-'61+**:N!7)6_5R:W.QMC55#[LVZM,U"U8 M;'G%]7-GBKPZ6][O&B'IMH*XG\B49B?O[N*-??JNJ\`/Z>6LH/M*_Q2'KXSO2@WEGD%$)K!E_GS+5`89!1L_ MG!FG3%0``$>OYF9I0$;H4_=_X+DN$Q3&/IGB"-3>EBE]QXTC\K*]TJ+^:S7D MZ&0]PJ/'!."/]T-_-L<3\G^3P/)TX=U23=K!F84K74K$"R!.-37!:C MC_2]0"%"8W)C7!(T1QX$H:`ZC^MP&J^"1\AH=M2D;S5DJ-B<%*80@-UR;*:N*N?-%TC@EQ"V05<.Q=9KW'@`T6]?A$&;'+YLR< M6DUDV0C&)`S[F3OZC56,8(LN83-BE\V9.;4:RS:)XGCAK/R-%8Q`@PTT/FU& M[*)-ADE)K<:BD0@OHI=ZV:Q9P0@TT\A>O2<^WH-&[*)-'32K.3^S9;.*(SSN M?KW'8+7%E[`9LU'27G,VOY;)NS?:!FJ&ULE%9;;]HP%'Z?M/\0Y;U) MG!L$`56[JENE39JF79Y-XA"K21S9IK3_?L<^$$CH!7@``E^^R_'A'.;7STWM M/#&IN&@7+O$"UV%M+@K>KA?NG]_W5U/749JV!:U%RQ;N"U/N]?+SI_E6R$=5 M,:8=8&C5PJVT[F:^K_**-51YHF,M?%,*V5`-EW+MJTXR6MB;FMH/@R#U&\I; M%QEF\AP.498\9WKUBW0M)5#;F?24SS/;>].*%O>"Z%$J7V@,Y'HZ>9,S_S@6DY+S@D M,&5W)"L7[@V9W9+(]9=S6Z"_G&W5T7M'56+[5?+B.V\95!O.R9S`2HA'`WTH MS$=PLW]R][T]@9_2*5A)-[7^);;?&%]7&HX[@40FV*QXN6,JAXH"C1,@DB`G!GQ92^YX;2=?*-TJ+YAR"RHT*2 M<$<"KSL2DGAQF$RF9[#XZ,@&O*.:+N=2;!WH&M!4'34]2&;`O$^&/OJL;T6% MC(;DQK`LW(GK0`H%Y_.T!%]S_PEJFN\PMXB!YQY#>H0/;GI+8./8TNM%WBL; ML%$V13=6;OYGP=9GH$AD#AE,[,A\FTYX7E1$3V_C$2](TC4D:3#-\].!! MUO@2$P8\-I'UO&@",:DU$4^BG]J`Q\J';D)EQ&#J;!HG MX0$P$#:[X.B']GY7&_!8^%!*%$8,F=C,,'A>SYM=(FO`8]E#'5$6,;TL@3;? M=?A[?4Y@YIX?WZ+'1I(^(!K9@;#R43:%VA^\#DI/S.@YN_86/19/Q^(XS;#A M2!#!3^UP/D/QB\89P?$UIR23=S;@/CAXVXB6Q<7P-E<I08#``")"0``&0```'AL+W=O9S$6S2LFO MGT\W$Q)HPYJ<5;+A*7GGFMPM/GZ8;Z1ZT27G)@"&1J>D-*:=19'.2EXS'E6<9:[E^HJ2N)X%-5,-`099NH2#ED4(N./,EO7O#%(HGC% M#,2O2]'J'5N=74)7,_6R;F\R6;=`L125,.^.E`1U-GM>-5*Q906^W^@MRW;< M[N:(OA:9DEH6)@2Z"`,]]CR-IA$P+>:Y``R!#DBTF+L$_19\ MH_>N`UW*S6#DZ>OO)5>"["G)>L'5E?LC- M%RY6I8%R#\&1-3;+WQ^YSB"C0!,F0\N4R0H"@&-0"[LU("/LS9TW(C=E2@:C M<#B.!Q3@P9)K\R0L)0FRM3:R_H,@NJ5"DF1+`N\,&^3'):9G"-C`5# MU?:"3\:QYT5EQ-"Q\Q^'@X%?/[!W>XVN!?=UN[2A+F(ZW=.RL-$NSZH%]V6[ M-*(L8KQL?,;NZ!I="^[K=KRHBQBOFPQ/^X7->+E?"^[KWGI>U$6,USU77MOS M]SZH?^]>"^[K=GY0%S%>MUL^V%73:V0MN"\[ZME%S/]D*?32R^TZ=%]XW!/> M@KPR/>.8VH9R<:8=NB\]Z4MO>]3N$SXK?56+HMB2#IO'47=$T-0U#TJ[:AQ4 M&8;<-9ZQ(QT(3_I=RU&F!(6[193%B8@#H^9JQ3_QJM)!)M=VVE$(UC_UD_@^ M<;/4+\`@;-F*?V-J)1H=5+R`5^-P#/U#X2C%&R-;-XZ6TL`(=)&UL[%E/;]LV%+\/V'<@=&]M)[8;!W6* MV+&;K4T;Q&Z''FF9EEA3HD#227T;VN.``<.Z89UC1"SF67"72(6=L#/F-^-"0/E(<8E@HFVE[5 M_+S*UM4*WDP7,;5B;6%=W_S2=>F"\73-\!3!*&=:Z]=;5W9R^@;`U#*NU^MU M>[66\/7.=K?;=/`&9/'-)7S_2JM9=_$&%#(:3Y?0 MVJ']?DH]ATPXVRV%;P!\HYK"%RB(ACRZ-(L)C]6J6(OP?2[Z`-!`AA6-D9HG M9()]B.(NCD:"8LT`;Q)__/QY.1`R:"'1BR^?_/;LR8NO/OW]N\*1R5D1SBB!4- M?A.KL$S(P5SX15Q/*O!T0!A'O3&1LFS-;0'Z%IQ^`T.]*G7['IM'+E(H.BVC M>1-S7D3N\&DWQ%%2AAW0."QB/Y!3"%&,]KDJ@^]Q-T/T._@!QRO=?9<2Q]VG M%X([-'!$6@2(GIF)$E]>)]R)W\&<33`Q509*NE.I(QK_7=EF%.JVY?"N;+>] M;=C$RI)G]T2Q7H7[#Y;H'3R+]PEDQ?(6]:Y"OZO0WEM?H5?E\L77Y44IABJM M&Q+;:YO..UK9>$\H8P,U9^2F-+VWA`UHW(=!O-29#`P<7""P M68,$5Q]1%0Y"G$#?7O,TD4"FI`.)$B[AO&B&2VEK//3^RIXV&_H<8BN'Q&J/ MC^WPNA[.CALY&2-58,ZT&:-U3>"LS-:OI$1!M]=A5M-"G9E;S8AFBJ+#+5=9 MF]B(K5"MQ:FNP;<#N+DXKLZBO89=Y[$R]E$;SP M$E`[F8XL+B8GB]%1VVLUUAH>\G'2]B9P5(;'*`&O2]U,8A;`?9.OA`W[4Y/9 M9/G"FZU,,3<):G#[8>V^I+!3!Q(AU0Z6H0T-,Y6&`(LU)RO_6@/,>E$*E%2C MLTFQO@'!\*])`79T74LF$^*KHK,+(]IV]C4MI7RFB!B$XR,T8C-Q@,'].E1! MGS&5<.-A*H)^@>LY;6TSY1;G-.F*EV(&9\F_W4`BA;JI)6@8,[F3\N>]I M!HT"W>04\\VI9/G>:W/@G^Y\;#*#4FX=-@U-9O]2!=(.SB"QLD.VF#2I*QIT]9)6RW; MK"^XT\WYGC"VENPL_CZGL?/FS&7GY.)%&CNUL&-K.[;2U.#9DRD*0Y/L(&,< M8[Z4%3]F\=%]6QEKB3/.%OT MO_>0>O`R?M&P8A;M&CN19/'<_,C-WBWV=2MR@]@L$&XB M3P4DK*2Z*5FP?S(`SR%XYE&I%W\_$Q3E)W'H+JIF.[7H7-3[;@H\!+ MDRQ9YN\!UTJ6R\#SMUD.6\,6D":C>!TY49X97K*.$26KD\`58\"NQ&_G% M'3,W#.9IP&Y;NE$0OA27+7:!NZ^\+PI@3,ZHD'!9.7/&IM)IP&A(.G79%:I3 M!)5<=O&P3NY/.W229/6.RSK'?I(LKL5AO1J3M1T76S8\1U;M*R(G?9R/3<=! M3^^TV\RLU&%O)&PX:T/>Q81=]RZF6=?I.OU&-9-B<=MO3:=*41P0Z'_JW M%S-G\\+V:5>FX4OU`-;AFK5B@*Y[H'_W'?:Y1)Q<>$![&X]Q5"GI\ZXG]_-7Y((C=FAJ6#&K^[1<=D*?":A.=2,H@/PK">^'2[F/FP*Y,1YF"Y MG\8.3HSR^.%EA2E'C.DBX]TJ[CMR]V/JOG0L/O"J-^S0,ZN"_66,V M+5.-W13)&L_(`[9\:+_O#X?#0>=Z,!@,[6['MKF1YV5$!_'"W_AL1=&8F;89 M],!@V!T,KRT0:=L#+NJB#+H@T._U!KW.T++Q/\]M;\^@:9OV3-U>)0PT>94P MT.15/C=N-9#YRYZ"Q;SFODH8:/(J8:#)J_V&,W!?NU<)`TU>)0PT>957=!KL MJRA4:NZKA($FKQ(&FKS:V.2SS,!#[5XE##1YE3`XVZM\=87UW#Q)%ZCZUZ7L M-M92Q;7)*/27.59N:?#XQ/[FR0K_SI,\1XU\,EH$[F,2NR$.6U6+ZN^!EMA% MP(;!V,R?`N\9PJ3E;S''+D2\E80Z.]ALUFWW[7;?[EG7Q<*F(=&1OPC6T;9V MM>R=_H,9F6V/*TYL&-="RI6O*,&TF!=*]RFVX*[FGE9L@)BH0D*Q11,ZBG*D MJHZDA9J.I(&BCJ2%JH[H.KLZ5V7)1;+&!M9K!SO.H-TN*C^J<@X#$N([(F8W M"=)FVYY'F^RPZ-$VI^J*_++5-Z86^_!9Y`Y-C[38UO-(@QU:'FFAJJ,<-Y5W M)?!ZB<_2\PXFK^PMW7Z(1IGJ,7)X?AA^9KG\K\MZ^$#E8C+:+,DV*/8J67V2 M[8BR0Y0'R\-BJ"A.P'%?(VMO(\-=K<*7^W4T]U.';RYS$?PJ*T.*LRD?X\3Y MAS!XC".?UU[,`N;[-,E]+^>;W[QLNH]/=P^?3@FDPN<<^?8>^;"3LCW.D8^U M_4XGPBY:Y2.XE.4W&0]LF[\,:KB`!O4A/DTRP`JN8@`GZ&"`U4;%`.&I@P%F MQA4#!*A@`#H'HN*C;C-#7F=?SM=F$))TP4%8 M!&G@D$6:BTJ2H68)W2D$>."9B`4=&5($@WLD5DMGJ`<=.5( MX0I+5XHD%'1E2.H)72F2W4>$K2X&.HV1H5?E0: M=1*37%8\<2AE;SF.=OMHKP6.DF"EH%/MW30'8G;U8-46EHU3/#5*6<[Y;W(9 MAEFUV%5TV=&8I?&"><;_CO!3(X$8@ATJ)9"]J4*K\)-\_O\5<'Q31$-_YY,J M3*/(IK2\)5U/N@SVVYJQ:;5_;5P9'SPV;\'DH1BW.FP2O@Y"/#W(9E-L0NRM M,SR0,RTNEE.80UB8/!98%EOF$BRL.$_%`D*)Q19)!`MYY%0LB"^PNFR*+;"P M7W\R%A:N)19;PA(L)/M3>:%)B27;OJ=H>WN7'WFQ1_!B*JOPHEC"CZQ40+"@ M\JE8PH]LH4FPH/*I6,*/8$BP;`@Y%4OX$5Z@6`BW4[%J/]IP','J*=K^>J-+T[%$GZ4\X2MF">H MCL*/LNU[BK9_G5'EB+<4([Y`$;[#$;$1?G2H9*,"17A-CO*N8I07*,)?DG,I&[I5(#X%\;._D"-'MK`%DBI( M]_XZ3]TZ_N0N92D:YIX]?EACR"FB^!%V]:QD.?^\Q].&E1%9;84D`S:'5B'^ MIW5.S,B?`1!S"_QZ4@GD(H*7"XR%!!;"&>)51%#'^XJ8QZRU2 MUWT5HWLT$O54S/X7&_$H*K=[SMX`Q!]2K=<#,._"7[KK,'^HOQR;XOB/_-%] M!%-YU_?!ER3G$&-3'']BOXE`+\:3JT@WGS(\9X^_QCH-QN:_[J;]X>V=8UT- MVM/!E=WU>U?#WO3VJF?/IK>WSK!MM6?_ALG8ZY)N\":?,UY'Q%^;A(IJQ[[) M0KRT*"V5+&POS/,TF/VZTM[8WHF0RR(;IY/;'C8_7)YL'&U$^CR?#>)1-DA\W'I)\ MX]_>_<__\4.>SR/>G>0_;MS-Y]/O7[W*!W?).,ZWLFDRX)C?)7M[\P^-'^L_=-CIT'9[ M,HIOZT^?W\2CO#%SN>QE,DLSG7$8'<7SQKCK62S&1+V'<3\;->8>/`S3^H^> M7%?);9K/9S%$/(_'C8F?=Q_ZLV':@JR#K353=.'`+!XQ9)A\B7Z?/-3'/=_6 M_]IOM[=WZH^ZB]E,##Q)\P%3?$KBV=I#/M_<;.]L[K;K<_B3G*2C9!9UH.1QIPE4RSV5S$ZF;C:3QIC/33\72<3:+>/!O\THIZ=_$LR:.+Q=QD MGM?7[*(X4+5,;Q[/%WE]^/-/2>,WO_+/V6@QF<>S!ZC"CAO#GI]G]=G\FW], M1J/H]Y/LGGTG<8Y>#J/3/%\DL_H+I6"%A#]!G9JK/:H._G4OGJLG^$.#8]V+ M\][%V>E1Y_KX*#KLG'7.N\=1[Z?CX^M>].)C[RAZ]K*QX610:N=N_6'WX]75 M\?EUU.GUF*+Q-,[O#"&2ORS2S_$HF(5_5^;A/8PH#<-$Z'4?(%!,R;KW:&G^/)((GF690OIM-1 MNH+KUQ?7G;/H\9->7EU<'E]=?VI%E]`4>IP?1<=_^'AZ^0'JM*+SX^OZ><2) MZZN/W>O3B_/H]#QBAO=7Q[T_/KSOG[T\/SXX]D5?.YO:XA@N>1V>GGW(6^Q M3'O/EEFWE,Q_>V>[M;.SU]K=V7U\W2C.H^PFPMP/[DI[;YL[0O?'?0[GO8#= M%J*23Y/!//VS#XGTNCP&!!EBX"5>+2D/"2O!I+O_$!PX$UXA^75\<_'9_W3G\^+AZL,?FA0[Y;W]_5:@S_*5OD*YPSG3R9 M#5)45=+5U-!KPZ@HGLWBAV@ZRX:+01/^KS/>9(+5UB,C[@%7>C@8#1UOK!]M M,D]E11K8XI8:^#GS57.^GV5Y'EW.LILF8%P`T;$YNY?B^3D#V&2[ MCV^;FSY*IG@S*?/@!PMBX[$\Y_^P'^K3'<9#S&9_7EC?^G/M,\D53$+"FZ2Y M6@_?55ZY%AHJ)$G["UMYG3EWYO,VF7#4D=O?<)Q.+)H18!<[:3##T;9)HOJ6 MST3?FUDVCOS8;-*8RVW"$[D^P>D$7R9!+(HCK'0IW11^R,H1?L,&_'XIW*^F M&LZ2V& MU^+(P4.D4#9'L22SJW:,)B+5A>%<-4+[,$K*D$AQ%07*D:FS]S#.TX$)WE$Z M6N`0U@?\D:W=R5'LD$=!PZ+SA;D70HFOQI./X&FWT_LI.CF[^./::"D8<7)U M\2%26-"YEFWOX.K_O-+[7D]_2P&LS`!TAG_&:592(Q>_KQ(X/2!HE70Z(O)K M5_$7^O\Y)>L2]1\B\D`>G6*Y5N8<-_#I0SK!DR2A4PA,G;K=NW@":O&\T$_0 MHY/G"7L1B)Q5GG=C\C*4J,*U^O1.+:OG-B>B\W@@5X21WJNWES+GL?E,QR,! M@8AFQ%KD$&KY7"6AZONLL_KT_&=RGYZ072GJLBCN1S4&2##W8*_3T_RQ,]%J" MG#'6F8A<"GV7C8;$CZ\R:#E8$<.+P0-I`R$DG1#\R_2M/Q21N^#OZKC3 MD]<4&=/_)1Y/_]7]4S[YSYVS8QRN.N6/3TZ.N]=RPX[_U/V)(/XX`@J.(_]O MPOYOF.R1H:WH\/C]Z?FY*.U3.O6M//KV\?G1(Z_V/EY>GIE'21+DZ+37/;OH M?21&T;EL6L$AE#FYN/H`T%V M5+8ES*'M??SPH7/U2?OHG;X_/STY[5KFI=N]^'AN:GA)IJN[(MOQ:\P9_?MU M\F4>'8Y(4O[O^J;/+V!S!T_SUUBI/GE["X.`>Y..R5*:`..$*=69F)[7AU_C M"2PF\8*(&6@3`&2C=&AHMWE;D/<31@QXG4ZVO<0O*!>C<=$;PG$[Q MV2-!DQD;SE1M*JWJ";:-Z6*6+Y0N]_[-3)@WV*=B/3S"#;O@GXTCE@2VT M6YMCS1&8B4EXB(89WM&<-0>CQ3")R$^;QU1?\2;+YHQCAWXM,Z*KS[#BL-!% M?MC'B9'>6&0)$.H1,V)LVW,\F2SDEZ]@Q5;T4W9/R#.S3;-9R$3YQD&W;=Q( MSQ+8A2;Y`IZ23!J12\$Z<]`X\!Q>2![PV\4/Y()4B_B/^2=ESYGEV^E1\,K+ MZ/XN)7T#XULL:@?,ICC_D)Q7Q_$$=TN"*']Z@&E1-EW\%25NXG0FLBZOO\^\9URRE9; M8^**;2[_U4AV1?<\P'P1.C&_PAZ=]>DJZ\6XD(:BO/*/O_Z?/.HX^;HRU8@" MO?B][?QKD@,1%R.D/D$:B#-A.*SZ\V+B/`A3]?E=/.>I5&\KZN*80"=&X$$4 MT$LVB]*8'CJOY2'RDN"\8HN/Y'8CI0$MDE%*["P\;IQL9RLZ2O+!+)V:TK/; M0^585OAK2Z>0-''<;`9+#.?A>F=Q2[@046-MO]W?;V$1D#<3LU%\;RHDPAA$ MF06(1RD=XD!]275U$:<9HG&!68*_+^N#08M4P,TS=1X=^,1U@48@NIPU!06J2 M.8`,95Q%`-$!O19"*9&>&H\F0?O$`]8PRAE\)(.[23;*;I7=C'"FBQ!&&V31 M7Y(Y[C0O2L$E!-6N-*)KGOF#(EOL!H\Q/`BZ`2=A,*(\D&FBC.;RPU@R.#HE%(3-O9/U M91_F24-(3R?1>?;99>]+48@'9IJQ]^B&.T@2RHA[ MGYUTW24@C]A(J7A9H+U8E>)*OO(!>1E&+S:\[U+\LO$2`8;T*S#!8Y8XB&A'@J3R# MNN:TN$A9^0?3='(!S\7$EXKVU!FRO=NJ'\`Q01XHVSC8_FYI*[V[.)Y\2:/N M79Q%GT21PQ3U\R#P`,VW6M'9?+@5O?C'7_^O1CT$@_[QU_]Z*6D$;K--$,%2 M7?(W28LLX7]4(]#O%H`7N]W6.002+PR<-??OV._U?[M)60+`F3;X43EL0_+J)E\_Q[=(/KX0,,B)/ M%?P:[1X782_Y+K-5J.GCKS1!I\ZN*)5N?IU9_61^K]"E%PB'8WM"`?4A\H%] MEH\EPWE$IG\Q#45%Q#=Q$3+"7.K0H!H->9>">&2ZC"6PXX70"I72.?80"RPQPZ(.T:_%%&0:+^8*53`Z M\M_=?GP0Q\]50G&5')K/+2].M=\6\T\6-[R!`V5$4IE%KWW&^%-'BNY(WV[^ MA=6D;_.@0L0IV:$(UP"00M^NFKGJ#[Z:H_>ZSJ"8V_OXWPYL02;QU<&85MRR=0JPJ7L$2$W8X<.T*%1"D=&PY MW7G\"]11@\I<*6Q6M@%`2=S'?Y.[D0]2X2;.!RD4M=>TF.\>Y66\?+^<_\9= MA/^*XW@>(O0LN57QVRQ80=6[!6^6$)Y-_0!5[CDP'I:Y:D)I9.AVEMT+,S$/ MSEMQC$+"9[@@2P6]AJT!W$^2_FRA\+"];0`/S`<,@AMC@%.DT:\%+*VRM-K\ MP!PZ"6\>36BGDY%R]LQUT+&>DW*<7^#Y#<:D#EN0!^](9DZ.KG(:I8F/*DWS M,0^"!+>$`5.'`:%5/-C=VMW]+O+VHG)\8"'(,QGB?%7+=_'U"CTXUA840"F" M+G''#`6]6<6.93"J.+&^#S0[NOIP"!:,4PH_V<1I:GV8(6:EOGEE2"1I(2-$ MW@\$NH=QNL0A4Z'!79K<`!3D"GSP;`G8EAB2`C&^?BFWSLM^L!(9!(1YE$/N M8$"Q_#)]MZ*``@[O`ZS%O;XE<4[[2V%W>P6A<41PB`:F0)=;5ULBA/,N>LI) M65W(>1@(1?G6AXL3*N8NWE%8/K_35D.)@"K+G*T8Y*TGV6S?]R1AK(M;&>@7 MG+ET@M10E6O$OW#AQ9N0#O>P6*0C@%'4=*,^0D7Y@T"H3*X+H5+21C&#]'8, MP&PNIH1=N+16'AX`@ZWH+HE'.+0,Z[>BVWB,US*Y;45Y3![1)>OH*\A]>!+TOK[*%FR<\"C2R#`%VG,8?P[1D M/,6P07B=B'\0N%3;H4A-;$XJ*@!3FT"I'4M06K`JYE'Y*AG;"4K53"MMZ>(Q MCZ+.C=)3.3'8W,0?RR=JTX0)/(4;O2,1HJ0`+=AS0G[(O@Q5,I!ED47"?)\I MI".`M?'P,AV)_LZ6:3;R(1DQI*37]SCXTH:Z#[0)LC"<_E;]V++=/B('?*JY M=!#MU9%:L:E0GWAA&D&>028:%*2 MLRR[F6<(CWXF[,!3(H7&'M5'Z=.PJ-Z?7=X16A8;T!F(HY$.&H^G>N.!X@S< MQ^$(EA1[RU0CZZH93'JX/$[:KC99Z0`$X&FQC,)E0U'.'D@(HJ!H!'!@S83T M.?1,L>FL#5:Y+)_`'[?>LAS#Z-GNUG8!I5J@V"/_J/BLG'ST.[P:V3,V1*(E M%)EDL'?V<#A3%Q5%/P'A+II>$BN%\\<1%!=[7R+68%?*=-.N0 M]^E-R5@<2^O%^&#IUUD-)>!1)I>KT%A'#DPDL_0N.Q6X$"9Z\GG+FT-T!:6% M_!BJR-F#G\L2A#>G9DM2&.&YY99*':$W487B-#"*%A0GPL51;3IT^YZJ,SP) MC2WOYZ172(XI-<(VB!A0^>*RP)(],O&UU11QPGYE#^@\YPA0V'4?V5*.%"8< M;*92.0D0)%F+G9%3DP9`7Q"QPL91M/-6SH68WZVCO7(\N03X67OO=>O-[D[T M0N[!9_/:Q!^9[$+,7NH'(`,1<5PJ!;C@Q"FBE\YI?3!6UZ.9+H!M&8)+L%DY MKP<3K=.+7K=[Z00K7I/D?%@*:&&]>4V.W@K!28T".P8OI4UR%@6N3LOE"E?? MZ"U%07+@0HN4&+D_W'$\UD&QR^HUR57Y7YN%B[\TV9"*R"B;%JH]2>[1XR*U M)X=7<_2M081$CLO0`1+EK.2HZ[R1E!KB"5R5YG+1MJLI-[B]NQ6])P.L6PS( MV&SR0^VNRS4BI(2/Y:TT3L=_O.969<:G)-*QP6@*O8'DA6]-(KO><)JU%Q*0 M\601#$AT:UOA-VU%[%%Q1D.PG3CW,$4B309K5&1?4"++HCKSHZJ M'C1*%-Z4+PE1O%/RBRD*YB];=E$2:5"V$AL9Y$75[L->Q)L"$X8)_3V8*(M^ MM`W7KDV\AY4W/$.Z\X4*^@IRY`#<13>$-QX]2IVP8,F=@3PA+`SWKQ7S!;8: M&:C>J._:,D@PK=X.K),^VVV]V3MHO7V]8]OG/_=H=C[8?BL&-!#)QC0J/*'7 M17H,M\C(H=EW2,?OMW?=W.TW!ZU=/'<9`'#03 M+2D;ILT2&,]`^]4&`@G[UN[>P>M*@4N%V];FVW M^<_7[0@#L6+]%<==WLRUI;')-^`\D#F/4V0H\*`HQR[H7XS[]*B'\NYB=&OB M-ZEX1/(;6LJ21:COD[^(GX2C$H+`;R[B?%EE16;)65EA8=Y6)@;A\TWSBJ8F)@Q+>H%QC7\1!+F`V!7-C#_QYS@= M6>5`5-(0;_XA@T0=-ENS*8$601_;1QQ`C@'A@=-'\Q"7J>@`TR;H4Q,#Y<4O M0XL`!.ZSF:U7[!QBCKG!:)P%.Y68PHD;I;>6US`]0F9'7,ERDC51TP8YP!%U M2:=66TAT4;,6(?R9'1H:M*!'S.R`U,,Z.9BJH@`#::Z0FZ3##4E9R!=E`]!E MQ/U)6B=P>(M:MB/Q#8Z)2YY8UQSZ3L!5^24F^568-!1\,UN9>T`0K0J1W-R8 M?PTOO2BYG>3UOCO="_T^GU+?^G'#Z,2EB(UW+^*74LEC\,5:RSO2+95Q7_^Z*R[_W:8@9.5X4NCB$-VNP?%,2Q M"T6NC2'0@G!'1@VX6GCP3`F7?$&GC*#0,?)=<-*WLY`91&'\GOZ97/$! MG(4P:$/KD+/*M-CHF(PVX7GY*UDH::H'W^`]%[F;30*(@6!RZ#?Q9W`XZ(CO M>C_:3PWE:$T+R+F\&X62[&BH%G/Z6!QPRUH_[LP/:[UEMD;0K*UB[%CMZ7!4 M85&E]+@_Z)8!+6$;/A)]-BY)(_^BX>*\WHH^.F?\F'A*+1D-V'\G(9I:3.$, M(BI:&2Z\XJ+K#^^8DV&&QK)59F>"HK5R%+Y5SWGF2GKQW/7T\:XD86V;FQ?< M/)`2B:FRCR56>?]*08\UN\C:0B=:H[%O-KWK,$**BG8BH4W5P;IWW"IJC!2.Z4`K":6Y]7#5=CS>N;/(3NG&<31<6(:G>DF6 MW-7E0$;R<\X_0A*4Y5&WU3#EV#,()$_"$HS>E$HF"G1ORL.>>M^<';ER"44Y M)37[_JX8P@&1AN[R@<);C/URB'L2_E)JP3J+$.<-)P0:QAT M0V4:B+208)Q\T(=P=22HS]4&GA\M3R9<4>]2VHD.6KIU9"?UBC7^(/I4K MNKX2]!2)9/->6]B08C>7K75D,L>O&"JA=8XTRZ"_91N6O_CLQ^$GLP-=0H.2 MS.[=7Y\:!LB%&7&_3:0M%#V%\\($B:090G_&"S2)GG$CRTS35% M:=^)DF+]#]8/4)>BBY7E.ZMH;W31.Q'Q"/G=()4%U0K@E4JR!W.5HTY9O9:P M7)(1%A/=>JXXOE$.81[TGDF[*UIFK('#_5XDM[IE`QM4+"ORY.7\ZYV@DM-E MP!:D5&CKVHB"5TR0UR?+V'`QY8N-<-+>HK^A#A).%I8AURYC9W!-$?_XZW^6 M6[%2GP6:HB@R+&J&92C"]6(#DBVDAO_3(*O%PFXV$%S]+B2)V@"-ZQKKFWXV MR\,#YV7_B639PEB3?[08'@2O>F(:5)NUCV_A*;$7>UP*2]_N;AV8?_C8SE;/ MOA5Q]V6I[]L9=W_,4D*@K(/P4/PB13@UMEA(:>D^@$I):6?MH)/%N04]2A;X MZD?Q>TFG?F(L@=18F;+I*I`UQ04Z;X-LQN:*X&7ZD0K$@+N84E)V`_:`KTH9 MV[XTT\SZ_?<-?_H+6SOUO;0)=,2#9Q=>&`FTX-7@Q>1DFL,$MYD4), MZ\19RZR0'!;Q0:(^H"9_B2[41R=UO"LI[CPY]T8IZB47EI$`^O+B@=N$ZT9P06:?!%_56^@X:+E="1:(+E=, M&EA-678JFH3H#7A5M`.N]%>\W30Q!QRTI+F6[#3<4!W?3\T?I$'>\AIEWB'0 M-H#@*PT<=&%8\Y"R;DJ1#7PQ4^Y`J2;&RN(S``U)X^L39:AJ_&KB$+'\M/A< MA5&E]F$,#@H-O#]AJ->B!F,?TRA?*X5?W\Y`F'BG*CUZ((4/`8XVG/$N&7B? M2"VII6M]<)+9Q*E.0`)GY-"+"J^[/C9AJ'35]_<5R40[V9#;+@.XC<9&#^A1/^BEMCW1L6"L"8*R>=<;+>8`=W:(YP^_M,(MGV(F; MZ*A8@K28:_G0$A/(XIO4[2C%#8?U;]?EZ8T2H*:L*^]%^V?N&IC0H?`%JTPX M7W0)LUVZ;%SDZ$I?W$G6E(U6N;9"L5FE)Y/2-8&&%+K:H';EW6/6@Y&^=.X@*MS+NL"E M=(V-,S?TZ$$^-Q?_-#7.J32ZC1K#%$4$NR^*1F;`$_JKL`2"B?B+BZ9GD$1M M<:D":?/:=EH@<1$_(/Z@U MPHD]CCU#7)BBQA,U$FI/$,.WS13QHG]!7K8X50E;D8(67USNP00UJ(AXA?9G M;X#-9N'>RW6V]W]@TX[4L(RV4N#<*%>;U#+?XMO>:&T2B&SRY@(PX.]EM[;ZR/ MVTJ/4M6J9`^.4N\F9BGNA"G5)K0O-A-056^:VCMI+4JG2F6#8@A'@]#=Y2:"E1!<:E\"2I[H-J2#!;F`(5X;?0G%OF:UJ2 MH_(+:`+K(K95`@*68.="-KL@N4LOB_3 M&6XS1?8_&-UHI0T!4UX2[&4_J6.*L[`Z, M7ZT6C"B%>KIAQ!9MA3%!!#PE];003:59#)")8LFBKURJ&+16"PC=30R+3JX> MNXLA6X6N%-_?@>I,OYYL`@)QF&8<&N4M\Z'5U-F@<&T3'["*#^"=@7*1Q=,; M"3DE"H55-U=!7H'B./ZS^Q@'G->T'N,,\E=,HJHI(]O;=A&`]/VA;S8TRM6I M[BS'^FEVMNTU=ZL`GF`T@A8#;0]="85&"@6Q3&C0'_VG;=IN@&ICS\#47;HG MVO0Z+8F'4PYU!?KP*NSST:]+RWAB(!%(,_-X\25BQ?MQ.N3[18N^-&VE5[0$ M7_J6X"771SZ/O,J;Q+I7P,.;]`O;\A37^T=5[Y`Y0DM[\F)@]4MP`ZG4T2G( M[^R4,8P['V;&(GDH^FQG:Z]\JCLWP<58%V:&:RSII.1>*R![Q*569B_DU+BF M9U6U]=GVUGZUCY4K-10<@]!7_Z;%:,$7J`34-2R`O(5U*NYKH*13M5V9VLXK MRAVZ:UBVQ^5=P=4:@7!$IWWCJ`0H*K M:V\XL-1*2'IX]:[O0?0.^`MRBD;E[5.[V?'Z3<.9>N3CF\&CK_NO7?-?@U?J M06['L'?9C76UY$?=U[!TY2#R]9OM5EMMI&4[GRRH@\C"OVR^U>:+H&W`IH&6 MQ2>1-/GN_MO6VP,\WM!;,!CQ+F(A[VWJHFUZI9^ MZ0H12B2`;CR\`:%:9K6#)77T@>'&$Y/"XZJ]M[UF"[5^1L M)8A$FGAR:B.4H[CSG:4RK;>'\IJ:V4MH0G`?.RF=?=LLH&RHD.B1CQ&%L=J? M4CP*3D3.Y89#KKME:E=+[$)J,?"*II[HV%Q9?);#T5Y+<-`Z@4*"UNX9K-\4+ M)F$,@PE*I94RPIWJ&HQ$#Z>UN.56F]N15"`G][1D79]+@4)YO>PO<"AM@/'R ME2U7SF_H=?A]U36?5UTQY.MZ?F1Z'KX*A]3?UBH@/L9V\/ M^`DH%H#*:EDX1@]"_5.,VMT4_)+6H0$[V]_A#-:^O@=^K7:>VOM;^V_6O!"X MJ@V]66&F\!9$X4?-U-*9WQX]WY4UT&JB=? MQX9CPX;JC>:GU#^6Q:%CV28+_&5L5:BZ)L6K],+QZ;45=A$8D9U[X_;I$SGT MF1S1-[I`XFZ7(AE^$I`&Y*SZ;T+G7!Z9K:#$KR_WE4ZNF4:6TI74%]$N,B:C MLR#<=I_58&,N)VOY;P8I;AX%,R;Y2QEAOP02BS^`,^+-:359E6DTJZ:@C$W? M<("E=(;ML?H(E3Y&0\3OVE"JX\JE#`)X?RN0@@FY>E_N8`]4F^6D2\>,D.#*27N%3#$J=$2(SQ\2^Y!)Z&A81'#B]T"43>(93?&^P M#`E&L9IEQ+VR5F-?TM%.CN`U'5D#_6&4DGGB^]%Q;GR7I3OQM_Z5:3/?KC[X MY-2-=KZ1M@!5N?9-H49[*;BZL_>=JR;Z3=F>Q&H;`+A\UHUZJ%8=65+6)T<8 M'1WW#'"UE%M&7;CJ!S5R<:O7=6/1=9=^<;_O(3YB(#&':@)03(?1+^`Z<9&K M6!*(^L>;2DE"!@[,(F7=,_CJD:7EK4I:6(L_BB"4+HZPI%SU$3)>$@LH$32R M-!"S];D1X%2'$`R#ZU,`E=_DHTRDB.53U2`T?VGO?F>4JK'[SJI_K5O+$K.13YZO;XZ.J8?*K4:H12^KI\"8:E$=,? M"'&711I*V%N,J3!8-J(77&7K5`6_2\$$%9?H1?&OQE_/.94)6/.ISNC?[;6' MZ)%/B1ZM_@#<4UY=NJ7XE!<^*J'"QQRP7:)C_I1WKGS'*?ERE7'-(CSA6'JM MZBY\RD*GI8/SU(T]7O-]RIJ'G?_WC\]&+\[U*11UD/,W-8X2TM6CO"$F^M-+ M+YI_>^E373>ZYXV?#JWAX`(0;9UP2X\8>B?I59&W]T[%>9 M=;=.E+6STDUN&OP$`KQ^\J3?0M;?9M:]WV2O^[_)K&]^DUD/GCSK-XA`>_LW MF?7IJO4M>WVZ:GW+K+^):C7_IN.OH;#MIVO!MU#@Z5KP+;,^70N^9=;?1@O> M_A9:L/-TW?H6?-UYNAI\T[1/UX-OFO:W,0<[3]>$;]KMTU7AFZ9MZ(+O'UOI M)ZW[*V2NL!HUL-7_WA`+_WN#K_[W!F/\[PW*^M\;I/&_-\_F;J@U--6/;^B: M_[UIBHH'ZT[<7G?D=N/,00CX-.?T+/AL1&/]\&%C#^'#YCZ":1L,"-]L<"%\ MV&!%^+#!C["JXTLZJVFP3O!ZNC=35-B.71F@09-5@QJT636H0:-5@QJT6C6H M0;-5@QJT6S6H2<,5)&@(^*J9&M*^:E!3]%>.:M"\RLE_&T-]7'E-"JHY9Y6V M;[`O>*_!M>!9@UG!LP:/@F<-U@3/&AP)GC48$3QKT#]XUB1[^#"@S"O^ROB[ M_Q8```#__P,`4$L#!!0`!@`(````(0!A(*QMQ`(``-$(```8````>&PO=V]R M:W-H965T&ULE)9=;]HP%(;O)^T_6+YO/DGX$%`5JFZ5-FF: M]G%M$H=8C>/(-J7]]SNV*6T,RH`+0LCCE\?')S'SVQ?>H&DOCQ25QG,BG77=3"-Y!Q(8U3+_:4(QX,7O#P9/2#78`?$I6T M(KM&_Q3[KY1M:PVKG<&$S+QFY>L]5044%&*")#-)A6A``-X19Z8SH"#DQ1[W MK-3U`J=YD(VC-`8<;:C2#\Q$8E3LE!;\KX/B0Y0+20XA<#R$Q,G5(>DA!([O M(%(I\OCQ0%S/FS@RR M0X%6L*3/RSR;A\^P#,4!69TB29]8GQ)I=$1"T#LZ0MD^.@Z[&1CF@-&[6WZ, MM?HKATRM>-R_MCY_K:<#V9?K&-C3&?=_Y_RUGDY^C8Z!^SICKP(KAT`= MCHTV]IMI$.G)C:^1,[`GY]U<*X>XGHI=4YVTU3#3TS.;X8>GQ/`=:&!/+_66 MTB$'O21*DBQ-/&8]S/3TIM?H&=C3&WEZ#AG6&V:&PO=V]R:W-H M965T&ULE)G;;MLX$(;O%]AW,'1?FV>)09RB5M'=!7:!Q6(/ MUXHMQT)MRY"4IGW['8J,2(YB1[IIXOK7Z./,<'Y*N?_X_71?.!FG*8]$!?WNH+NUKM--V2KA3T7Q]OGS8 MUJ<+A'BLCE7WHP^:+$[;N]^>SG53/!YAW=^I*+:OL?L/H_"G:MO4;;WOEA!N M94'':]8KO8)(#_>["E9@TKYHROTZ^43OF MVOU>G4O(-M3)5."QKK\:Z6\[\U]P\6IT]9>^`G\VBUVY+YZ/W5_URZ]E]73H MH-P25F06=K?[\;ELMY!1"+-D/<:V/@(`_+LX5:8U("/%]_[G2[7K#NN$JZ5, M":<@7SR6;?>E,B&3Q?:Y[>K3?U9$#=00A+D@\-,%H6QV$.Z"P$\?A&622O4^ MRLHNJ\_2YZ(K'NZ;^F4!K0?@[:4PC4SO(+))#X6)*YYI.YJ+\4U"W4 M]-L#T_>K;U"&K9-LWI#$BGRLX&20K`!O8(2TA8RWV8QXG<#V'=@X'<+V^!LK M$8%$QHK\EB)"@Y1-1S-B2&]P7\[B&V^L1/-MJ5F(!*4NY0'G-0X$F2L@KF4MCP-M[P(@1F$*9 MLQ+1UQ,SV>\LM)#<7QJES#AD,#EN$QDQ(DH1D96X5&6*:N9OW"C>!\H]A6%3Q#,V^W$5Q"I91 M[1LSAIME"-0.\W#L"I28C=.\5I82H13:RCG2<,E2X9<0`YHI/7EO4#O3H;L' MRPH"N^Q9#4S903/BNR6)\&=;C`U"H*IM:&@` M8/@LPR,E5E#"@_-,##?+(^C8)/`TVSB-VQ:<'?51 MSV&_H)$=2+!_M*OS6*$D43ZW<>:08;Q3UK%3"+]JMU]#(^`$SNC!D&R65_1J-(RQ5SC-Z[P3P2G2PB&!U'Z!,=HLGV#6`\*R!A9N,^V:ULED_TZCAO$G74QFDLG**$4(9'222!O*5@LL,Q(LZ= M&=B3MP0S:H2'[KUQ&HO'E=89*GP>*U+%M-]6,=PLCV!CCY"^**ZPH0$HD1(Z M.I^X,"Z]7`F67>N[61YAGH\A=Z'#2K_7')[5`.1@\@GS`E4 MP`UN#Q8V]@N) .8P_NZ(R57_DR1D,N8=#2]]'&;B'],'49M!JW-#.`L>+`9%G M3'L\XV/O4*C_-T[C"BCA(5*A+LACB9(*RCQD.L:SB-Q=.9D"-OBQ1P$A4IOY8\,^PG>QNW MU@",P^Q5/K!+GM58.@ZG)8E'>.[".(G.8`E^`,7),\-^.IZUA@C/!W9X5F/? MW%'RYA,DO.?,)TK[(MJ]H+\53^4?1/%7G=G$L]Y`;LC2CNK&OL>V' MKK[TKV(?ZPY>/_>_'N#/#26\IR5+$._KNGO]8%Z4#W_`>/@?``#__P,`4$L# M!!0`!@`(````(0!C4UO6MP,``)`-```8````>&PO=V]R:W-H965T&ULE)?;CILP$(;O*_4=$/<-F)RZ49)JPVK;2JU4]7CM@)-8"YC:SF;W M[3MF"&"SZ9*;),#/[\\S'GNR_/"49]XCDXJ+8N634>A[K$A$RHO]RO_U\_[= M>]]3FA8IS43!5OXS4_Z']=LWRY.0#^K`F/;`H5`K_Z!UN0@"E1Q83M5(E*R` M)SLA6%CPX+.<1#['8\87:LT&@B648U M\*L#+]79+4^&V.54/AS+=XG(2[#8\HSKY\K4]_)D\7E?"$FW&ED%Z#=G M)]7Y[:F#.'V4//W""P;1ACQINOW!,I9HED+F?,]D9"O$@WGU,]P*81!5"\K]+V37HIV]%CIK^+TR?&]P<-(TTA#"8:B_3YCJD$ MT@!CC:*I<4U$!A;PZ>73@F(/>V3.E[;BQ]+SDJ M+?(_*"*U%9I$M0E\G_!Y=+W)N#:![]J$D!&9A+/700*<5!6O.ZKI>BG%R8/5 M"MBJI&;MDP7XOAP4B(;1WAKQRI]#VE:^@LP\KL-E\`BQ3VK%!A7PV2B(K8C/ M"I,^8&A`(#+#08S8@)AL&;(-WNB.&SGCHB*JJ"=D/GO?/+DH)K8B[BNFC<(B`Y/A9$9LD\T:5R1#19=L;BOBON("&93!<#(C MMLG:3"`9*J;G3$4W#A<^[Y)?X)I=PV7$-I$ZUQ"]H+O&9K;>36',0CH'Y ME3T?-^SN)D?XG-JJ@P,:WAY? MKY#[!T/4*^2^QN7#?A?[MYS)/8M9EBDO$4?3OQ*HK>9NTY#7G7+S`%K;DN[9 M5RKWO%!>QG;P:CB:0Y0E-L=XH459=8=;H:&IK7X>X)\/@VXK'(%X)X0^7YA> MKODOM?X'``#__P,`4$L#!!0`!@`(````(0#4MFEI20,``-D*```9````>&PO M=V]R:W-H965T1^?8_OX;*Z?JM)Z9%)Q42N,EJ)FB?W,E'V]_?AA6VCPUI>XB'R MG*?L3J2'BM4:320KJ8;QJX(WZL6M2B^QJZA\.#17J:@:L-CQDNOGUM2VJG3] M=5\+27+[:1/TA[.C.OEOJ4(?>,U@VS#/)D9V`GQ8*1?,_,(/G9? M?7W?SL`/:64LIX=2_Q3'+XSO"PW3'4%$)K!U]GS'5`H9!1O'CXQ3*DH8`/Q: M%3=+`S)"G]KKD6>Z2.P@<$CHQ:"V=DSI>VX<;2L]*"VJOZ@AG1-Z^)T'7#L/ M$CFA'RV6Y/\N+@ZHC>^.:KK=2'&T8-$`4S74+$&R!N?S`4$D1GMCQ(F]L"T8 MK()9>-SZ0;1Q'R%S::>Y10W\]AK2*UR`]F2@74XV8D,VJ35#N<4'IQC_/":8 M@S'B$08?C##>XCPHG`,R8E@$)UGR@[CWQ1!1LVKS3)8Q6?F#8I1)6$.79]*( MI^0A(B2C)F[)2S_T%\&J']N(',\A&_&4O.Q]D8R:CKR,HX77"T9@6(.7AVS$ M4_`0$()1$V*RWX"::G[Q7C'B"300H?MAU#4('38 MO",F@0)Y>:2M>DH==B-2.Q'.;!P%T9(,`QO#306Y.,W$J*?PH%\T'1Q%"`]\ M.#R]-[)-9E6E5CV%AU,XEBJ$^Y%AOP6?5:L(UJ91#0F'">TB1U&7]O<"GU6^ MR)GZ%0[5J6.?%K#X/?:L`F;.W5C]_0P=PYR5=J9^A=/ZU5HF-G*# MV!G*#*YQ[##P!*Z8W+-/K"R5E8J#Z1X(E)_^:=_9W`1M;]*_@,:BH7OVG&ULK%M=;^.V$GTOS^^QY2I#0<3FS+V)>ZF1F.#L\,CRB)^_#;]_UN\JT\ M-55]>)P&=_/II#QLZFUU>'F<_O<_GW^]GTZ:MCALBUU]*!^G/\IF^MO3/WYY M>*]/7YO7LFPGR'!H'J>O;7MKGYVI3?JHW;_ORT'9)3N6N:(&_>:V.CWX.XV-C<^@\O M_;[:G.JF?F[OD&[6`?7GO)PM9\CT]+"M,`-%^^14/C].U\$J7X33V=.#)NA_ M5?G>D/^?-*_U^S]/U?;/ZE"";=1)5>!+77]5H7]LE0F#9][HS[H"_SI-MN5S M\;9K_UV__UY6+Z\MRIU@1FIBJ^V/3V6S`:-(;MZ:M]__O@@*3JDL2FB3XM4F& M'&?&168?E4M,73PZE^GZ#9`+4Y%JIU@Q426T(Z&#U%'S$$ M:E22MPJ6ZHP@ZB=@5%D4 M1E55!3JSA@%TR`#9"`X(1/T$0"H+:,Q>R5CP,S`1W;-I]D%\FNF8BZM@]^+& M0J9)+!TFFJQ1%%P!V0CUXM*Y*(P%ER:4+!D%/1!G`)U?R*K^'RE5;![ M<6,A%%"+0\'2O9*B((WN%N,I4(E<%,;B4!#/&05]$*<@P,V`N%JG M><[5C,E9GG'`"J,O`TKT;=,%H`3JZNY4>L@:PYKH=#\4/543>C7=!VER2XOJ M5&Z/6I/;I/R^,41YI5H\*4S,"9*!34Y5(2B4F)!C;R)Z3QN3UB32P17QB&*$Q&.4D8=S0`8L21$ MV"AM1VH$#%*,T,?O&BJF/7;B^F!,:2PP!$3W//RKJ-=KJR)5,TQ M.B'P9M29GP29\[SM$>:5GRGJ!"Z.49*L?&1/E@II<+I2JL?U> M.$?XR$41J3RL*8S))8)O?.U`?[E&2OD(M`M$J&@&P)@H$=3D$L%T4C7%8J%[ MXL*%?D;&Y++!M=!&N6P,VQ\'7SQ*'G6TVQK61%K#,;E78_*H M6B/JR!BY2F*CDZ0NUH3&)%W`MSI#%)>+6,GQT[T%>,6,D+&&[Q.HY$-)<%7%_?9++-1N&9? M.-[40XQ7-J:[Y]=S[*NK-=$.-E%"V93L$6(N7,V().U28\(5^LD&"=OSY'$? MY4V7J>L%`+ZDQL9$ITM-[H)E8JG[X*9=:.P+J35AK@,5*>N.?(CRJ)"T%;R. ME9)>:`<8X9QM,[+81)UMTCZ&0TU&R:R.=A>T-9&J.2:G:@F3V?,]HJ/9U8RZ M.DV:,DIR.]#?A2:CI%1',P"^E-HH?TTF/T]*=2H&19+2E&^^[$!?2I.?(Z4Z MC49&NY3!R&S4N2X=8KPN5;)WM;@E*IIQ94RT2ZG)[5*E<==?S2@BD=*D%\F! MDB#EF\,ARION*"E-?"FU)CK=#Z4T$:0TGL,X4JYT'D:[T5972(?];[<7L0.% M%F5">D$O>KT$H=W&-*'"9ZY&34[=4Z:%^OD`']-',Z$3N4Q8D\L$WTP,4;PE MTE'*J:,9`*.DB#ESREVH']S397L70]`1;/I&A.=+C6YTV4BV3T)H%XC92OUY=.:<&U" M!'](&:*\N@N*J@X4C45FU--M4::>66JBT!<]6$]7^A@/ZBB%37V%M29:LP\5 M=L$4]OR"T-%NAUB3VZ+\(66(XM-=C))1'7,B]WNV:RJ=_4$;?%/0YJ]69S_BZ]7ZV[ M`WC,@^9;Y6A`T.QYEO`L)<]BCN-\^D0>'[-0!_WTVRO/$]HC@,RS3J/5&BM1 M0A`!@98W-B9+8WATN3Q/`H]6-L^3PJ-I]#P+>"0$ZR0&-GUPD8^!)\=V5T"= M``$VL)('"+!GE#Q`@"V?Y$%]L+V2/*@/=D>")T5]L!&1/*@/-@V2!_419[J. MEZLUGD&$,?#D>'@5/`D0X"%2\@`!GNXD#Q#@24SRH`\^0(`Q>!$FC(DQ!B^A M?,\Z1DWQY.][\+8(8\2:QJ@I7N9(8U!3O%*1/*@IWHA('M141A`!-;XZ"&,B M8,-'`\D#;'A!+WF`#2_H!4^,^N!=JN1!??`B4_"$0("ON9('"/!=1O(``3Y[ M2AZP@Z^6D@?LX/N@[UF'Z$2QIOB0AS%B)T:8*3ZJ^=FR"#/%UR[)@Z["QRK! M$P`;3H5('B#`<0W!$P(!CD9('B#`,0;)`P0X12!YT"$X!"!X`$"Z_CJ8K]8B MGQD\.8ZS";D"(,/1,\D#9#@3)GF`K#M?QK4R0.=T7_T\#SJG.UKF>=`Y>,*0 MKH/.P1DAWX-3YFL9&08(\9DB6;"O<4.2F,S4XA3B,R4;DAV3$U<%IB;.#!.3 MYI6AZ73/S7J2<'C]6+R4?Q6GE^K03';E,^[\EN7HL?J[KUOX!0F?]/WQX^AL``/__`P!02P,$%``&``@` M```A`.4E]'+4!0``6Q<``!@```!X;"]W;W)K/ZF2]L:8MZ_/&)DO7MMBYJ'?E^;"Q__[K:1';5MOE MYUU^JL]L8_]@K?UM^_-/Z_>Z>6F/C'461#BW&_O8=9>5X[3%D55YNZPO[`Q/ M]G53Y1U\;`Y.>VE8ONL752>'NF[H5'EYMC'"JID3H][ORX(]UL5KQ^`?WLL+^TU6E7,"5?ESGLOO1![6MJEA]/YSK)G\^P;D_ MB)\7U]C]AU'XJBR:NJWWW1+".4AT?.;$21R(M%WO2C@!E]UJV'YC/Y!5YE'; MV:Y[@?XIV7NK_&VUQ_K]EZ;<_5:>&:@-]\1OX+FN7SCT^XY_!8N=T>JG_@;^ M:*P=V^>OI^[/^OU75AZ.'5QW`"?B!UOM?CRRM@!%(^$RB%R/`-QZ9FWW5/*0ME6\MEU=_8L@(D)A$"J">,!> M/*=S@SA(J#_?8][EVW53OUN0-+!E>\EY"I(5!+X>#&D,1_WLI'!$'N2!1]G8 MD6W!(5JXGK1SQ/1V0:@OAA3*7$&C=(=I7; M//WX(E,_&1_U0PSP�V]9M":!Q#G>.T?ARLZQ?'NC@I0L)>/M^/W$A_GJG/ M@R".I?P:+2@N5;II6AQLT#++$2%^3\O(Q@R?(>4P].1CC1$W-Z5U3#/B8)T1 M(48:I8C!;1>>Y\=RX_Z6,QU`_$1&T)@E.K-Y:<87F6GFZW>5(F8JS:80&D<" M?6.^?#W:U,](\52`A("0:X'4!P74$21P0YF-.CO>BV=?+L'.K;81SY1.8)"< M%U%7MEC!#8,@P*>A+'&=V5UN0+"WJ\P(,79.!0AWCF(:44/93$.$0?`9-]ZD M%=7F)1[AJ\R[E?>"#4Z`D&,2^E2V"2$?1A$`&OOR#+I^O%DK'*?+EF!K5_7S M1_(A!G<.PWB4=/C<;#4Z*\,9_H<5-G.5E3=BA1ADM?!]\_=(QG^_@>P(H+ZG M-&:=VEV&0,:.0(AI"0(D%`M(HI2AN$W5%18T<3^[3<,69F8<-GAHIX-=$F(: M!+DZA`1)$H+E%$07D;=N)>MF\L2&K]XSH88II$1S!9_ZQD$R`9C.OR]9!L%N MK_,S"C,5()&(4>3*YB%4Q"A70.C*")J&]"['Z-%&5U%^EO5;IP(DMO:B)#+4 MS00"Q5O02(JK<[O++^C8+P@UVD8J0(*;GR2CEJE"?LE0Z`U#45YO!$G54*CK MW6@\*B()0NK)>M-9?LE6Z`U;\:0I"):J:\1Q"-.DH6)[1";"H)1)[))$(C26 M?(2AUO2\I.Q7&2],GN%MJ0!-]<=)B,[S+I/Q;IB,.;E(!0@U\A+/K*I,`_A! ME,B4UKD9'C/=%V%6.>K9HS0SQ6'G50UXXR\197\6:`\O8 MZ=1:1?W*YY04WON';X<9ZD,_0C6^3V&VV@\BG>$!C#8O^8']GC>'\MQ:)[:' MD.XR@B[9X'`4/W3UI9\P/M<=##7[/X\PQ&8PEG.7`-[7=7?]P(=^PUA\^Q\` M``#__P,`4$L#!!0`!@`(````(0"]H)-ZT@@``&0L```8````>&PO=V]R:W-H M965T&ULK%K;;MM&$'TOT'\0]!Y+O,HV;`>V@K0%6J`H>GEF M)-HF(HD"2W4ZC MB_ET4NY6];K:/=U.__G[X[O+Z:3MBMVZV-2[\G;ZK6RG[^]^_NGFM6X^M\]E MV4T08=?>3I^[;G\]F[6KYW);M!?UOMQ!\U@WVZ+#G\W3K-TW9;&V3MO-+)[/ M\]FVJ';3/L)UOUMP]ENP*B"',19R;2JMX@`?P[V59F:0"1XJO]?:W6W?/M M-,DOLL4\B6`^^52VW@:@0T@"6#MTSA`]!9"@,8$N3=1 M;J>+Z03N+%!MNL?06IH)([Y`C@)(YFJ*-S-%$,3F: MJIJD'[Q@2#H6"7D+F1"`^@$)F2B`'3\$M9RG\.",4F(D@%T>3&2:<*)IZHO< ME]`8VVP.^#A)>D!L226L0J@&'A9,`85+I*P'!P4A"$(&U3L?`6O/AO8B@ MP$0,ADCAS3RY6(S'P482F?1$&#$DTKE`PCOF9G_RY`1A'E\.4<]RX"'$Z9G1 MBR@4SLJ*^&B&?TY>?(;N1-V]B*W]-)+3=8[VLQB!=G ML$$4,J(78?2!#])$+@OGJ$`QBA2CD!6]B$+Q)B]&"C%&B\MSH`B9T0:W]:90 MI!**-[DQ'L6-UIJO"B\B4#`16Q6QPHU1ANT[\@EAXX@\5&:4#9%W#-=$/(H9 MK;5(@-*@)$L4"$G!D[$=\8(:LE$ M?#25&_LSE>^@X8B/EL&).!JR;4J<%4=CZ"E8?NDH>K36?&UZ$5D:3,1'$_1H MCQW..F!*'4\2=+P("Y.L`MD_#%;RH9F.HDYK+:`(J=-;A=29*M09I?:\>BQC MV%`B%94Z90/A'4/&2$=1I[46"5">[/M*;Z5@(:CS^,9('1O2TCL1?DCI99/@ M'<.G9FK([&2"M-9BNI0-W72IB.\"A2"CL_JE-&1,+V*[()<-Q&`5[()1])B& M].A%E!")6.4SA?_. MW/0VE$C%<2(OO6P3O&.XZ;-1!&BM10(A`7JKL/3F).'T/6>MQ6B.XWCI96_@ M'<--GXWB.&LM$@@YSELITS4412C&//K2.3;&R/8P,W%$'D[$ZSZT/ST?>4>E M[H:I2&K'-V%FK$4"3D3W`!7Q/:"PWP(?0,/+X"K;48S5$?5A$IO.S]O&/(!?DHZK/6(H&0^KQ5R`6YH#Y[H'C& MR:J-(_+0&K]<-G[>4:G[*%+,'0.25LR+:-TI3_*Z&^8ZF7ERQW-T-"?B=9>- MGW=4ZFYHZO0$'*G1!)R(3I>*^'1_%/7A;HWD8"_"X,,.6,B^;[`Z4%]_R::_ M3+(MFZ=R66XV[615OY@+-'F.:R`'<7^[YR'/<;W'KIU`L_`7?P+-'!I[JR?0 MF,M"]F4ZT,30Q.9[9J!)H+%E"#0I-+8:@2:#QBX!JW,DX&'SPX-0TP MP*-0TP`#/&(TS24TEZKF"IHK39/"!RVU$BV%#QI;19,!:S2AF@98HP'4-,`: MS9JF`=8@)T63P@=ON)H&/GB[U#3`&F^"F@98XQ5-TP!KO'1I&F"-=QE%DR`# M'`UJ&F2`DSU-@PQPBJ9ID`'.Q11-"JQQX*%I@#5.&Q1-C*QQ>*]I4&V$9#&Y0]-`Z1Q=T/3`.G^AD&ULG)A;CZI($,??-]GO M0'@_0C?>HYX,3&;W)'N2S68OSPRV2D9H`\PX\^VWFBH9NT0'F0='X=_EKRY= M);WX_I[MG3=5E*G.EZX8^*ZC\D2OTWR[=/_Y^^G;U'7**L[7\5[G:NE^J-+] MOOKUE\51%R_E3JG*`0MYN71W5768>UZ9[%06EP-]4#G@BBROX6&R]\E"H M>%TORO:>]/VQE\5I[J*%>='%AMYLTD0]ZN0U4WF%1@JUCRO@+W?IH3Q9RY(N MYK*X>'D]?$MT=@`3S^D^K3YJHZZ3)?,?VUP7\?,>_'X7PS@YV:X_7)C/TJ30 MI=Y4`S#G(>BESS-OYH&EU6*=@@]U:(.T+^I.I9G[YUR MIX^_%>GZCS17$&W(D\G`L]8O1OIC;2[!8N]B]5.=@3\+9ZTV\>N^^DL??U?I M=E=!ND?@D7%LOOYX5&4"$04S`SDREA*]!P!X=;+4E`9$)'ZO_Q_3=;5;NL%X M,)KX@0"Y\ZS*ZBDU)ETG>2TKG?V'(D&FT(@D(P'0TWW9U8B'0+5_CW$5KQ:% M/CI0-/"5Y2$V)2CF8/CD&&(TKE[S%%PT1AZ,E:4[<1UPHH3TO*VD/UIX;Q#2 MA#3AI4;8BNBD,)D`O(81'#]G;`_Z"<6(#8I)@F$+\0+8_F1CWWM+88%`@+J# M&+$%@A3&+0'>>!G]F?V&(&C&I*\@??#J./%=O6W$9]Z$SBQB=\!D=:AJZ&:./ MKM^W^&"7W!\]LXCSL>T3HF98!T^PW1==N6F1F6G%>L'7>36+.)EDD4--$SF> MUZNW+;I9'SJSB-,%C`XUGW1!$/AG?T-;'G666_0"-LC]P:U7<7X&%)((=FO3 MX7CV23*FVD#O&K]L4-.%[ZX"859Q4$81D@@I*,8-!&YQDK3[8G.RJ="M"PGL M]58;$JP)AR0Z16LX"5A!1Z3H@FDZ^OWAQ#E@8[+V'`H4M4-0.%%"GMQ,.YCI MP6E6\;2S[1T*%%':)Z/I;'@13Y3`:TL)VVGO-7S,;[4+3M:_0Q(1YTB.IGQ` M123IPMEK#(F6.23Y'"(1"Q81XM(T06SUS2"7GD13LG'$8FH]B;3X&(F MD:(+9J_1)%IFDV2E%Y((,8Y,G21?.7L-(M@PCR8<1B=HAL'N2A"IX=JM] MRE[3J%[%`\JJ+R31>4#9T"1%NRM6]Y1F'MP]C>I5')-/(Q(AYGAJ@L4Q;\TK M&Q-S[;9]$-@(DBTC*F"I#DE$SR*#$0RIH1C[4_*"%P::_%)MT_>:7+)E<@6LCX8D MPE(VO_ZF@A'FO7YG]?<@!/%0[Q5/^-BF^:E MLU<;,.D/)M!3"CR3Q`^5/M0'>\^Z@K/$^NT.SHX5G(;Y`Q!OM*Y.'\S93G,: MO?H?``#__P,`4$L#!!0`!@`(````(0!>PHBYS0(```4(```8````>&PO=V]R M:W-H965T&ULE%7;;IM`$'VOU']8\1YNOA`CVY'3*&VD5JJJ M7I[7RP*KL"S:7&)01B-R4O!H:SY\R9&<;KJT=9D0>NC5#UQHO\T".\ M9BH3=;'Q?OV\O;CTB+&TSFBE:K[QGKCQKK8?/ZR/2M^;DG-+@*$V&Z^TMDF# MP+"22VI\U?`:WN1*2VKA41>!:32G67M(5D$9``=8=J)YOO%V47H=15ZP M7;<%^BWXT0SNB2G5\;,6V5=1CR*S M)=Q=^O-XD5Q&@"=[;NRM0$Z/L(.Q2O[I4!V78XD[%KAV++.EOTC"V022P&74 M&KRAEF[76AT)3`U(FH;B#$8I$)]W!%80NT/PQDL\`KD::,/#-DJB=?``I6,= MYMIAX/<%TR,"$.V506VZ,H)1&6N+J5R[P%`F/B\S>X\,@J$2<'G)/GDA=M(. M-!]@%N>E`3+=(8);Z=ZBB\S;R1P6#B9F.BV"Q[1=!#Z"@0?+]T@A>"SE M(J<.8(*&#O!S6D$^;P\?'AK3=Y'A$$3)_+P37,63YQS!8RD7.76R&M.VBV$) M7^7_S."YL4(7&9OYQV!%4*SI;EKT6*P+G?J!+3IB1D/S<.5#)]_N3GOPE0AR M06AL:?FJ/V[INITDN2[X)UY5AC!UP(4:PY;IH_VRW\7X4;R.S](=:,&+H'\# M2[BA!?]&=2%J0RJ>`V?H)]`?[=:X>["J@41A$RL+V[>]+>'OEL.F";&9N5+V M^0$%^C_P[5\```#__P,`4$L#!!0`!@`(````(0#2;9]RPP(``/T'```8```` M>&PO=V]R:W-H965T&ULE%7+;MLP$+P7Z#\0O$>R_(Y@.W`: MI"W0`D71QYFF*(F(*`HD'2=_WUW25J38;=2+9:UF9SB[J]7JYDE5Y%$8*W6] MIDDTHD347&>R+M;TYX_[JR4EUK$Z8Y6NQ9H^"TMO-N_?K0[:/-A2"$>`H;9K M6CK7I'%L>2D4LY%N1`U/U M-FQ7@>^G9,KXB=O?G-$KR8VV.G<1T,7AH.>>K^/K&)@VJTR"`RP[,2)?TVV2 MWB8)C3^ M&9*)G.TK]UT?/@E9E`[:/0-':"S-GN^$Y5!1H(G&,V3BNH(#P"]1$D<#*L*> M_/4@,U>NZ61"R4Y8=R^1BA*^MTZKW^&A=](FCX_)<#TESZ/98C1)0.L-DC@< MQ/NZ8XYM5D8?"`P+2-J&X>@E*1!?-@(.$+M%\)HN*(&S6JC^XR99)JOX$2K& MCYC;@('?%TR+B$&T50:UX7TRQ?B M(!U`TPYF=ED:(,.E$>RE6XLA,O4#V2T<-'LX+8+[M,<(S'['X^2R@_G_2"&X M+Q4BYPY@@KH._%LTA5[^>_HPJ\]_C'2G(%E.+UO!%3QXT!'$]1UNG&[@H+!%M8/UZ_^6\)D5L&I&$8!SK=WI!@7: M#_?F#P```/__`P!02P,$%``&``@````A`/A20=6+`@``008``!D```!X;"]W M;W)K&ULE%3+;MLP$+P7Z#\0O$>TY%SL[)++ZT=5DP/NZ@,EUO$FY[5N(*-/8.GUZOV[Y5Z;K:T`'$&&QF:T(.EZ9DMC7`\VZ3JEDR&LV8XK*A@2$U;^'012$%W&JQ M4]"X0&*@Y@[UVTJV]LBFQ%OH%#?;77LEM&J18B-KZ9XZ4DJ42._+1AN^J;'N MQWC"Q9&[6US0*RF,MKIP$=*Q(/2RY@5;,&1:+7.)%7C;B8$BH^LXO9E3MEIV M_OR2L+>#;V(KO?]D9/Y%-H!F8YM\`S9:;SWT/O,)IA8YJ[* MZ'@63>>C<8QPL@'K[J2GI$3LK-/J=P#%G:C`U4F[Y8ZOED;O";8;T;;E?GCB M%(F/F@)#K_(UD:C.DZP]2T;GE&!^B\8^K.)%LF0/Z(8X8&X"!I_/F![!4$TO M"64,);ULSS&S!_O,WBXOY28$AFF>A9RD&?]/&@]&B_#UK'XQ[O6'U`$T&6"F M/>(D-4+>7J$'=ZG[$D-DTO5U:!Q.P9#6]S*9^5EZ9<2.'OI]IQD.$1SQ0;F3 MEXN9G6;]>[L\^#15B%P6@\-T7LQX\:]*_*93^D-D.`_QXKPMX%TB\KQ'&N'9[?[K/"J!ISI483@0FMW7&!BUE_^JS\```#__P,`4$L# M!!0`!@`(````(0"STHBPK`(``#0'```9````>&PO=V]R:W-H965TU:GB&7[C!-YN/']8'I1]-Q;E%P-"8#%?6MBDAAE5<4A.HEC?PI5!: M4@NONB2FU9SFW2)9DS@,KXFDHL&>(=67<*BB$(S?*;:7O+&>1/.:6LC?5*(U M1S;)+J&35#_NVRNF9`L4.U$+^]*18B19^E`V2M-=#;Z?HSEE1^[NY81>"J:5 M484-@([X1$\])R0AP+19YP(- MO1>.$R.V-U;)/QX5]5R>)>Y9X-ZSS*Z#Q3*<74!"?$:=P3MJZ6:MU0%!TX"D M::EKP2@%XO..P(K#;ATXPTN,(%<#N_"TB5;+-7F"TK$><^LQ<'W%#`@"HH,R MJ%VN[,!.V=76I7+K`V.9^+S,[#TR#@R5@-MK]JO50.RE/6@^PBP&Q,0A0"YW MZ,"=] ^9=9XX+!QUS.:T#3VG["!R"D-';CC M-(N2`#+[=_^Y=5.%/C+N@R@)SYMQP_CB5G?@J92/G)I)IK3=;%@F;A#\QXU; M.)7H(U,WT1LW?DKY0RRY+ODG7M<&,;5W$RB&8SE$A^&XC5T7O8W/TFTW-,GP M`8962TO^C>I2-`;5O`#*,%B"%^W'GG^QJH7,87(I"].J>ZS@[\3A9(9N&PNE M[/$%A,GPO]O\!0``__\#`%!+`P04``8`"````"$`T[[=P(H"``!F!@``&``` M`'AL+W=O6%X]JI8\@+%2 M=P5-HI@2Z(0N95<7]-?/V[-+2JSC7V`7`$&3I; MT,:Y/F?,B@84MY'NH<,WE3:*.UR:FMG>`"^'3:IE:1Q?,,5E1P-#;D[AT%4E M!=QHL570N4!BH.4.\[>-[.TSFQ*GT"EN[K?]F="J1XJ-;*5[&D@I42*_JSMM M^*9%WX_).1?/W,/BB%Y)8;35E8N0CH5$CSTOV((ATVI92G3@RTX,5`5=)_EU M1MEJ.=3GMX2=G3P3V^C=9R/+K[(#+#8>DS^`C=;W'GI7^A!N9D>[;X<#^&Y( M"17?MNZ'WGT!63<.3WN.AKROO'RZ`2NPH$@3I7//)'2+">"5*.D[`PO"'X?[ M3I:N*6B:1%D2+V89LFS`NEOI*2D16^NT^A-`R9XJD*1[$KSO2687T3R+9PEJ M_H>$A80&?S?<\=72Z!W!GD%)VW/?@4F.Q&\;0B<>N_;@@F:48*X6#^%AE639 MDCU@Y<0>'W!C`B&HJ,RJIVN[,%>V9?6IW(=`E.9]&V9V7MD/!@K@;>7 M[+/+D3A(!]#Y!#,?$0<.$7*Z0P\>I$>+(7(^-.:T<'C8I]-Z\"'M/H(S,/&X M>-O!Q7ND//A0*D2.'6`'31WX:4KG\\C/PK\;T&\\E-A'IHV07,:OW(2Y#GVO MP-3P"=K6$J&W?F93[.0Q.GY.UJDO_.OX+%\/3U["QIH4+* M>/!BPH&>TO9[+*0EB5J=G*)B3,NWA"^=<1"":#=_KVLZ^J,GCR2]^7A M^3[*Q5XWR2O@T;467%#@DT@RG@I;H5T(EF+LQ0XT]UELF!AN6Z=YB$=78\O%.Z\!3_)\ MAC4$+GG@^`A,[4A$`U**$6D_7-,#I,#0@`83/"89P=_=`$[[/R_TR453JW"P M<:9!]Y(MQ2D/=F=DY?IW?UZB=@D)S=I7J2D6),9 M+>:TF+V6^-P:[K,1J`>!?Q//`-9[__QS]@4``/__`P!02P,$%``&``@````A M`$WJEYA>`@``\P4``!``"`%D;V-0&UL(*($`2B@``$````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````````````````````````````G%1=;YLP%'V?M/^`>&])NFJ= M*H>*`FW0"&2UTVU/E@>7Q"JQD>U$S7[]3%`:LK&/[LV^]]QSCP_U[6S M!:6Y%!-W?#YR'1"%++E83MP%N3O[X#K:,%&R6@J8N#O0[HW_]@V:*]F`,ART M8RF$GK@K8YIKS]/%"M9,G]NTL)E*JC4S]JJ6GJPJ7D`DB\T:A/$N1J/W'CP; M$"649\T+H=LQ7F_-_Y*6LFCUZ4>R:ZQ@'P5-4_."&?M*?\8+);6LC!,_%U`C MKY]$5AV&8J.XV?DCY/6O"!>LAM`2^Q6K-2#O&$!38*UI<\:5]M'67&^A,%(Y MFG^WMEVXSC>FH94S<;=,<2:,E=7"NLO^7#?:*/^S5$]Z!6`T\BR@"^Z/?6S_ MS"_]\=4>84^GR):A4V(3IQH)-S7HO)HS908DCZ_ZFO#IG?R_!Q'::Q1G! M-+^C21:^MB0,AH7=!CC9<\X?8FSY`Y+D&0VRB.+%;#;8)<#X=\],D^`V21.2 MQ,/=,,G#C],\C>('3.-/BX1\'6QA'YC/8DJ"+X-IZSY)LOLX"VVCO=BVYWVG M/1TLP9OUFJD=E17%?"FXG5[[W]*@*.1&F,&2/ULS'JSIO*$94\I.Z!9H!(;Q M6@^">V[]8\6`?[W*P29'*WO(`54GT_73/*5C=R.[N7HQY!VWM?\#``#_ M_P,`4$L!`BT`%``&``@````A`%'#0KNA`0``&`T``!,````````````````` M`````%M#;VYT96YT7U1Y<&5S72YX;6Q02P$"+0`4``8`"````"$`M54P(_4` M``!,`@``"P````````````````#:`P``7W)E;',O+G)E;'-02P$"+0`4``8` M"````"$`T45'SVP!``"="P``&@``````````````````!P``>&PO7W)E;',O M=V]R:V)O;VLN>&UL+G)E;'-02P$"+0`4``8`"````"$`1E^3"8P"``!(!@`` M#P````````````````"L"0``>&PO=V]R:V)O;VLN>&UL4$L!`BT`%``&``@` M```A`%/SKYX?!@```!H``!@`````````````````90P``'AL+W=O&UL4$L!`BT` M%``&``@````A`#MMWY,Z`P``R0D``!D`````````````````#18``'AL+W=O MI08#``") M"0``&0````````````````!^&0``>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`"4VF9)\"0`` M%$H```T`````````````````@",``'AL+W-T>6QE&PO&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`(@BM2H5!@``!1D``!@`````````````````!EH``'AL+W=O&PO=V]R:W-H965TPHBYS0(```4(```8`````````````````"B&``!X;"]W;W)K&PO=V]R:W-H965T&UL4$L!`BT` M%``&``@````A`/A20=6+`@``008``!D`````````````````)(P``'AL+W=O M&PO=V]R:W-H965T.Q MXC(!``!``@``$0````````````````")E```9&]C4')O<',O8V]R92YX;6Q0 M2P$"+0`4``8`"````"$`3>J7F%X"``#S!0``$`````````````````#RE@`` F9&]C4')O<',O87!P+GAM;%!+!08`````&@`:`.@&``"&F@`````` ` end XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } ZIP 14 0001062993-14-003005-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001062993-14-003005-xbrl.zip M4$L#!!0````(`!QGKT2K0@O%1C@``*I]`0`1`!P`8WED:2TR,#$T,#,S,2YX M;6Q55`D``]CQ=%/8\713=7@+``$$)0X```0Y`0``S%WM<]LVTO_>; MZ]/.6#+?7YRD-XILY]0FML]VVNNG#$Q"$AN*5$'2MOK7/PN0E$")D@F23M)I MDXH$=G^[V%TL7OGZWT^+$#T0F@1Q].9('2I'B$1>[`?1[,U1EDX'SA%*4ASY M.(PC\N9H19*C?__T][^]_L=@@,;Q8AD&./((^M^2DB1YQ)2@2<0JP+.SV,L6 M)$K1/$V7IR[@6(KBD!@'"]7-)C-4_2#]V,]S&/T_OWU$(W"$-VPD@FZ M(0FA#\0?%H2>[FF(0#U1\N9(D(`]'L9T=J(IBGX2%,(>Y25/PR#Z?*`X>WV/ MDW7QIYWRCSHOK;JN>\+?ED6#)#8TU3Z$)2^QIIT$=92AJ'KROP_O;[TY6>#! MM@`^V=3BY!/B#6?QPPF\@+JJ/E#4@:ZNF4`1?ZM&P<4ZR5]6BJ:U1\;/&B!HBW\JOB>JM[Z@?BL;$D_I7OUZ)[`VR,P M`(1>,_V?)EQ1-V2*>'N#C\G6!Z'OEG8/K(BZ.4/*4WG,+3)T7]]#.. M,DQ7GQBI3W=7GW3UTP?`-.,[BED`N%TM[N-0GAL3 M*F=5(;2A?QZE0;JZ(;,@22F.TDN\:"'4F#?P,<0;;YBSJZ.[X5J&HVM"@]AO MK4OVYT#1U^JL);LMZQ@*4!Q.(I\\_4)6\EP5]H_J*HHFBKI%=IOKKW&812E0 MO0A""*GR7"]CD=L6N6UN_.D8A)_%M(6$MPL<`@$(P\N8IF`U/&[C:"5"J/#8 M!O`;"<-?HO@QNB4X@=[*GR1)!A0[BKV'[*YAW4%@D&>F*H/_5BV)T=E0'\$C MGSV^"/%,GOP4APG)Z5Y]OY]`_)E=9RCM^UA+;7%U@D7,\ M0ED4Y"\27NT(^<0+H"VAUYQ<7H!\FJ)IIJ[I%<,]P&T'61ZOUG9QF^(T:V', MOY.D`J&6[&ZK;N+D!3QIP9?]66W@+9+[>.81I277_ZIU/`62.=>"+@K\G9;E M!:`(X>HJ?L'OP&=/I@%X%N\:J[U>F2Z,)[]4H]:F6DGXI$+Y]9)C$_CPS"0M M`JXY4-S7)^6SDH)0Y_5)(4N]8,\J["M+"W+1E'<=N;PJ_/OZ9/-T79`4/8S8 M#Q&AUY%2R[>E@VJ+YZ*U;G$0[8QX9'%/*)-._Y:DT\M\K"=[UK?M^>M+6[%G MO9D]ZWW8L]CHVE=7@]#H6N=&_[9:N&+/TM[*T@8N5Y$VE%46D&1EE/R4/WY] M4O[.2;!:6_4SM5RY&PJH MZ46[=4NEC2\/44W)$@?^^=.21`D!^[E*YX2.DH2D26=+4#5;-_0-C`;, M^D#77$^N8AFFVP'@R']@$Z;)5;16\74&NL$)V1FG-=>;H+)###I!::XDP]2M M5H!Z,B+'4EU-1'"@.7JS#-6U7,=4&G&]IC'D-NGJ.H1T!XR&A=\E&V=W"ANJ MXBJF88G&N9]-)T`26E$-PW;4-IC&,:2#-//8HLTD@GHSMOKRCL9)!T>Q3-UT M5+$3W,^E"QR)KL927%=U6B":1)`MSP+HCG)3`PV>/WEAQJ;!WL6Q_QB$._/O M$II2+=W1Q![A>6Z]X)-0G>:HKMX%8EZNB\NIBF%9YK;7-^0BX4>*;FJVH1UF M=#N/:7I'Z.)M3&G\"&)WD0T\UW8$]=90;\->0FA=<1S3D4!09FK7>,72M,Y= MB:X:BK:;"%;)MX0@$T1=19=&03/BOP_P?1`&:4"Z=ZLPQ-$,%H6=D M&2=!'VF7">,6L6>M9]`6A80V+%.Q+$D@9QFYBV](B%/B7V/:B\?HBFI:XD!R M/Y,.8"0F`%Q+-URC!9["GN[P4Y\1!?I.<3[B()=N@&0Z6M.M\:0&F/C(KT_U M&(:JB,%E#X.V*)KKQ'152]4E@?2I"4M5%%43.N)>F,LHP+$A26_.7\SAJ]TT M#'DNX\CK'%HLUW7<^D'#`89]H6RN.MVV--?N"%10=PL;48:=Q/A$ MMPS-<1IPO*9%G.&;&CI.1BOB:'N';AO&S466X2ULX^@HL:&KNJ4:HI5524LS MEICLDN,]\OV`V3X.KW'@3Z(Q7@8I[C!.5VT-ADGB=%LM@[8H)'K.-D#XOADV M)5@,:F!(=TTQ1`>/).MW14T($+<97899\A:'?$-N^_"I6S"R%`:676"\K$02 MH?;EA+HA*0XBXI]C&K%1-U#,%AG/&R%#"KR@0U>Y]8"NN5X' MNJF9CIC'RP(4WO/U-I&1.HB1X()/(@]')^SAA\U574\@TNXS!'$NU[,JX M6(9SW["E!FV6K>D](>?1=QZ'/J$)FV%.=[:4-M>I!L-)1==$O]HFWH*YS*C- MU&UQG/0<_P]!%%-X.@&>E"0=7--U#%-,N[C-*7!?9:RC/,N9IDFH*-Q&$*1[IK2861MFL:A1FH#Z`L)*=''N`[8 MQ`O+*:3)K%_JT9=WY^N?X]49691;Z/8!W&;6 M$=@^Y7TA;/S<0U>%/8,GY]$!BZ2.>H)SX+!$O_K9.2?1'E6_FMH+3!A,7\;@ ML;(3!>NP\)0$IU$0OCE*:4;*@XE:NZOHL<>8-8%E63+]PJL MER`BG"EZAE%;-+(JZ@M0?X&D":0F3OL"H:03M/_`L/%M%H3L3;$Z*GTZZN"Z MM&*)>\!JV'7$4W-8H^%\[%XL[,0M5R&A7H##&Q+53`5VT@J@J&72FK^\%I[C M?QTY*)NI+FXI_2I# M-1Q;W$I2,FG#NJ7TAUF+OC*.DYYMP;!5PZQW3,ZL$Y9^`H2`H]9S^E>*9FFN MN\=/>T`C:R:6Y5H-T=3X4/_JL1S%5O8[;3^8))7D.J;6#-.FHT[2J^E+=+RJ M`9Y=6843.+4&(6LU$%I4JQ$(OI\7-#7=79SHI`=;LX7H)G!IR5Y2`[KIBGO_ M]_*_Q2&F^;36;WC6<_=B*JZXZK[-JPL22768NBMNG#F,Y(PL*53FMQ1!B=&" MS9_^E5]:U*NKJ(8XJ7^`;4_X9&U(-PRS!3ZPLX>`7?UT$=.S.+M/IUE8[I7M M.YUMPK,O=)+JLRR]+<`I21*^8G]!>G9)W:GLD]WFU06)I'H,157LIDAN"5^F M`+,#ZI\)6T(OCGKUF_LXEKB^MY=I/^!D%::*J7I3<'S-MBC\CD2$\CT&(W\1 M1/Q^I31X("^A2E7335T(_A(X7D@`275KMNEJ?>!?LO/BF^;I.5O7;-T1TJT= M;IW`2"?KIF/K\F`VNPAZU-NBC)LPZX<,:MGV@]C*.XJMY^E6:+^WOV<.P! MEJS"-,78#KO/X=I]_Q(]PL!P-%W8O+67:R_@I.T,P%G2X#9N>T'CQ3AFF_LR MJ%+X=1PE;\DTIL4^J3O\1)+M_3/0BU2IY%L*/I!T'OL;<^\[-%J.;JJB7WTQ M0;Y1#4J'<,EF'(8FB2J?!'F! M7,.R*F=S-GS:\6]ACKIJ/L__DJ0;&VNS3:V;FG3=<(11L32:%Q5&5N>Z:HC' MWOL4IF?CU'55WX>T-0II$S4L1YSP.H!BWT[C"PB@P2S*3RIYJSN*HP1[Q8P4 M_Q7F\U/^'UD>+,M]R;6;(*]QW;FJCFFA8IK65@+VI23Y9I4H[5FV(IZ/_8I* MK.&Z;Y]]Q\BHZ%;U).%>QCTAE/9?1W>KJRH-$9;',\J=G6]Q$GC00F=!F*6[ M&W?D]%B_X52I;#A]!D"/:)_3:>]H?R/LNP?$'SU`FCDCEQG;P7,UY16%W3?] MJ;SY;J!VT%Y>O(-M]&7$XTNU6PLJ^*76F0S#9C/MS_'L`YGLLISIL#NIFB$3 MTGQ*<$+.2/[W)-J]%[!O_9G5@=ZS_/M&++VY1A$GI_I`7-X95W,6NV._9VN* M=0BKP+DWD-*S0YJE]82QN*FPO-"B]L;"GC-21[.K=TJVP?3RX/8/CZTP`<%O#^S@)*]E\OVN\72%N^$ M;`[B9G7I':X!S3QC) M5]]>+A8/#+?R38#F,%X&OFPLMIVM99U6Z'F+$)^O?0K7(:[.R'W/H<-QS>KF MS+U\^T(H.X17(*WLBI"M0O/Y;>+ON5FJVQX_V['M>HR[G/M#*:E)QW7W*/(Y MD'O,^"*(H#M\N5C@6C!@?]:9:E"\#'I9PW4M\=+7MNCK/XJ2?_EN.[_N-RMV MG>M:[&E1U9R_UQ3%;3"+@FG@ ML>'5YEK&.`P\Z(KN`,_;,/8^2ZOHI^_#]-42X1#(OSEBNPZ"Z>H()>F*?5=\ M"M0&4[P(PM4I2H,%=+T1>420BN#HF/\^3B`N3U\A7C()_B*G2%66Z:NC[V?I MJ[__[;OOOF,,8!`31S/VZ/+J[AR-T`"]'=U.;M'5!;J^.;\]O[P;W4VN+M'H M\@S=?OSP873S.WMW.WEW.;F8C$>7=V@T'E]]O+R;7+Y#UU?O)^/)^2TC?;*A MS7\NUXR_*YB_J'3;\JE#Q.TY6*`B98#LD%\6Q<=TSR#^`G#OY@0,$F=^4*P[ M)V!#/LO/T70-.%D#1O$4Y9\\YU\\1SCR49+=)X$?\!.):(X?"+HG)$)+MGQ! M@4X0(0PF2GU^,^ECD,[1Q^'M$,WR8RCABKTF2\82KTT9J@?`?!D"S6E,@4BN MQ0VH((+GBWQ1E\%89C3)P!U0&J,4I**$ST3DL!D)NOZF-]2`T?0"L:]>#]&( M@X/GX>J8U5PA/T91G`('=@,=@08(.<5MCM,X3J$<("QX^>A^M4>&&F%!+XSJ MQXBKGAL%U^]H`9)ZF&/&$7AK6-L40_2?^)$\$'J\`ZX`7K)(2(WZA#:E9!H2 M=CT$$Q2O]QHEZ`=F#P$?\B*P"P+H`5_$^(10B]VQS5X)57Y$C_/`FR-H^.-2 MP'@91`P55`73Q#/.]1B,E0"CB@K*"4QQ09C8).QZ?%E78BSUFR>>BR\;8 M*0=TLC"WV'B]AWF(;HK'R3Q^C"JFE7\F-&'8>?.7`,'!H(P/3<(.29682O)@ M;??P\#Z_R35O-#3-0),K@ND0W6WCNB^NZ$WFA*15F^)@R\0'Z>HQ8CT&>H07 M/H![8/3!OSG_YBZ[90WE%^V_QXOEJW\ZFFJ_2M`HM[/\.^2B?_S")7C.@D"9 M6>@S14`:SAD!K#^RB,]4Y2Z?SG%:N.`0C0EE^H)2`"4_?(;P(C_#NHD@8&$A M3A+V.5B?Z1EH,F65#EY>*Y^WV_\E%=,9?J58VK@Y\D8L#^ZNP^KQ)JZR59[' M>0PQ8P"F2K8"+2OQ1PRM@MC2?0:B0R0#JP-;`J0\/L+_>'E;ET:75TLW^PQ% M=9,PX%]Q)?Z.\KY&UZD-P142CP;+,A2\S1+PL>0;Z#4K;<7<$QHUIF#;O-D! M[2B;`6,$'LSF$XZABP4'YDT>XL>DC"$\YO.V![1@VE&`A^BB\/"(V3E>+FG\ M%+!&A2CTN:FQ^S%82"D44WJXSXYTLHFA==B=120-/+0@8#[@ M)_G%&L>L@UKD`>X>[.,S#RHQMQ$VVP$>A]DN@Y39UAD,@'(?+`Z&<`-CYYB` M"+]Q?+$$'IMX3+QY%(?Q#.)FB/)1XQK@@I_Y7888*O(0G"8"*B%(H3`&-0:\ MDUI`Q.`]T2;UA1B0+TSFA@UR0Y_`6@!B/D6/-.;JG6X1",KO1X+'0,4BE!>- M`@+%7AY:P%^J8$#X(I3R:,:H;FDLQ4NR;@Z0]Y'PS@3$`/$IE.%[I7C6Q$[. MQ5-1=!2R:GF=^)YUN"GY&G%L$J'+^"'OA-;6AKTBQ6%)0F&_+"S19!XL\V!# M$A[>*I'L&#%[@R$N-^`Y"7U4QJ2*SQ2&L?8(&).L0J:G'W@_]6<6IZ^*Q+-\ MM7GQXY#U5W7A5DCZ(#]DQE$TJ1`#N0.GT''Q##0W"$BKDD+F/,W7&10U-J$V.O[(&8) M,PM9R\W=9>7U2>563D:;YHL)"&`]L`\2(,(^%Q_DH6:4L(!Z%2$^PD4FRZ<4 M_7BG%3>V'2%'^5<%RNT.//P04J0*YOQE7>Z9S&V6S.:9!B-H]5==U_L;_R_<-EBD6>RNR? M/2[NC,X95>63=T!H2Q8197QOBVD"I)&]G%/TD>6M8GVF=,A M.(/2O-79?V"AR8*Y4H+>0=,O18ME>JA8+>N`P+8P32&R"X;#;!9,"7F;(/8C M5_!DL<@`ZA7$%IT3;QXK#+'N(?;T<5XOG`J2HRGE&2&]6&U3D>(H!/3S&F]6G&G?@8T@V&F%QYY@->[,IU.!"L+X?A]SG'B#WBC/( MP8/9?/`G<&/-G/(;T(`"Q:MD/;3=B7-E&+@9?PVK_<#2LJ([JAM/"NHIKF`O M4M4R_&QK[)A1R^<.H$$@L4@JD7C(J4?W";/GG:H\/.2)5-D^FR$_Y%Y>F6+P M^`CF%BSR$(<_@Z+9[J`4YU&0%X"@BN__O[TK;TX<2?9?1=&O.]YTA)KA,!C/ MV]T(&WQU^X;Q]/H_`>)8@X0E84Q_^I='5:E*"!N;PWB6B?4V"$F5E965E9F5 M^2NPV-'`#)L]7%'`W(2[^Q2XZ/MC4%MP/UHNH,WZ:'FCP0V:%)[0UJ[`[8RX M@LM6`]D=P9-J#-&,;1DZ/\V2PC]>C=CS]9P!.1RZ,7DIYVZ) MVMJUIR>>2P*#@XW6A:9*P#IV?/G,7-;L]M@UITFR,1^H)Y@`%'&*@> M*%0VP6:T:!,U_=`W;I!DF(1G+(TCW`MM,0!?KN-X!",NW00Y`$/^]PE(J0I#L"YZ='DB//X5#\P`E#U*#X^H83 M@0J_=P+'OX>'FQ2_POOQQ[[?ZL`7(>U"=H>@,/@]>E=@&"B6!<;3T&V2QG8' M0[`4>MPC!VTJC9S&"+3[",9*6RKH!1C[I8"8DH_&))8='3++YP!R!9:ZOK7? MQO@U1N$BMIT]BD/DLZ@9=4*[#H?R(EA?>K0E8&K)II;E1_-E[*,MT6NY=#\0 MSMBZ;!S@VP*WZ7=X@@0BZYX$$.T,&O*NC^/?H:W'4`EGZ&KOPHX@KK/I] M[(OF=G`.^(&*+&,_0:M0WXS]`Q0%9$&7-II<<'G_"PN)<$81S8.G&3H][;370`B$.5F?0P?NBT*_7&<"1@BMEIV3.-%M2;$ M`4-7?=PI0U("AI?'IN)=+20FGH)B6VNF+A73YITLMWV0G+Z5W[.%O$T[HI3N MBA*<*^[8NX6\]9NKLE50!-`@D9+]%2^@I0Y>GMCUF_): M*Z"4*=YU!FQ0E$EI8OZ'2/'NB6V$=LYA8QU[--(^S"5 M`N_]-W'J(@A$DYVCJ2_MW:5D-X`E,QJ0_:%I#C*KQ%:)RW&MCB^:P,Y+14SI M.:`<:>N?W?PXO`FBX7#9J5S^0O@A;#M*A_:URD9A&8O-^:8_PB`:W"-%W#2A MNKQG-2(#5M]0Z?NT;\&6!:N_ECN@ES0D\_%^S=8MG> MV\G3R^!K,5^TR]D]L;%NJGJZ9VJO73=OP467[,"WYTLENY0K\+MSNV6[`-Z8 MU/%1%Y88"_@4=3$$C4&DE.:X!=`%:(R`0]6?T+KOB!..;;6EK3/&?<*$;UQ\ MQ(]"* _KQCYPME.[=78JIV[&P.ON[D<.6=K[LF,;S5#W9+A'%>T#VAJYNJ M5@N1GV'\_5$T._032\ M,9K8GK`3N\:&`9JRA._%:S@TU10E##UD,]YJ!6@W2/,66/._H=8Y#'C&H826RUX/!ZG[/1B"%DX1F<#$+&Z# M,S'&QQ^6+",2_G!`."IZ>IG)'S`R$3MW,V(4">^;T[RF M-39\)9A'^F8) MG-J8F'/DG[G_%=1LREQH?(BY$=":N%$'RP3*M/CG`<"JTK#-MWCREQ:$C%<&8D@XE99(]Z3RCS1&Q?DOT^0$\F!/4IKR1)C6*)#A."WW MC!*#L-8GXJ6;BS>:5+;0ZD&W`Y4YC_N@/!%0\A7'-D+JBUC`PBO'#6_ZX>B] MO]Q+H@)7>-RA*$IZ]'NX)CY2`2V,6 M(\E;9$!1^O"`U@7M1>P8R!PI]#V&HG(?JPG$AGV03BSFZ%/K&+]A?&5*T'ZN M#SIU&:M&SHA17H$*&*,1%#\0=62Q*ZY$'^N%8(('*)P#.B^!B!_% M;*+0@;P5IZ;2'J`75;&!>9]-%#3I_$[*RN*`"3%.BP?;8@]C(JO#DKYA8S3! M]$I*<=B!]IPWE>;G#AZB+M$EBMG7"5>KN[5WPR*%7=G4K+5C<1F_CVY$Q<7 ML.B).[9ZW;Z67(.OIKH`E?NEY_IP1M&LG3U,T1.OU`H#]+?71@VM5[:6!1P7 M)*0V;/22D].4*9G[/[/J0.9K4:!2))]P3G%,2&.B2,7Y&5=-4`X?)[SY^H'V M(GP9XO'S6B;_-T4M+/PJ8QOU@EVGK-^>KE1BW>!>3$@5;PB[R1#:? MY(<:"K,F(^93PY5Z4J^4T*3RM\97E>=A=(S>%+](T=-$EX.2)<1F,&B42&89 MDJ5!9C1M@9.VU,8FM2$Q/F3YQX-*].'ON4RQ5"KMY$K9/0H4T-O0[*?5#FV7 MV`[$07-$"MS.KEW(E^U\J9`@H.($43QK.;E/HXFGR6_-KY;K8%`-GYU%^\Q! MT]E"\3T:"O8C//?YER8XSQX./Z&XHQHR5T6C:D!DF,;E=L,1)NO0+VE+I5'[ M;5;U"7=.*TX0:[>L?Z-*$ZY>UFUW4>40)_S&M3RI%JZP04C<19-D>"9*0M^G M#@RZZ[E&%:\QL?T7$X"=`>^&4JT!U8`@J&4D7G"HO$#WPEH M#E9E$QF9A0$T)P02KHH7SJ3]"V`*9)$UWJ.WQ>)>=UT]V MP:GD5E4VL010^N[,T$/;J#IC4T%V/G;_>3G1:9GU/N42"K>,8K+\+OCH<370 MPX@)5=$QC7J9V4.ZW.U1)+-!KY"A1!@'W-C';^2MDMTX(T@B7"SV2='B>%-+#U4)_>#194>E3+G)QYNYZM MQ)*(X09,A^;)#8:HS8%SM#-A6>@-Y>Z42)57:!'\@.4GY[S"6"$`G11$E<2Z MH@F,=MCW7&!5)L`5GCL37K83]T_X_S<6X,J"_Q9!@,(WZ,++WU9%;[V[!7_: M@C]MP9^VX$]_8_"GU:O0OQOF4[QPS[<()Q9ND7`.DM;HL;,8\@.;OUC/C3FU MWG5Z"S>UA9MZ![BIU0KU9J%,?4K@$7S:8DK-ARFU6B%A)?V1`:6X!_^EJ%+< M^2VT%,R_]5H,8MYLL:7>B"W%_,L5^=\MRM1-Y5T$>`TP4]/ZF;&F_B=7RFZQ MIF9@3;V'+/R=P::$$&XDXA33MH6=ZGYDV*GWF+#U[A9W:HL[M<6=>D?<*4-W M;\&GMN!3TW6%[V3*O1Y]BA]-P:\PA'R+0[7!.%2FK&G;3#.WC,RMI3.)G%%5 MU68?*!/D!02L]S+1MA!8?T<(+!Y?$P=+7%LB&);6BD#$XBN;`HNET:>PL<2U MC0?(>B]]\%^*D&6:RFDP60D[8XN5]=^`E94^"S<#+4N:&!(GQ;+4E1<`@BPK MOO=%Z)WX]AD/O!DYRR1DZK(!"Z-W[ET[H;_)LCX@RI;9@25`;B5Y^^;Q-5!_ MGI5N4Z#C#9MG1>:9V^9O>2/G5>-O-Z\V![$K=;HL#[[+?/W'P/):U81/@GRM MUN3=''ZN-UUY"^FUA?1Z!M(K#LL]%VXS`W-_ANYE6^%P;7XH;@[PL/578FUQ MP_[NN&'QU#(GC#F9!):6AN_UX8H>YX(I6^\,VR*4;1'*GD$HBZ?FB]./9VMS MTNK](:#%&&;CP\W2E[#1-B?+C_)]/^GX49\6@D+[I&[Y]`&!SSXE()@^;6'. M7H`Y$W4(6ZRSS<,Z$YGV,>`97W@%ZAD_$$.?\?FX-0SMX MY3M]NCAZJ!]?>/6GX-6B3Q4M=#?8N^XGT"E-4*C]\)^?\I_^E>X!7'[\48NN;A;@ MTT1G4O;3OW+%E;%HBNR5,0D^UGI/]!$N8:._ZN>=D^')S=,)_/!!9M\+O5BI MB`W/KOXZ`E7>O#FX>JC^M42.[1#'"H7"RN0L0?M*^70UOF_?GK>BJ[,J7%Z` M34W/F(G?2C@5L_3?RAAE$K]2/MVAOKDE['EPOHK@2_")-O[-;R*^.6R;I*V53NW(]_-6L8_'';?1P MO\AZF#8/5RQ72>K7M"S>G/P5W->JQW=WS8>E"E9AMUC>VUF-9,WNPIJX]@M7 MED$5;SN/GNK]L+YN7_2_+Y6!^5*I ME%N-;?%"-];$/N\6OD]N'QZ&YT?1'-3&NVHG.VN2C@?]Q MW#YY??SI.=[MY`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`;.6"7L"(RR:>21Z58I<[`EBQ/Z_IAQ-9N$ MKQZ(`W(R".=/Z81F*[V047D&=,B9GT@,;/<"/M."/R#RE<@UUTM-CDZ/+O6: MD@R>AJAQ@*B<;F7LHOF.E#^"F'5DL\3N@.&$@IXX@H M$NBZ\!069N"GN(X.T_RZKI,\WV0]>N)4.Z@M93J++%*8;-'$I@D9J9DZY%QT M'1+K6\_[!K=W"'A)5)4X7H>2'OF-&4R]L`'8;,> MW2YE6=N$&$4H7E9O0&#&JAQKX#01FSJ86*-0J!1Y'E%\@`$G3"HH?90$/IG$ MJ.!XU1DEF+()\[;9$P76WO/L9)C:P7"$),1EC8@!B!+Y#<].4C45CZ+8(D83 M@;ZU1WVKK\':2K8SS/%_8&Y&$_,W3LA+>; M,N6.9S85*'%-BXY9*G.@#=!J0L`V@,,%_`8K``''+1%^Q5D\#+%])5#=C13B MAIM$76_WGACTTN6"?`/7O,N%0!HGPAB\B8^R01(_%S+YO.JRJ.C@;H:BP@J7 MZ'RFF+P)2PJTDQ&9*S.GOH(@B:%GI-AK)?(2>`KQ;J:H2FUP2IU@K>)_"`.` MP*=`IS*$)YU^F[@U7G_E(1--Q+O'O%0X33A@7M-PX52 M9L]HVM+/H8)'1KJ235*$8Z&-/?[B:V?2T;$?.[M3-JMPS!+.TI0;E>Y\16&M M__3K[JK6I=\)'G6I6\;@'(!O8-`X-R5S]N&*HH3GORX:*N1_L4B4<[H797!; MP&N9HQ>IM,S9C^;QW='#K_X]O@'_KGXNMQ/E$GA7<_1AFHXY.T#)7+?-YL6P M>P'7!R?+S#N>A_(I`N8D_*3;/CNA`6O5[QIT>9%@4S+PBVDG\Y"?1L:WQYP/\X"V1[\4YZ#8;GY/B>J/1P:`K73AZI'_N:[VGQE*%O@36'!AS MNF>8*?EKQSFL]K\0MVWC&9HF-.^A_OPCY]F5R- M!YC3^..=.C!-R)P]P,^]I_-KNG`]G$3GCXM4[KQI94BC8=Y5[9RW:2/*[Z[> M?U]$0QG$YV!.@\4XS\(V18-&_%E<(/KQ8N45(U9^=KI_<'IV6C\]W)R`^6Q8 MSF=#Y7K9+@<6=G:S=@[/EE$'3<01A;03!?BI7!:>BGWSJ1C#T)EP(3&>ME#: ML_?*>QDC>,>(G].O)Z]*Q\KO^XP!\#E7RMI@+,HF4[#G,]F$XRL.[D.8@"/7 MZW1&OG76&V&(`V1?A]B?2"@1LUD,Z8[(WU'^+)U7ERM*()KXN&(ZW"(&JLU_ M(4`(0G_/6/M&0/V%[G\NV-""K4!>+/+??8)GGX%E'Q>W_NQIP3^@[]^.UW9G M'YQLJ[-]Y(TW+HC)(47"\3:\RU[@B-OX2!*$SI`'&(^[7`=.&PW)$R#TX*4$ MEY!G2KCRF&DZCUUR(H$M*MU;@?@1GQ4HX%?5:8?FNYG%#IT-C_$A,;`-<)EE MV%"<0(<%[EB#S]!J#'(TRP-.TX/I:G*&U?2#O)\V%B`>#>__6JP2,,46!060 M4[;H6\AY36]^WH2=>\P^H@N#F["YW,Z`7@*U-&]GIJEY35]NAO"M[MT/R1C$ MWS$\L$23%"LK2GN@.N?MSPR*7M.I&GUZ>*3/O2=R6.NU1?S.E/!+*0N*?-Y. MS:#H-9VZNJ<2WFKW%WH@]?!BE:56KZ?F-5TYNIW`E18P8E*[P_<<+>(ZI.<< MSCU_4HAY35_@\Q"?NO(N^)?KX]M%BG93I@\LI'%6V]L(,N%":MHR=DA'$%_` MPOI!3EI+M76KAJU;JU]6?IQ#&.!N MOX6N:^'86/M6+W('5NFKO42(OY?A%I]%\DO!\GL#FM\TGI\.6_8"FI^RFA@L MT3Q1*LV]F'7VEWD6@-H6S>6S=CY?!/J2M*6#2B8V3C^<:R4/)*?SY4J%';M8 MW+%C%+C/>V6X%+M,8W'8,F4Q^'S2JS@&B^Q..P9Y@LOQ!O07<&X\WA97)BK( M1]IFH!J)4J:T.^,Y??]NHUA>>"W+]\IE>\=D><[.%O!4U,('8GJ,!33W4J.M MN=//I*]T@UN,5GZOW!U=/S0G%-U?=4[Y`J2]H8/79^=U^N4';1;1:Q;*FY\G M"WPQXM[02_AZ,%$VU3.PK*''0YJ/)7]G0F@6_H[-W]G3<^ MJY^WGQ[KXR6F$I.;5=@!=?W*SID$O45(C^ECA\LB[D@.*MVCVZ7V#=:=HG*) M%Z7L#9WLWOY%X_[`U]LM^F6(DWS9GHO:SUP";6_H*;H.E=OF\*'J-:[`*5H$ MH"(5@"A7*NV^LH=3-+VA7P^#'YW@)\]>?-])=Q$'.F7VP=*]\^K9ET+5&_HV MQC@6*.%!T&_5'SOC1;(#4B(=8'_L%EZK-*=H>D._[@]H:^;N!\_@@_#FUHV3'$1$X>JF8N-^@4\'*^>SV5V;,JC% M1H1X*6\9Q"=)Z2F>GH[S*P("*DX8OUF_H"+@?NP8PB/Y@84+<$ M6*QN^T()X'WCCJ^6K]I-HB3'[TS'2VY'>"*,EOM/A,=GI]DP9_KRF.*8![A3 MIF6B.Q8Z\GS84TL`?]-Y/1V98\H.VL`'SL5'Q,6L(2AC/D@KH$,J^KTFWI*Q M#N`='J7AZKMRE&5:ML7ARV,+!M3J.V.*Y0`+^DY3P((KU'+XE5W!*K`)+C4U M,0D-X:@>AH9P8-CB"`B'7E$!"6V6SGKXZ-1\FO<9D40*>R`H.=*:$(5\\0NG M50O:D71=3`*NRG`?>_XHQ,/+%(/H@$X_ZEK5PQI3"@1PHQ'8S)C^R:C:3RX? M369;8>^)KJMT=A`]AI)NBI$T`Q'D#3PVSC`;^M,9&3T#K&)%>1IS[E<^/YI+@K MV!=G^NK]B/L`4HF,5FC^+I\-/"0X7=MJC"+"_A6R[7C*C2]^R>C1QFD"C`!; M+,+8FA1C%5/4W@I\Q[@&RNT[!E[JB;U7V0]-;8GR+1E[":T_,[4,GQD$0V.@ M<(L3*VEOUO/Y1KG+S(H5\-T-CM7J3PX[DEOHF;^WGP?3*(Z/72&7B9NG_U%/RZ]0]GY.C23H/G[=%TC)^SX M_N?/[\&OAT5/AU^]BL7XR'G_W7]4%UW%[Z5G=QSDEB4C$_]8.C MHS%CZYRW*'-AZ7-CWAY,4S)_+R)Z;G#=K%VW?YQWKI?=A]R[_C5;U(HV7^GM2#\UKU^*Q;NZTOMR8![(OYZ-ZV*+PY;;G[(3.8C M(U)3N;RHGUX<'UY43L$_W+^H6IC6?+Q?/[V\V*@TYVI\S/2+-BNY_9K;H4YJ MT:J@J009[6W-:U:Q$4P)ZG`=;NH![_,(!,C0/WY_:@0(/_?_4$L#!!0````( M`!QGKT2KX&UL550) M``/8\713V/%T4W5X"P`!!"4.```$.0$``.U=W7/CN`U_[TS_!]7WTL[4<;+9 M^]C,I3=.LMEF)IOU)+GKO=TP$ARK*XLN225V__J2LF3K@Y!H)[:0N[YLUB)( M`OB!7R`@_?C3?!IY3R!DR./3WM'!8<^#V.=!&#^>]A(U[O_0\Z1B<<`B'L-I M;P&R]],__ORG'__2[WOG?#J+0A;[X/TZ$R#E,Q/@7<6F@GYVP?UD"K'R)DK- M3@:#Y^?G`W]59;ZJ81X./*_?S]O]9NKT<'WC"*O%M#*;U; MD"">(#C(&HK"^.N)^>>!2?#F,CR1_@2F[)K[*1NGO8)<\P<1'7#Q.'AW>'@\ M6-5"*KGXYSV:/#KY^N[ ME/E^F*&SJE7K):MW].'#AT%:VM/:\+RE/@2/X!;&GOG[\^U5J:*_>!!!F**I MV)S'?+H8&+K!&8M,EW<3`*7[31M2BYDV)QEJ:"!_-A$P/NWYBR#4&CEZ?WB\ MU,\OXB[I?ZB(P] M<%$6(NLB16S,Y$.JTD3V'QF;:4B.C@<0*9D_,>(>]P^/,@/X)GO\VSF3DV$< MF#\?_Y.$3RS2PTD.U3D38J&'Z"\L2E;:B]@#1*>]C>JH4!F%N-49=*6&H92@ MY'DBA&:K(JZU+!.K7%9FOV`U0U&6A`D_;TC_MV8RY5&840QD,IVFK?5#!=.\ M_ECP*<8C=\8JD9H#/C.MLZCG<1&`..T=][QG,%.7GK<[Q,;W>:*9O@4?M``/ M$=R`0J!R(,V1:R(E"&2S:';\WI/`[RI^TCQRL;B!*EZVH@R?4A%!/,JLV_7_ M+0G]CP3,6!A\G,\@EJ`G@R]J`J)IQMN@1H:62PV"(#H):L?V.Q+8#H,GLX>0 M7^*5/8X2X4_TIDU6YT8'TGQN;"(E"&.S:';\OJ>!7RJ2=<-AW6ETKOV2VEW& MR0\D]#P2?`9"+49ZRZWT.#=[H9DY.=;7)!?2U:S70$H)J6:9[,!](`'<.=>G M29'XAKFK6,OQ:([7GP27U5'C0)F?11HH*:'6*)$=M*-#$JA=Q8K%CZ'>I"ZE MTF;V<>Y'B7'Z?.(\>`ZCJ+85=*^RVB(Z5*$$J)N,"+)'))"]FW"A[D%,S[@0 M_%DS7AV'#109;C:*S@2Z#ME#&(4J!&0SC!-DXE@(NC.Z!FXY@@UB;S0.+_FQ M=\06YLS;?.RW$U4._!4BJE!A,B%H$3F.^+Y((&@=4ZUT:\P0.L*P89(AR-$X MB%S`?P2WH`U2"C+-FH@PSA(@J8)A,"%HTCC/GB51\"N("9ER&F!NGA2K? M#2-45`%#I4(0HW&.N4C@GM^"UB`$(R;PJ;&=,!]G."%5Z)IDLZ/WCL9Y)I\D M[MF\=6USHJW,E79:LC`V2X@@2>/\DCIX6S%LH8P:&U:\FOLKQ52! MJ@6!A#\)&)V%SW:!&3:9)Z8/0Q/O3#ZK;=O4)F$PX5J`+O(BN"+@UO M1H'A]'!O\A`$3""6X1-S>NW,-O47M_-;%2;JA%LK`7$ M(FAX2^JR:A&6$08C+E)U*R7"AT29$^H]-R=3'BNM0\W*XU6L0("LS@FOVRBZ M$=^J44IF]2*M<+NA(M9&PS/T.8RY2`6WV@U6G%E`K?CWA&5==@3)!LXWGPSO>RM%+9=! MLQ>&:=%GNZEZJNWL7BG5'KN:*?^IN3A+PLB,D2S4H#)9-E!D\Z6-HL.#1=S?!U3CCB,X1S\`+%]SZB#!/4H\9"#]DT:TVSYI3!BLN>,Q* MQ;346^=^-WF&B&[O0RD3&`K!%B/!@\2O95HT4&0:ME'04K)5!LKY@&D`NV9U M7/,]6$HR&(HEW:G?QA\OHD(Y#;`XUYUS61L+:+EE]5F6=WC-(/5AW+Z,6LM6 MTV6QK#L[LO/(K1CL)GO-<36RV4DC#;(NV>R%A,(187:3RN:^3-GTWD:&+UAD MM8^+M'%*&H%EH")F>X)6O\LXN!D(IM+3>.[AK-A;`T4>_V:AZ`Z5)GYY!33: M*5;Z'"^6;IA_L+N32Q+KT<-K%I>-:]5.0'CJO'*;8@@]D7# M:7L!,P%ZR4L5%P?#J7'9_3?]64'(@7(5R(Q3$D6M43@$0!H'*#V+/87F]667 M7%SPY$&-DRA/%ZL@Z$*Z3F;'28EBV"P>Z<1&LQ2!E"EOEU";'+'B-5CE8KH` M5<0@G;]X!^D-A9X./C/Q%0I251?A5L)\.<8)B4+6)!KI%,;T]C[C_A/$6D03 MK3,,IF$<2F4$?@([FEO4+*:`.-8DBO=&PF^>%4GH"&!10WO.8)>'M+48EUJ^ M=L;?SSIL0))V=F*Z>=0%M&PR@T,L::UF^)2B5=;B86'GD991(IS>6)-@BCG[K^C8DB4?'HVAO MH83V[,HNQZ4E801)N'&@7`=0H)1=7N2W\U]%F'BF)9;RFO3.?!OY/E2I]KPAH!OXS'MIT*]MUW\:RQM[[)F^R>H7!/&=U- MXH/Y',AEQ)_7$_.FD?SK%G8?P[_NB\3"_TI;K_VR;W28WI9J!,X6/TO09Y25 M-W"H+?K)]H:ES2NN!7>MV.D695/IG%>WW80*5F(6F'/HAHW2'KK!:(1N;(=- MH]248^+_4"$=VV&[3:P'#1_+_X^->YV37W*FI!&&HF41P"1

VN:Z_RUBS!30^M\?T=W_I71,B_:E3?H#G1HG@7:=\^T"7)6Q,(:"&< M?8@L?[.N]8-DK=!OT@AJ$TZ-O'UC<=,5[1P.?*[+7D":B[/2#OXNW5=IJW5A M<6GK[=O61IHCG8I2EZWRN816*T+H44NITK]]:ZAI`$&<1CQ+G?_J]Q9:(<S)=KY M1FR1AK)<#\=CO80Q57N?M`MM[IYJI*7F+5_&]&SA+6^HV.PMMU4D M-S4V2<=;[:$]&ZC+#7;.O&;9UR-?`/H=5604N%>L#`F'BF_5$EQTTIYG1,$L MM$W7/M'J0SU`TI&\/BO:R=\J\+C\[5E%-;C?\`;`JB[2'R]+@8(@#7,M?+YK M<0$/EJ]GMY*N;Z=P4FJK_V48Z\5KB]6_H6+SZF^K2&[H-TG'VZR!](?"BJR; M`/'T2@D"^[<3W(@M=F\A?LL8VV0GG;YS"[-L=3)O[FFX_-[6KJMJG)/V]E-,-]%*/V(RT3`7?@8A^/0-_OI]:!3ZFM%[F*LS M/92^7IBO'D3;A_YMV]_N`P5?@[,70K"\.=J!KI&&]ZE4!Q9>J+W"S<@.5-C4 M^C[UZ,K'2V>#VEO:;[B"=?DN)H1-N]SKG/`2YEZ(Q2KE;*?J=^EEGQIWY2=; M%\T_#WHAUD_^!U!+`P04````"``<9Z]$\P$F:>DG```'#0,`%0`<`&-Y9&DM M,C`Q-#`S,S%?9&5F+GAM;%54"0`#V/%T4]CQ=%-U>`L``00E#@``!#D!``#M M75MSVSB6?M^J_0_>S,MNU29.TM,STZGIW;*ER''BBR)IG*Q?IB@2DCBF2!FD M9,F_?@%>))$$0(`2"+"%JNF)3.)RSOD.@8\'P.'?_W<]]\Y6`(9NX/_^YL.[ M]V_.@&\'CNM/?W^SC"9O__;F+(PLW[&\P`>_O]F`\,W__L^__]O?_^/MV[-. M,%]XKN7;X.SG`H(P?+$@.+OV<05TK1O8RSGPH[-9%"T^G9^_O+R\L[=5UML: M^.+YV=G;MUF[#XD\G\Z0/._>XQM)=Q!8$;I^YE@1^/3^MT\?_OSIUX]G5[>C MM^__^O[]7@.=8+&![G06G?VG_5]D,?_[[.:F_^[LPO/.!KAD>#8`(8`KX+Q+ M&_)<_^D3_K^Q%8*S=>A^"NT9F%LW@1V+\?N;/;W68^B]"^#T_./[][^<;VM1 M2^"_WF;%WN)+;S]\?/O+AW?KT'ESAD#QP[AOCDZRXDC"7.F77[*R'\Y_WMX, M8^'?NBDZVUJE7M)Z'W[[[;?S^.ZV*.K>B;9E]Z7Y]3RY^089[NPL,9T%;1AX M8``F9W$SGZ+-`GE0Z"(TC<<>?G:9ES7.%I+9T<>-N MWL[!?`R@H*RYJK(%G:$FH+T<@[=;&XF)2VI@7^A,XF*#\-9L/PA>]\]B,WVES[DP#.XS'L3:7R]L9QD88?_OS^EV1T^A-N])_, M1O=%1C[M^BZ^?(/^S'4'UA'P'>!D'>*&CZ!2W'G6O1?8N3X]/'@'D`AP#,O$ M"LX@'F]T#.0-98^ M#GRC>UIG`H,Y4\"@#,(R1'T$"RR-A1H*H`,@(D'O/[[[B*K%#_W!IZ<,`4_S@4N1#8[Z;!ZMP!;@(:^E'$"EWZYPV86E[B M^!=KMP@2Y6Z*4/&N3'B(XR$1KOQ3$1"4(&/U2U,F3T3IIM-ESMZD6ZFQ<[=D M6II`0?;M3'.)H"@]V@N]KEMT=Z$(D6S[Q?1V_HY9<@@_*WI(:4/H!L@8NYTD0J4L858 MIC#(Y,MHB0-%'3(0OS4%Q`A:.(`WW,S'@5<`@'@O-7S^GI8&+XA/8_#-$I8! MF+IA!"T_NK/F18]G%@@H:'E7?L.6'\#&R(,E#(Y M'(IE-`:BI`X%B2(EEH9$9PDAY@1N:%O>_P$+DF>!JF(I'M1B6D)"5XJ"2L,O MKSW7`["#!)H&D/QT$$ODGHU\"2UA(*I"0:#A%]M.,)\'_C`*[*?AS((@O%]& M\>(:FM'(PQ5'A?S8Q:J@,5QL12GH_=HP>LGS/0"+`$:8@R"]EL7@&T_1/&+D MHCIC15&.@E)C+]N)=`^!M_0C"R8C`!D>2ID<+L4R&@-24H>"1&-OXXE8/X#G M??.#%W\(K##P@7,=ALN=?CE$*LKFD*&5U1@AJGH4I!I[94_$ZR_'GFOWO,"* MB.@0[N<0V;^O,0HY-2B6;^P=/8L<[.AB#UTICE<5I0H!DV(I+;&@JD1&Y&-C M[_)YP9*(3C4FA')$5/;+M0"7G%H49++W^[^?%_1`[3\=NFOATO+P-J7A#(#= MH".Z2R'7B/1=";G>E*_AFUT(9A>"U/'2[$(PNQ`DK(U+6QFO/R)=A"&(PHLQ MCGG;18I,OIFM*.9O:CGQ%Q6@C$>JS9^&'9@H4,KDP"B6480)Q6T"JBH4$J8. MEHX5SBY\!__S^7GIKBP/R1M>1!T+PHWK3Q\L;UD*_(O4R58!N.HHA9'F=P&W MQI(FE@,>.ML.EDC2`;`!DAI-C'<@2O4L/GL<1;-'D%545PC9^FDW6UW[*R18 M`#=WH(@4Z5:*3.Z6KDCDY2=;_N!5@?J6[T.PL%SG\WJ!:!!`3_U]-`,PIU4! M$($:*4X\-72%CTM;25OV#A@)G15^K0_O_:W[]9?0GEDA*+[T\!3-1D)645T! M9.LG:0_@D8@CBS"RB**^8/`\-P>O)!PR&@;HQ3O:]#TK.:F#Z,\"OX64YR6> MHMOQCU%4.R[/5DS2-L$#*'W@(QV6-I;HVD?"3_%QV2L8A,61CJ-D1M\9);7# MBZF6K,V&AU"]R/*G+F*DB4K(JSZO;6^)MTUU8M];!R!SZX#4%!7F$49$]=^J-( M?P;;A%).(0H2"F,>W/%B[@BQ?C'A.K")QX8_*HR(]&'*GV*Q29L4&25VFW!* M)90%\7D@(JI$P49AY&/O&#AQ]RCE]G;>*MS6&I*R,A0\%$8X+AS'3<3I6ZYS M[7>LA1M9Q27EBE+;#4_D4EJ#1%6-@I7""$=\#!_OR$J#TZX_[6-U7!N$VWNI M_'AH7\*%MPS3,VNE">P(;>T=QJK?EM;><:"9*'N^%49;!B!"%@'.9POZ>.4) MZ;6<+^-041>9WG:+3(>_0NH-'!6TAIQ'80JN*O>4[*2,8Q'XBP@0S/!AK16X M]NU@#FZ"$&^1N9^,K'5Y;:A.[=V*D5!MK>$7-@7%%Q1&>,J*5KZ]5+ZUZ`T: M22$*+@HC/+>N'\`XE7T$(`B+(RWM=HI)Z;;6B)25H>"A,V2GT>:S6JM<<J*1OX2CR#*`W@+WWWT.REN1;;#2%2;YK MY=E`3#X3D\^D%G(FG\EN!#7Y3(3FKS]H/I/\:@`:Y^]A[#-.'(CN`QCG8&6N MBE15(BZ44"MI>0""5V'M\J7D!4_RZ5XLHQEZY7K=D0(BK+3"1#A+A5L`8UE! M[?*JD`2.\X7R0);LS0#..TS>E>JJ-U\N+<4 M>Q>@@;YB[;EIB6?7DD6KRI&GVCU MMCM=+PVSZ^[IPIH*6%.`MD`4--`O66Z19,]E;_L*:EUP/:[2SH M7+RM")!J3PI(NNB7P[8+%A`@/A';S'N3@0W`M@-UB.H\G2RU*&%K#C*;K[\@&]J,[HL774+[`'>4FS+^.1 M7Y*YRZ=X59?7$CT.-?7+<8N_AQ=&6*=$9,KY_ZIB>Q_C)!93!!B_YP4L'?5+ M=QM/M&7M2(2$7FJ??!!*M0$SJH;Z9<*EZL4[6O*.DJT`CJ&E?JEL=]-Q#VG: M"7#&M"42/)VO`S^\!),`IHF41M8:A,5,,8@&YUM)4C_<@F@6.+N1ITAN%/2\ M'D"^]H:7Q]P77+\WO'8AVSW.-+%JUZV=3OG!]+4&N80;]4@SGE&#AS,*P M!?CHF#*8EL*RAZ9C=^HG7TBP-R-H^:%EIXMO\5]>LA3G_&N93+U9PDMB+K8D MD13IG:KIOO??U!KK6TO?;-C\^J4Z)NA.27_+47*W8Y%:4DLO8*JF7QKC+.ER MEGN'$B>M*I:="Z,5TQ(JNE+ZI1@NRGIIA:Z-QH^NZRVC4B8`SM(4U(JE%8%7 MZ7,$"$N*ZI>4^`>:#&9(MHL5>EF?@KLEUOQ^4CHL3WD2ZU9/L1:NKN63*VX$ M_9(ALW384X']H!_6"(=/,!I1Y!FU'X`*OV&9JR+%L92\%1TKG/6\X&7G^*(9 M*W8M2,]5L>M*>8X'DZ7"9*FHA9S)4K&%RF2I$)NM_J!9*M"+*Q[8X\W&:%JX MW/P#/8S7_G8OT(4=N:LD>3QE>TWM!G8A2=$&M"2L=0RA7;:,5L>5#W!%[KBS MPJ]1;6.'(5ZG0(K&+HB_2H]F2]OU0$Z#47#8<]U4=]OO'$KNKI4^*1\$^8E, M"J>0+.X36:22Y!-9E@8GLAI[7LH'NRR.@UWF7-. MMA5"X2XDI``$5@BZ(/EW3_GL&[)D@B-><;>?C+=B*TF'B&&TR]%<%CX;%-'S M`]P5(7(H4H7J`H0JBL"OX==$T$E&.&)>'EEPXXVM/NK-+9V?XRI+!7B_;,N1 MS:FM7;Z?LKQ]"!:6B[\4'7\@(]O7[R63:0@-\U=9FSCJ MU@O@A;/"W_,>!1>3"6(G2/=BG)JG;!:H9I;5Z\'G\=V@4GW]DF%E`B,Q[>>E M"P%2'(U2T:;O63X^*(N/QB[VOQU5`)J_8@%UCHJM=@$>P^B796O/@3N!C[1; MQH=U\,MO8(/R@5;.XN4GGER\U8C3C:!?2BU^C6O/[;7G]'9Z@8AA],OG19&^ MY_IH$CN`\W$TP/8/5@-MXGQ,0^B72RP>NH`39\<8``]_IKYOH4FL"\8E)L!1 M=+>QW&#*N7URRNV+R_.G1(O;`,GC6DPD*47)F!+*-QZ=$D&T"\! MV0`L4C:"OYW`?&YYBFZ_V<0HVDIDV_3ZXL#_MR'T`79[#*1Z$+'E&G:I:00*2JENQ,3'G]TG]]GDR`'=U/ M/J_MF>5/P0`I>^^3M2K@7J=J=IA(I*J6N(LIKU]*,;*D%V@(@W"#1JL'RRM_ M`TJD#O,)+];1$F).=?5+7S9<+A;)<4[+R\X27_N3`,Z3?>SD%V[!6MDI6K=-J!3TJDC()"6QPUT0@7`4I"S;\K8/?'@/IY:?GM7!8?3`MHGW5*%AOH^JFPCYCX"Z^@2.=+3FQP6`FDD M5,DK/6F%*L64)Y@P*3),BHQ:R)D4&5NH3(H,L7G\#YHBHY$I.\OOV@@]2/.Y M-C"U:_9J)=F\['0>#3--@DI(_J$[]=V):^--.HT2R8/$4<@3#Y);.8DR--#0 M0$,##0TT-/#@$>D8\VD*TU&FY@36(TRKFG&TPXRC%06["O!!JL"W`?1ESQ++LN8BS9@&11VM*(2R M>(W^D1D3@S&LP[`.PSH,ZV@!ZSC2B%0GVE(KKM+F"$HK8R5)8C&9C*;8@T+J M4A1%^0QO.(KA*(:C&(YRTAR%$AFAS$S9=S(H\U;Z60OBG*,97RBIH!4QV$L1 M*9,=$+M12!&(\BB?90U/,#S!\`3#$PQ/*/,$UD25^2]K+DN=F#X/:48;R,IH MQ1V&$9)I%GA(AA"?EHTVN&S7#?'0MX1`Z@(*=]\JUU"XA50^<1OJ8:B'H1Z& M>IPT]3C6B"0X+6X'*M'I-!N_Q*9"S8B.@-I:L9_L.S^;9@@/LSN%'(5,]WV^PW'%-CE@JG5/7?2P M)H>@FMHI4]VKT@TSU>(IG](-*3&DQ)`20TI.FI0<:]\,]R2X^Y@7][2Y_<87 MYY2G&9_A4E4K3M-9AE$P![`+%D'HRLVI0N]+94"%*I3R.=^P%L-:#&LQK.6D M60LME%(U;V5!E,KY+0V?5,Q-FA$-AEI:T8OA+(#1",!Y%XPCJ0>HR1VI/"U- MEDCYG&Q8A6$5AE485G'2K.)((Q)S=LM&)?84F(Y,K.E+,^Y!4T@KXC$`'OKI M]"T8;4;0\D,K7F1J:,U&I'>%%$5$3.6SON$MAK<8WF)XB^$M!X](-2;'%)4Z MTVH"FOB4J!GM$5)=*R[4">9S-XI_7OA.)XA3_`,?)_AOA@X)"J!T>ZV0I,HI MA2%%AA094F1(D2%%!X](]6;)[5[=6E-LMG6WQO2H&3L2-8!6!&D`0@!7H+?T M':D;8,C]*`T`D012S@D,JS&LQK`:PVI.FM50-KXPYZIME(8UGV7Q&/I,5)\XIC'0.JGN^V MYW\XIL;LX$_EM*89-V$KIQ5%Z02^C?Z%%NYJX(9/32W^<'2K-J-*M7S*)WY# M70QU,=3%4!=#78ZPT,,_#^Y2L?!/G=M\++S3GF:4AD]9K:C-,!DK!V`10+SP MU-!'&SEZ57D`B4,\Y:S`\!K#:PRO,;S&\)K#1R3^23`;H@2FS73,XI[R-",U M7*KJQ6F6XQ`\+]'/S_@+35(WIM#[4LE?J$(IG_,-:S&LQ;`6PUH,:SE\1*J: MYK*!J7(Z3,>GBJE,-UY"5TLK-A([V*T510"6-OC*9"9\_2ID*7P"*I_O#6,Q MC,4P%L-8#&,Y>$02F@KW_9][^MQ[*CBG/LU8#:>Z6C&/2)=6Z(;WD\*P MOTG^G\9^Q"JE4'%6TI+_\"K,)D`JX%V&2)\0YT$9HWD_3G"32%V$M+)@!B.] MH)[0,10CP_51X:N(^[QT'3Q>5*[U\A3-9B1642U!8RLG:::J#]L_0G`_^1Q& M[API560+Y)LI-(6;6H)15$"[.:P/W0#V`?I_9P!LSPK#^&4F-ISSKV48I['H M@M"&;BQU`:"ZU:/L6\*"U;4$6=P(9#?X5>$^8"N`$^@=_#7EE>?C=ELUD MA.ID.X&YZFB),J>Z9&C_HO)T&EY,"V`%+ZTJMCV51BFF)69TI<@P_57E0$SY M*/GU?&&Y,'Z#+XZ]W#6VPVUU#2UQY%*5#.G?COFA%>(G6BM&29$ZN_,2''6T M1(I373)6OZE[_$;0<@#RK/MH!F#ZKAJBV1R@@7[L`>)[GU"=%%J^.EI"RZDN M+6ZI,L5O")#V>/;N@A7P@GCH^+Q>`#\D(RM08R^%3%4-+5'E4I6"J<+@S(6S M0A."&[K^M!.$5525LW2*955I+7&L5)&"H<*(30]-W0^6MP2WP,)A"JP;3PA5 MN%Z**W\]+1$64)N"M<(PSP"-+?X2H.DBF":V9&/,77X[_E:5UQ)3#C4I6"J, M&?4""-RIWUE""'P[EP`>S2+QG]Y^L)CZ'!_:3O9(\N?NNC% M^2(,013VL$'!#5+$(;Z2P,,?/333K8' M\CR[=:NG2`M7UQ)X<2-0=B`H##0Q$O]7CMZ"%:L_E]`*U$44I^"M]1;I>.N@ MN@W2:??:;X].Y52^M=ALCC:;HVLA9S9';Z$RFZ/%ILX_Z.9HZI+]T)X!9^F! M^TEN;D"W0S<+R"E4;* M.#I5^CV*2NF4TQ=#P`P!,P3,$#!#P`X?D;;3^';@3Y84$X^AYA82K):-7KS5 MM.1"_$JSCSTU3'+BG7B['7AW`/.X/@0+RW72'5SR24\-(122H!K2*J<4AA09 M4F1(D2%%)TV**-N1"N-Y2!S067RG?@,I)C4:T)(#U3$$^R%JF`U1`UI-AH!J M"*&0#=605CF7,&S(L"'#A@P;.FDV)'F-3GC937@E37,RQ*,H&\[&U[OR^R:; M7?;B[5OIZA>OD,KY@6$XAN$8AF,8CF$X1UP$VSM(4)P*.-?#A%LH+8WQMZ`E M*:IE"NU2765:!"PM>LL(,8.+.?Y`VFM\V)(GEBBCZ8(3':5IK;WK.,9CI^%J MF)P/@(=^.GT+O5'L'^=MDJ2+RZ"0K(L+JYSR&M)N2+LA[8:TGS1IIRS2[HAC M=PEZ2+J]\1T?`^/CWP)U2\R;IZ[6K(A3_2.FM>3!@M_2=!@Y,LWI3^J9#%TOY&X%YIS'O-.:=QKS3 MF'<:%@_>'\(O+0^-\'Q18H&:)8)375-S&L.A>D4BZ8;92B=`(OH1C(/.`S=\ M:C)X*]"Y0BXC(*5R8F"HC:$VAMH8:F.H#8O:="!PW`@/Y?>3H>7AX8C2HBY62^W2#V(IOX0 M!Z1CB8?+Q<)SZSG$@6TSG:1NVRURG-KFJ_@@1-/Y%)/I>0`6>&^'/VV27O/W MK3*3(K>0RJFI(=>&7!MR;R`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`^Y<[OODO)E@_HHC=+H[L_^`_MX\/#\O;GM1DYY,[K@!-RYT M?'(^7#1\`^<89*K3G48WDW@!^B5874V^%+<;*^F[`3E@ M4!Q=WP6]O&+/\8_A:(U^)P_PYL'Q&G1SM@`-.#E%@)-S<1H0%`=ORXI@9W`9 M*W.']X3Z-QY^:IV7!AV<+4`##DX1X.0B+>2#4YQ6'U7_/`5ISOV(KP6/[YY&-IR%_H8_4ESTV)_)^*A)3-3G%/? MU3Q\Y1OZ^V$XN/-OND\O\GV3W)TTURQT=R*>630RQ3'U79F+8R%/-XBG?'O^ M.<3,>MV?2?=-:H_2W+/+J)OGC_XDL3OI+LHI3]I M#EKL[T3$&LZI1)%">?,RD3S/ITVHA9]*G;:$R MZ=/$YK^VI$]+QFSRS!F%0V_]^M@?SN+[^`A8P=0U:Z=HB-;6DK`(FT!^RC&6 M2/TXC?>+EC?%5<&:M?GP)5KHP1G87_`O`9A9U3D0)E9O';AD(\A/6<.2"?^7 MS`8O_NNWV0P['_[O1@#:0G_Z%)=C/T>)F=(,NAIW;^!5, M`&-J70YLRW5;ARE!_092HK`D6CV&7OS'IO\R1S<&WP30I%?F@)-0N75XD@S0 M0$H0EDCXM[N^_1Y?^+[81+>K8G[ZNM4Y0"56;QVL9",TD!Z#^3Y]FVR&CN*$ MBMVGKR+\F%Z9)QA1KMPZ2$D&J$@7(7D5^L:UQJZ'&I;RW2]6ZPVN1[/$4+ZD M:Q:ES:)T+>3,HO06*K,H+3:WM651>F_@ID0AOL4K-A/\*9+>XNE'^=,=AS21 M/01UFM"2F]0SAOR%ZDJY?@["Z1.ZEER8#T);%&9Z"[PH$UIH)\@D4\A?L*X4 M:[!`?XW\IT4<<\+W\3Z)8NSNT&9XT:8UTT[(J4:1O[!=*=LP_O6\BG^[ZWB9 M=C0L+HH>V@PO[K1FVHD[U2@:S-W]I_@C8MW9*UY)&(5WHHA3&^#%NMQ`.U$F M&$+^8GBE5+V'#;KB(+?;#!^Q@+UBC/Z0)G@Q)C713I2)QI"_:%XI%_J]P.+T M_;ODSO>KA^('R`YKA!=K1@X3`*[*=9X*$^P\_/2_0J>!=$ M8'=?0@11N,L&PXK"LBF/U)E8HXDUFEBCB36:6&.9YY1'<_+$/'_`^U^^=AY[ MWY_M3;P+M306'=S2=M"JWY*6M.<@T\B/0_**]_WF=A3?^18?$(CE*^4K.DYC M@IY`::S5SD`SD/R8):^$Z,_!E_BOCC-[B&-KSA6^4=,E*ML3]`IZ>ZUV#(:9 MY,85\?'KT7VY&MY/U"MVIZ1#D1@2]H-!(JZ$O&D0??O#]*OXY3;*Z@[.U0T)SH_T)IKM3?0C20_#LHKX^SA1SQ"/2?7)TY\9X%Y3DW7X&A1 MT#M8+;;:09BFDA]#Y143!_PZ#_;BN>N/^T-W7?PPZ<'M"/I#N9U6>P'!+/(/ M(O$*]SS_-H4_$Q:#!?TR*RZ(':$E0?Q)+;7:`XBFD7]HB5>\%_0W?L>90\\9 MK:8OQ8/>![.N_@?[HO>)#"_XVGW47=P8#5ENB`0&RKUV+@\K3$AS2SI3;"SC:-_&7)"O'&Z(^[KZ/7[Y?=ETGQ M7$:MNGPX%^JV$=FB^O*7#RL$FO=Z+\GW*F^=^(B7X*Q+K\^'*:%^&W$EF4'^ M\F"%4%$LT/R[/?P^^78[_2Z&+*TV'ZZEVFU$M6P"^-DZT*?4?W7L9?B_'8`UK@`Y780AO!)9NBYC);>AW_W]@*`;KR M_U!+`P04````"``<9Z]$KN6\'!)8```JZ`0`%0`<`&-Y9&DM,C`Q-#`S,S%? M;&%B+GAM;%54"0`#V/%T4]CQ=%-U>`L``00E#@``!#D!``#=?7MSXSAV[_^W MZGX'W,FMW-VJ[IF>F=TD,\DF)4NRK;8LR1+;W>.MU!8E419CB91)RJ]/?P'P M(8D$0(`\!.&NVMF629P'B=]Y``0._N._7K8;].0$H>M[?_OAYQ\__8`<;^$O M7>_^;S_LH]7'?_L!A9'M+>V-[SE_^^'5"7_XK__\W__K/_[/QX^HZV]W&]?V M%@[ZM@N<,'RV`P<-/$*`K_7\Q7[K>!%:1]'N]Y]^>GY^_G&1D;QD%.3B3PA] M_)CRO8WU^1UA?7[\1&[$X@+'CO!UM+0CY_=/O_W^\U]^_^LOZ.+:^OCI7S]] M.F+0]7>O@7N_CM"?%G]FJ_D!#8>3'U%GLT%3TC)$4R=T@B=G^6/":.-Z#[^3 M_YO;H8->0O?W<+%VMO;07U`U_O;#T7.]S(/-CWYP_],OGS[]^E-&Q6U!_OJ8 M-OM(+GW\^9>/O_[\XTNX_`'A3O%"*EM"2-H<:WC2^OG7M.W//WV['LZH\A_= MI'$7P="\0L)_(TS=5:(WOD]>MUA4(0N?L&$([VV M#IP56^U-$/Q$Z'_RG'O6C/G(L=;.LM40T(O<,N4 M/76;E'/&VU^<<-V0*.('IX^]>%VZ^-%^_LNG7^-0\$_DRC_20-KQL+5%;O0Z M\%9^L*51J#,/H\!>1"DC^@Q_^T&%!-\F3R1%\M/I0Q%A)X^%PZN_#Q9.3AWZ MSS^4'T;J5T"ORM(D3\ M"B]U'V(-_1VY:&/9?K!T`IQCYOK*0$@M$WZ402/0.I'0#L1D_%'RFN@K6MGA MG+ZG??CQWK9W^'W]_.M/SB8*TRO$<_WZ\=//21K[3\GE?^#\)G*(NI8]W^2[ MD7TS>=FYF[60(M:FGJ?A\N:[%39)VL'95?1W>KUE5\'I)+_L^=D>X)<2#Z"* MS-!9_'CO/_VT=-P8E/A''HOXTC^&.#79Q-;2>7'#'$HX=Q,=\W=K05&@3#T< MLAGS02U!]U.6XBB%WW#C%6XJT^&K+6&-VAL]_7C;*_@*,,H`(C`&YV'O\$'W4E@W?O[;D)-/D MUL)L.:/:XUNYT2N]5=M)L@35=Y(YKF(G>=RXD/>3BV:,'D^ZPN<_+1MC_](2 MQCI8L251[GQCW^=0P+R7Z'=ZKS;,F*+JXRS/5@RTD]8ITK*+B%QM%VKL#O$% M3\P&V[^V#;:>$RX"=W<\JY#''*-)'GK'3>`0R!`,",13[I)X/"(JPO+HIB'H M9'4=&Z0G+=E8_;>6@V_V;:>'TP5.%&:VR87CTS9@<9DI&BY`Y]G+1>H3JD+( MCN_B$?42D?MF1&]V%S+#>*XI&[:_M01;*[#)DH79ZW;N;W+H8=Y+]#N]5QN> M3%'U89EG*X;C2>L4ALE%%%]M%WSL#O$%3\SYDO"IU6F;B-PU8?:'TW>,6:!\2PY:RSY\ M-8O6+G;A@;T9>$OGYMS37_.'8P?L;+2L6:(UMUEM`)"`_NV/J'%RM[Z MF[T7V4$P)C7EL@.)>H`@5KOA@9 M>'.HI9\8#_,W MY_A*/IDH:97[\)QO!?;IF2,>[N-S48#$#]/$D'VUAQB=H7G3F6&>V8:#YN!XQGA@K0B#X5H8+I(TH>JI/5%<;AFM6U M`F2?-.=@&_H[(L"R\O'JW/5L;^'B)_!#5[`O584DO_1<1`*[&%U".>#EZ6*) M"@O6!8R*2]C]%)'!P7FNO9_UL=SET[7'>\)?FG M_[AWG^P-5C_L1%T["%Y=[_[6WNP+ZTU4:-+%)U(T(/!74@_&'&1%EIN'%*?, M7'`K6@#!.31M>=&*$C0*1B1)KF=+ZSXU%DX^"'F&V?D1(EKR(<* MB:9IQ!`UA0D<$LH`Q0^Q)(DP(F"0I4%)&Q1DC3X@SVEYSE*JQXOA14AE^N[K M@?>$]?2#5ZQT#H&L6XF^)[=``,X2!@/H'.=R`!\3I(!-K[E.RVZ*&#H\PX6CO!2=J6PXX"1?)T,A0@0%90#0;?<@++ M82_!)[4&>N?(=X?4>=-\9Q=S04[,IF5K4<%)P8BDB/5L':^1\"R?2$75<.QE M/F&",;RV<=_D$QZ)IFG"(VH*D_!(*`.4\(@E220\`@99PA.W09&/POUNMW%; M7SPCU=O%9$=(I6=K.]`,D6AF2#0CU,!,D`J@HZ/2LK+30!P8'UBQR;+]F6.K M,T3&S@!)SOSHVLU>)P_R=TX0O4YP3]%2BWB@O2-?"8JYN4S3+/,1-`5*>3"]Y?/[B9?9$*%))O@D2`!FOB15PYJ0DA* MHLQ$43FC;`)I9'5&%X.S83])H`P()$JX8,PQR5!KJC=0=TS`'`PP1P&0Z7]C M>;]JPG^:Z9N3X9>E]MKJ`E3'U]"UY^[&C5PGQ%D7W3:X]C=8RY!D8-$K9Z&" M*EGRG-)D("A651+&?RM(+??ALLRRTM.#SME@.+`&_5DV,+#^:+GZM"I6"M8D MST%3S0(0>Q,O!2IO6+2I1A8%E2L";C=5E@?QR?-KA(YLQ!C#D%XM)*+15`NA MQJ+GM1]$EA-LS_P@\)]Q)E8HILUOD2YI9K2`6<',%PVT8)DI0&)]V6JWF*^JZXQ)C56%-U@OKKM M`.PZG((,^14XIZ2%M3>[^+89:VXX?)&Z4Y#=B,0H(L5@$$Y5T8YQ-FDV4[#Y"X*XMLM[RX4]V4!W+SVFHH2 MU/@:M0\C?^L$/6='-FUQ/'E)J_0K%*<5S!L?RILZ&'*=L!/V$I;YAZ<7Y#&$]>J@B0 M-Q?)D?#H7/+,J^_I0K$@;H/S=-JH9=]>WLM%_RZ@T50;H7[V8MDOI3F[5-M< M+L-N"YK2"-6!S6QXHN03'":'0IX3V2]HEB67$$@C67&:@(^ED_7$!O\A4CERQ`7S.9\#CU>['8Z9]KQEB/\8MA# M5S4JQH)*$17XXDH)%>$76HJ%JBVZ%/!B+L"<=/[HG`W[YBR^E`&)<"&FD`'' MRLSY[GKD&OBQ@A\DP*-#LV&A4CPX#00F!@`IS\\%HSG?4*77F$FO*FMZ'9FN ME6,UUXJ5KPXS8358E?5?ZBN^?C'GR^HD2`;4]"E897$$+0[;PPLMH+:#\T2# M;?]F")#:[IVGRS9`I;?2`SS^[\\_?OJ$=G@P^D3:?4!__?3IPR=\*8Q/]K#W MT=H/W#=G^0%Y?GK5)36FEW17N&_*T1\B)+`V@!<;<\S!G,^N1^>3,$M$<6YG M.7SN-E"RSA8*E947N,NDWZ=$69Y]?/R#S7+JQ=A/;70Z\KKUS(SN_G:JD558B@=T* MJ#J"4`6HP@@\(3(U$9BTAW((Z6U$2FQ\=#VTB%NT711!W+6,>@@<`@[6S?F^ M2T_N(?4;DA5UV"5-2,+G+IPPNY<\#MD3L`]VFWUX9F](_8?"0`*`UU%%Y>J\ MP$HMUWXN45@S%1*7GE M=EC.YFA1:WH'+>-;[9J<`A0*=B5#RS$><[Z('RE-/WOBU'<7.&O'"W'&/O`6 M_M89^B'9(3U>6?9+/I^L1GU8!ZY$#;4ZO(K*8&O&%85+K217XS6G"_]Q6G/TAGRTIGQIF;$&_BDPQ0B^66G2'OZ M@6=FC;M7E^-AKS^=_3\C=DD+^E)B/IR+9G,^]5^[GA]@50=>Y&"0Y1,VWNU$ M[\)M$!SSA,)$`@;W?)TIQ.QJ/NN.1-1T/AX/1!1J,K/ZT/VNY1`NWTPJ0 M+;;D`-:)XH"=[Z/R-(`RR=+`GPOPN\,JW+/@3DL M4ZZ;K\2TH=!0YP$;#2<5%:L<@JK(.PU;9@:J6@B6"&[5^'/\BSD+(36D=J35#'$J._9BZL&)B!^.`'ERW MI-_S)DXP(Q\XA6LMRHB8RR^X1`VLR"A3L(E%&@*9JNLV>*RX2SDP`:(MR:FD MB+8U:45&*5Y*%FGPZ4T_O>[T.:C282=;7"`T,EYCIG$5&C=@5#R%FC`FABQ5 M(\JSX!I/W!`=6IID.EP4E)A,D<[TD_%8^@_H(AL),SEM*#"1I&%CYG&J2'.F MD9E)Q*W,,X=<;TN90DIC^EEV+-W'AP5F$K;`:"TPB./6C5D%0Z7F M3.-46#7[..)19B1C,U?!\K$@92XGA*8?=W>T*''DXV2Q9(5LL4UQF>Q1&^BU MLD7QX`MF3T0HK9H]4+*7SH[\PV##F#6KC`X5+5P];F[Z*7I':I>,'B1:%F'> MS+A!0A5PR%<:,0CHV?`W;*P@T^U50GCE$*&G%LP/(P4&)"@WA M7V%8P*$5X?Z#$2."LLXM![QX+&#DII^R@8!,4Q[LP8<`,LHT9`"JR;^(@=@4 MC,G[I;J^W"@D,GYS]O3$"]/HE/"6?QA`2:OL5"1V*Z"#D(0JP%@!7XC,<4=, MVJQ4>GJ#;&L;[YS`)I@(T=_3AO_=]FE'XBYF''#$(3#]4T)23S7D8)UW.UNG MG[L-M"J?+11J#7Z!N\R*^U.BPV86`VKI_#UI,+49\50,MLW-QWI\7KTB5H M_,NG7Q,LDBLTLW&"A6MOIMC!%S;Z\FX?9<)PB=(1=^//[, MI3P9*S;9<;H;7TLOL+[_D)53[TJ.Y?Y?^8D_R$)I6U>[B$VY@O5S# M%BU:)J$3!/;K)/"7^T7A4$9!B^0UL%K4[S2!7"B[9(N0,4T&9;:JCMY"-KF' M=LG-=BU4U(5^^1NI]G5)?Y=+FJI\KS.L%:[C]0],.`,2SD`$=@"B9+IR"V:/ M6$LNC$TILAXC3G%J<1\R)C29S4W_H'4\9B*/D'>CW/N,(7-\'WS` M?")6!KU/3C#W1>F12`H+P,<,^<3&#IQ/^TTX;$Z:-O=E2G+0S(*BL`UG^`P` MR7+]0#`I%%,*2CXU=\"%/IXXDVA[?`<$F`Q1@+`\Y2X)RB.B%)+T$HJOM8M%5M<4D'C2 MB(-#O/M^9YSF*B#BF(,Y^R%Q8O7DAEB]3=YA)PX^K>]/5BBIQE[@T54'$LPYULQ M&6(X84CU.W<*20SO]@'QI[>A4,X4"H;L/'%705)P#4F'",4US-EX69K3*ID#+ICX;FO)L8*J>)4-RPKY`>OHE MJ3C5:=A,I\(,)Q?#YAR2ENE\.-Z"A^)BBSR.CUK`(KDHN@DLGTA11?.!.,4S M^8T(B([V"AN"9497\M%\W)BS@8NTI\X^@;D!*"_K4O:@E47` MP;@YGX*Y$4HV"9)-?AI.>AI(^D6R)%-_+HO<@/8XV?F`1FWCO[RSY3,=K@V8 M\_WW,'HYQX_?]$?+?G'"_$%C'6]YRB4^W^3:B=;^ M\A`"\P/G%B2?5/'2(QFP,IC65P7H2_1J+^F=-"IU,N$QIUQ13(@HW[:S6OUF MR*FTIDD)CD\V9R5"]I1)&#ES/*>XKKVDU8FO*[8"]$M<%2`K%K*$R%8L+-!F M%NF$X>]'MHC^E#3XLQFS+V5=S+$C!@$'\^8L:8@7^#/FUXLWCE;<)#?`UMJ< M"@*,@2?,)4/4@28[H=:)T`;_W?[2FER/,!?5I&TXV#-G#0%^K8?04>'$VQH+4PI!]1(HB'^%1*O)\[^,1!^0F+%JV MQ^KP*XYDU5EQK-N<90@GSR2R7)%5-F!Q3!XBU(6S0>:ISA.;%)-@3>CKEGW\F4";;+B/ M#[I?%^`G#8VJ2WXHT:51ZN82YFB1<$?1@:$!N78[]LC^QJ-/#4XY7G.6T3!> M1?I@.7\AT?)0#HO;$NJHE3)50(MHB*1)E]3@,CDJCG1H8H#%RG0XZX05/A'' M&LQ9)=.W`P^/"<+TK&W.6K*R9LES<)N!&$&9$C#!52"E/`[RB(\S<_HM@1S@ MWDT.'&K_'/?2[BV@GD_!@;PYRV/RJI_9H;O`,:_G;O91X8PYR=8<`\BW;L0. M."HU8PY%8>I6D>-QV$B++]-M(LD-LXR"U_.EME$@Y)B(.:MKON+,<(U5[3PY M@7WOC/;;N1.,5X43Q#C1HBIY\MS*Y"!6555I&#.K(+W<[E29IH:8TJ&$$,64 MM&"T8:=A5X9:P6K5.7',V)P%0J)'.GHB<0"LQT3"I`5,&C?L\@<`+81=617I M:MG5)!@:@6M"3\G$1?PXAF[.JI/LG,/QJFN'Z_.-_\PK7B?3-"TL(&H*4UI` M0AF@X@)B21+E!00,F*=HDE:(-C/F%$VIOB_6&!!2F7Y>(1YQ$ZUI@9NELSQ[ M_1(ZRX&7;0'L+"+WR8U<;K7'Z@P.'R-5&4!]L:RH.-@B`77Y4JL$%-EFTXV= MV24Z'XZ_SM#Y='R-QI/^M&,-1A>HT[4&MP-KT)^U_E6T*M98GTZ5>54S9MT? MU.4VNDE]4"_N;E/\H/XZ#Y8N688H^)ZNS]D=OM6$9,T'[OX!=MVAY4\=@CIW MXYP\GN77BDP3EJ#MN4NO6DE4C,^DD.,-^..LFEY8M(D M;TN9H_DKRO8'(3OCW'*-8FV&5X@JS4NN=IYKC<-3FJLJR6[*JR-EA5 M65F-0:8M)(3)G:4BX/'^2LLRN]V7?V?:#D(%@HGD^2KJ.&$MK;)$D+M=E-4%&P#G+QA$\9$%0]>>NQL3K#<:KMN$_$VY2: M(Y^$:X@,DH9,D*^<$$V_Q<;G.??D4,WR,"`IF&5]QS*4^&4CSN0."K);IEF9 M`"(2]L6BKG9`:)N61?:8>UB:6RAT*M66:TO';1LR(H8Z#5O/J<0:9G/$Z%`[ M++MDFIVP^EW"0$[(JIVKV:9E3`)G9[O+GK-R@L!9IF4`O27=5A`G$J4FH\*$ M:TM23!HR,I4':-CZ)%6I898R$DXKH!V"&\TI=S$#0ZI[UX2CA(G+\3/^&$Y^ M<)_8KZ1STR?*'5<.ZJ\#A-C2C55*DRR%204$A\=S$- M=0P^]1;Q=KT(;0Y4IGF(*F!52):EV!I_7&KQ^5(/R#YI6KH]U^[S[1NR;8Y: MH"M!9:1*+_HL97:8.X\OXXA-KYMF=SQ`2-A6@=3XDU>+S]#=AY&_=8*>L_-# M5R*QYA%P+:A`T)`)\11KV(888FL849[;81G!DXU!318+A/O=;N,Z@7$1C(L, M"5,JTAI_,JS\8K?*JSLKK^K4O9I3Z4N:='$:>>'RE6LD>1ZOPJ.KHA4RRB>E*S]`&]_V2'9JIXV6:.%O=[;7>GR4`T6Q M)*F8S/A#?U/]L=:+Q[T;.-@MX'`>O4XP`DCY:U+P>K*$2C45Y7A"JP0Z)J_, MRI)V--@MCEJ202$VNWO\NLP)=&*`B&(=A]+XTX/E<]_*@[W*@SS=@SM]LS%L MX?5F8Q@\N;,Q65O39V-$<*HQCGL'1R)S'N;<]7!.76,V1H*!V%!%#)HT6`G% M&YV-$1]@4Q$1DE`&=[R@1*#W7(>*3FLJA#9E/W)AL.%*@*)B-F,K\ M0ZBET\K*PZC*PR?=PR9]\QQLX?7F.1@\C^T/\S,0)7'*F[.F:MYP-5"%-3P)1(84Y&J2"LI!G MA:B)EST\1(%K9JA]BQQL-NUW9GW\`]$9CG^VM[M_CW_V;[X,;CO#_LAJ>6:C M$KR*YXXH<3'^X.3^:N4LHO&J_[*@)0NF.!D8>^R'S-E#%=+TO`854IC#&RHH M"W22@YIDB6,=%!BF1MH_/^]W+30^1_UOW/8S9"3IX)P@"%YQ^+^U-VJ[87;4&NQJ*@*59I<6*E&E78Y75K#] MRV0R[%]CG'6&J#>8=8?CV9=I?T;B4_:!#.>2Y^/I=<<:C$M6MB'NZ!;0UK>B,*B-WB><9?9M'P@.]53B:X@4*&A[ MCQJC6QB[T8Y;&7^8:%P$T+)?G)")1.;=P^[,D[M06S%9(L%J#^282U43.*8Y M`)-<1A&Y;@0XV3W%VBUYVK#!$SXY]8I'?N2$EI_,RMF;['P.[J(=:8)TEKF< MH'YU6GFMZH%77A@?S)(\LIDHTI)LP,C:HD-C8TZ#48"%K_PR=9PDT0",)&L= M5X83H^2Q3ECI"XSCX-[VDJ+,9!FSOW&7]`]RN%8X7DUPSZ;OX6P?NIX3ACTG M7`3N+JG]G!1+P4/%"29>N/@E.2_1&=;Y(8<&+;(2$#0K"R0%T/(Z8!**IE4M M3T\:U2"KDC:]Z(P&=W0$B3JC'II,!Z/N8(('G8>MK^COA`Y1PI8C@QZ#*N16 M#8LU_:0RQE/B1YJY]YZ[QQSG`H+-@N^HQY4SW=7<&.[")R7)R4L*/)X1"]LD M*K';U,^JA;(!QF,\_B5#,"99"OR+,?E,T!V/NOVI28`7]Z,O\UZJG8G41K]+ M#J!4^I\Q9I+'@0ECH4HAO%*PUAF6VPC`@*$6(JB25'[VY?JZ,_V#W)L-+D:# M\T&W,[)P7M\=?QG1ZC:3\7#0-2O!KQMMZ\55B#6"G+@:%UOFV13G;GJ\9.YN M?6_*D0<0/XN<2R)GCB"K&C.;]2V3D,GK(E_\^&R@E:UNT]NEDJ%1KFL909'7 MQ?1RO3C(L;:C>L4\DQ,U29Z=V:1^3XDD`U@@AWV)&;*HLHU1@\[98&C:7)"P M`WV)5\(V3=@5;"`=+FF?"AW/,%))`!B1MD98MV27$5G"%;V2#Q`]-UQL_'`? M.-S,594N35ZEZ6#R5U4U@5)8!;$26:PLMVS%DS7N7EV.A[W^=$:7V5E_&.1L MU*%33$WE69A_`EQ\=-!KN-'%(V+CE.)SE&A_O1MP)I^@U7 MA;1^7E)%4X`$55%L2>*JPBW[[&E=]J=HVN_V![>=LV'_`R);M.+OG_U)9]!# M_6^3_FC6-\BL*L'*K_'BJQT)9Q`,)=-F`#@RTNE&86E"$LZMJ5F>$U0A/10W MD2>%*G6BK"Q8X1,5R5)E4*099D6$IN-)?VK]\0%-AG3Z&*.19.<3LC?!(/=8 M"5.L:BD*7!H\.(^3EA3J;M*"HCP[DVR=;A`O:5W?T4OJ`Y!BE$LJR2I*&&3; MP\:CF37]TJ4?708C[*?'%]/^S*1T7!8$OMH+K'@(7+NHD/*/Z&%F>1YC@D%7RP=F&5$S=XP!XO+N<.)N-&Y+)V:2SFM@/PIV4ZR$"_ M]"B\4E&EQ]^).60?$7NW9/-U7"JV^V5FC:_Q&,H==<61&2# MK2)&6&&V#"09+GK]R7@V$-7KT/@5:^T'D>4$6U)3COO)2M@H_3[%;@3S,4JH M`-"7)YX,B<],3-+LF]+E>&I]M/K3:S0<=TQ:>EG2K\6/1YSVQA^S=UP\T0IL M+[1I-BR11U:@S(I[RE,"U?I45A7&62=9;IO5B+.) M)B5BF`I2E12&,5)EV>5VJL;R,,]P?3VPKN/B1=TQ703<'Y$5P!_HO.ZP?]$9 MDMF';K]/*AN99,$5$5H/ M#H2R`>9N>?Q+9FR99(<@->M/;_$H\\AD<9DUQ<.PCJ_/-(.\@ MU>'\0D`J\F_FW),(.G5V?D"288EU]/(4Z0RE!`7,=*6\:D!SEU(")28RR_EDLYK]"[KX M9MJ?C*=T(Z(DIPRQ\:??S?;ST'GVR.KN\=D"5 M=4O4@*JERQC#V(BNRW':D.!VE<8=9P7A2<&`-+N*J M`H;N`U7"3L'4),F-/R*V.$5QBJE-[XZ7E+PK^MOY[CCZ"?!^"'RQE;: M,#4P?D,8HRI5!,B01'(DC(=+GAK,48U%<@YE2F"@K91W?=$^!#3-E84#R@'= MQ[V[=".)#<(R3;-Z'(*F,(F>A#)`^9U8DD1:)V"0%1PCU7'LFXG.N9L@>&<+A$%X@7;;74Y$<:+]G-:6A]GPJ2Y?9]ZG&]'#*]VEC`RVO,L086S]5.54K M[=;Z.."Y:8!(-;A`==$$AM86;-\+:1&S*A,">`:2%6,A4=\F"N+[[LFYH.E MGW-J@7%+)@RV.]L-R*]"6BA-45;UXXBBV6(?1=4:KO%Q(K!&:8\# MGZRB1]+T`]J1QC3(.&ES\VQ)!2WR]3R.B;47%V.7!2A)S%1HA!4]0".*^O,` M[BZ6%"NYTUB&6Y:='35&KH=V27.TBZW'."M2@X],+1#)0-5`O3!PN-4J"R*' M-^GB(#H`IR\YL`)[Z6"_2ZNA)5_ZPD-5-.9G,B6:I)?D:$!2!"7U8)($69'E M:8(4IZRT0G*?9@@^H4!!UM3`K%L-.(5<09*\P:)?4#NN0P>_+3*F[CE/SL:G M"4]2RKAD<6L0S-3S4<6#073*25LL.X5C-F.3;[;$].76::H3)<\ MJ3P=B%$IJPEC7BIBRPU-FEMJR[14VR$TNVS'+&L/5"&**D65'Y8+DXF.RSA]][K[('"\Q4EI()SETC\WQ\LWN5&N+I\TZE7F`Q,% MZSX&4%2LH89$E*S*/8N:,0.T2#B@Z$!CGH77AV8QE%9GV6!M+6Y-'IQZASCJ M!_=.4!XFRYH>14AN4XAZ+>6:@-3K$8HI+=O#ISX.@K@-BAN99QU279XOYB,B MJ5ATJD6,2)?V4<8*L\*/*F9,^!:2U64I6R`D;I:O\-/0`B&Q$L"5?:HM$&(3 M'Q8(D?LHLE],_%91VLO\LCZRWL*<)4)=?[L+G+7CA>Z3$S^'S*R/*MFAO*0< M&51A224EP4I*RDJ5*B8IQ>SP+?JH/7)C._O3Q@_#/YMG:,H@8E6,E.1@?&VM M_.D)YRX>+#$J1_A4>!RM`L\:8AL MVM(\HY+'1>D!'@Q2XRMFC9SGHUWK@>_AGXMXUELFKE4E3YY;F1S$YJHJ#6." M%:276Z0JTZ-M4>3K_($6G1*;9Z^5$5:HDNZ-5DXN>&]+Y65J[%/IIK, MK/Q@0DWJ%*3[^Y?H2^BL]AM$DMN0W(G6#CKLOIEDNV_ZA]TW%EEJ:HZ':LID MY#?J5!5D>M6HPW-E6__B3V$1A0#/AZF2I35$9JD3!44EF M+`>041AGSLKH*18FE>;07(DJSC=:NF[_L%X_'#G$D4P"9V>[RV2!L="VJC-( M'J8"@_I?\*IK#?#MMY+PDB_"ZCQ3(QSG]ZA\0)X3A]A=3(ZRL,I72,DW8,>H'&,,#/Y3@8? M=<83I6[/G'6EAUSKZ"-)_ON)Y&A!F4-AX"#/`7@,H:PZ]'!"10&5D84T7_8@ M(_M*V$F^$AIFOG7`)QAW*#`SO4!;^E"^Z*'.]]$^<#I;,PF,DE,B$*!DS(;`@3,A1`DEPC@)W9!< MP:V&ONV%N'=09_ED8_R$]69(9!RCY5=UBW*4+*=80@F,0CD]H1UBJ505=RAF MQL-;Y!?09K0KE`24P!&6<:A6']$<`%9Q@I6`6.8"6P%D*_-5-+V]QOGO=H^= M/GXCFXG]2A.>0,W.]^Z%CA]*^$X!G<4ZK!D_H6:[ZCP<^[U5+):69 ML.J26%83LT,)/T3)4,H0??&P_T(9T_BVR4X>`OFB";4Z[*L5_01)PT@EL>#) M.=][R_#,WI#,3]*52%,6'$8Y)604E-83-`V3D2J=AI4R8]EO0H0H%4K(##90 M>3SQLC`)#A7K3IH#0.4TK"H0A6E82X`$\7C=P%FZT=0-'\:KF;W!WMB_MO_' M#[K[,/*W3B";2E7D4_"&JGP@H5GQ&4`]I;H.TGY3D34+M#$+1'B0/RD7,IB@ M?%#&R&"_6A6G/"^KS*]B'5)3@:WL@6$`+O3'^H"NT3E/<&>O2;J,XXW]?&V3 M8YWM34BF0*E2L_UNMW&K.>R:O(5.O"KOIO!?\UD;<_;5]:H4`"J*D["5C#/- M_VF_I.!AJ!:ZDA' MGNI26,:0$*",'3KB]P'-7X]:Q#P-#C(`2.?%ECJL*Y::?@>FH1Q)P$U$&$#: M-A4#8L70#R'C!)]=I1C!8*?;"/A/I#TV,%4!C0M%"?6`3OB]\W@@0'2=6,!B M6[%2NN$FT$@,D#:%VOZ_=9-H8P&(S(N!"1@P<:*Q91V5'@%Z(8>J$BI+-Y1X MUT.^Y4?VQO3-!551*UB@HKXT&XBS6/)+$O_)7("K'$V7]_QED/?NZ?[ M)^)./WN]]2Q95//I@0Q%H@`"P+V1TV]"&B7U8">*EX-6CQ[ M44%\M`^=!$R%''V7)9NSB9R/5%#B]ZA#/!:&J#2#W6%CIB?PF/`R*Y[(4&,8 M?F:';CA>3;"!I^DGUCS<;[=V\)JKAI45Y"05_UPGO',"WWHF_QM[SHR\#'+E M,_TU.G^T+D:>]1+D7(8^@1B'YNUVMJ-$%?.V*J5>1[]R8K.7W1 MFLTR)CB^'Z,U*OYNYM8YAJ[UT.W-[[IWC8=?CKS&HF]>GHF6S'DG)L?>HLIM MA=Z<)J!&_,OW%GEYUM=TX"W(K5:(\[U;:VMA5\YN9YS MAB\_7MA6%9P]42B%NS7&-",?XY: MI0O>B:EAG*UR6^/NG":@N?MW%:]%UM?TF+L@MUKQ]_=NK:V-M^7,5_<4%N+M5*6JB74MF.J1D7:._*)_2((9_@B^3O`P_R7 M7N,15RRVLG)#/]2?W33[+5H@K[F8G9-GI&VSWXG14;J@ MK[5@=HZRUO1`L9:YZ8F\[]FI4T%UU;W9O M"PM+=6ZCQX?FEV7S!#86=@L"3;1DWELQ.?`R=&XK\N95`37E?_O>0B_7!)N. MO47!UO&W+:,U)OZ>+E*;7GX-'F:]B[N[Q:/&==@LL1J6 M8)^(-&<(=QL%\!_6^\CM#/U M;S_`%]4"=0G?55TP:?/5%^Q92N@[?,]<>S<@\$L;O.;PWY[%&YH$D`_Z^)_> MW>N=]VR--I\UY@!;G!)OM M!=AOZ7U$^X+N[8?Z4Y5`3?^[JH$F9:KZ@GQ>`7V'5IIIVP:$=RGCUAS;V[%N M0P-[[SX:KF@)UV?_Z6)UF3_@J!79&L)[4;;97H#[KMY'D&>IWWZ<+V@%Z@R^ MJ\(KLI:K+]HS=-!W.JFQIFY`S)>U= M>O.P[]ZOH\OUK/NJ,8SS1&L(Y0719AL_[TV]CY#.T+[]L)Y7"M0-?%?U:R2- M5E]X+ZK`"?'&%YB#LW(#PKRDF6L.]6W9N:'AGKZ(>_SC?A*\D<:OESLRIZ$Q M[)>IH"'\ MO#:TX>V_8&A:<0C_3&S7O#O.+EZO5UN-"818@4TI!`*W M]C[2!^XSM)\\L%4#=16_?;^I0XE)ZTL<>(IPT@;CZ_=!^P`#D@8E)Z`Y96C7 M"QB:,'2G9_15C,CIM-YP0W*HY;/&A$&L@(:$@:.`V1\+`?8;V$P:V M:I"NXI?ON%9@B4GK2QAXBK`3AE_>6?W`^C[`@(1!R0EH3AC:]0+&)`SD2DB> M_6$QNUW@][/UWK:-9@A"B8V5Z"]*-,W^A>_%U*#/4[JM*OT%74`K?O_R754' M$AMBTX7Z&9(YD=OX,H"U+;>U6OVRIJNE6'][MFM4-+;.XZD,\G^?-][5[?:M MV84"94(;B\E,H28:M^CMF!R9.7JW%9Q9ZL#:^'=5U:?4+IL.T6SAG"AM?+T^ M"$-N+5`K6+*66-VJ*1L5KI>]^28B!8KGP]O9HMF2?`)YC07IO#P3S9KS3DP. MS465VXK*.4U@K?B[JKTC,K^F8W%!+B<,&U]4KZ:]MA:!Y0Q62_!MRV*-BKM7 M^._;V73D#7L/S\V'7;:XQJ)N3IR)1LQ^(R;'W(+&;87<4T5@[?>[JFHCL+RF M`VY>+"?>&E_3KIZIMA9NI6Q52[1MR5B-"K:O#\.9^W+U^&U&OI:_3-:-QUNN MQ,9";E&BB:;,?2\F!UZ6TFW%WH(NL!;]7=67$1MBTQ&8(9D3A(TO&U?;[1D7CFW`776V\Z66\.:[Q6,R1UU@DSLLST9HY[\3D*%Q4N:T8 MG-,$UHJ_JS(P(O-K.OX6Y'*BK_$UW6K::VNQ5\Y@M43>MBRV1MSMA*$3<1XG M"F>;E[>[R6Q-[V,^>3!6I$Y@H4I=WV(JZ@L7K]05D(L^BGQ39,9DJ.73O*NB MR*_W:CE[9N']=(.HD_2Z,+!C^-#&<->02YO0Y;/7;Z-Y5CUCE-_(49E>PJVQ MZ9N%F%!G/:Z-IT)]Y\;DG(-9R_L1JN-)WL%Q^'!R4;TNKC;^`)R<"@`5W5Q- M!#;DZ!87=^>/;YL'HAOY;_)-P MQET10/(^C<6$[=`:6,[5'.``O)DTXA1=61W(->3';LC_W2X6H]UZA*]O+Q7< M&)=6PHL5:9O%%%=7/3Z,);Z^"RMPS<&IY76OU;`C[\`8/-C^JX'E,8UA#TJQP:=W-Z>7\FI"JY!(NC$G>++)$&NMQ9!P-ZOLR M%N,5%@92O(>C3=YA?!:C>:/7U[ MQ#<\!;_&)I3P:#G"9@'%UE*/%RO(KN^_3EGFP-/R>JP*8)'W67D&;&_5P.?9 M9L`%X*>DT*7HH:K"JR'?9,WG]V3O#[UP_D3_>9BY+W,%-U7*0\)C\7DTBZ]2 MW?7X,9$:]5T:EWL.?BVO=:F',7E')^#%]GD-G$'4."8!W)\J*!4](0`J&W** M`:GH%Y%%H='MXHNKA[X&O)NY+]X9/SLO5VMU\0'D_^&"BZN ME(>$G^/S:!9QI;KK\7@B->J[/2[W'/Q:/HNB'L;D':"`%]L+-G`@1..8!'"% MJJ!4](<`J&S(*7ZS=D-KB"^&W6NZ3$7!&7)I)9Q@D;99H'%UU>/T6.+K.[L" MU_SRR98+Z%<#C[QW8_#@K-EMH&Q]8V@#<&>R<%-T8W7PUI#_>KH+-_2/U\GS M%M^87BDX,#ZQA`=C$#<+*KZV>GP84WY])U9DFT>5P;L/!`B2=V,L)AP_IGGS M03W(`3@R:K):H&O(E9'?[LOU#;UPLWN-KI_N%)R9B%S"G3')FT672&,] M+HVC07VGQF*<1YC!NPZ$6))W;&PV'->F>=-!7?`!.#<%]"FZMYKP:VJI[G5\ M/%!T1_[I/7Q6^=C*)Y99K%LD;G@%)5=;3`P&"%);L M,IAP')KF30?U(`>Q:E<6V;?)- M8U+2!P*"DN$)-:"R29_X;1K>/^!K\87M-%RHND0^!UF/R."@`7Q\O37Z0Z82 M0.ZPR)N%NY9'M77@I>@,69RT[:=O&(Y0KE`:CU4\86U`-ND(ISO\E^4][,@? M,W*?U#?)KS6IRT;6)?+8:`!BR1-H=(Y\38`\)$<`"Y4MCY-KXT[15W+9:=NO MKP.G4%Y3#:A57"<,4IOTGS/ZZ_&)_G9?Z(9=:Y;?'5N7C:S_Y+'1@,N2)]#H M/_F:`/E/C@`6*ENN#%`;=XK^D\M.6[T`'3B%\I]J0*WB/V&0VJ3_G#R01==G MO?4;OAI9X4C5TKOK+$KOEU=D?4/,\O;*[#0M8#LEAH0)Y` MD*T%D!]D,&>AK^6R!;4PIN@+F:RTE3)H&I-0_E`>E%4\8GU4-ND3\>\= M46KBC>([-Q>W7U6]HI")K%]D,]&`0J'V>C3P\@[\ADST)BRX4/:J)-T4-R MF&DK?=`\.J&\I`H\J_A)"'S6\)2SR%\\K/T-[NBP_[AWHU>VFMM;LD?O<_?N M_.9Q\4JK:^5Z%X!3TCUU.-6')L!SP'G/>LK(N=`:,E*<'K-`,8^VEP)!P-&' MZPMM"X,TP5?2O<+CE^%C]0-8@\.]&5Y;],X5+2Y-M7T+*OI<,3-%M\MAI@^Z MXJ?1[WRY^L#Z7[88$8);7G\$A,YJ7IC'5-NJ)'UH!O;%2G"NX8Y!\:S!(^,_ MIY?TK^YR?4L7"2POR(V*3KF4GZ)?YO/3!^;29]+OG44JP3IHKB01IEM>_`0' MUFIN6L!7VW(HK>`&=M:JZ*[AKZ'AK<%EWSW<><]#ZWKU\H3O5/33;":*SCG' M1!]HV=KK=\,%/6!][RE[$2);7BU5$W75O&R>F;:54LVC%-B?2L&TAA,%P:F. MZ8<+^O/>BZ_0Y+R[/K^M.@%1PDYU"H+'3N.PK>2)6IB&X&L$/!'!$21"<\OK ML,!P6G$R@LM6VQHMG;B&GI!0`W:=*0E89&OPT^O;KS03?XROKY;TSHY,=%=T MU1(<%;VUB*,^8$L\EWZ?+58*UFT+9(GPW?*Z,4C85G/>0L[:5I5IACFP"U?' M>0TO#@]T#8Z7CZ+3+O+1AV'N,^AWT"Q58-UR M08((HRTO4JL/PFHNF,%/VU(U+:`%=K>RJ*WA9*%@J\&U/FZO[H-O\8PU4?MR MG=\`!L!)T;VR..G#JN`Y]+M8MC*P3I8A0X37ED\#@H!C-4?+Y*CMC"!-\`5V MMO+XK>%NX0"LP>$^X[_)FHYML%E:3_?/EQ7=+9>/HK,M\M&'5>XSZ'>T+%5@ MW6Q!@@BC+1\[5!^$U5PL@Y^VXX>T@!;8OU/'5@W2U3BG!)>\N'(,$@LYK?Y?#4=TB2 M-B@#.V`5+-=PPJ!@UI'D;KODG]XS2=;(\3([-B!LSFJ>^8)VU0ADZ%%;!<)QV&!',-3SSP%O[6 ML>P7MIK?UB]T@<;S[;=@B^_1/_(+U&KQ2'JJ&H_Z,*VE.YRGK:J&G(>MQ#T% M8TR,,'7;VXWKX.':MA@WCDM)MPD)3(:[U(#,YISCY^UK9%&5AF3=`[Z[ M_$IOJOG'4C9R+I+/IG$TECZ!-D'O,?[^J2"WG*PO4C6./IZ\VS\A0 M`,0AYODRX-7R]MNJ2%)R?T4NVK;6-H@\&&\VYML>WVZ>%-7K> MW=^3^58US\8AEG-L>>+&T<715IM;*\H'\6HYM@Q@M;S%M2*(E'Q:@8FV+:W- M@0[&H\FA3MVAU8)=<_[,(\K,R:\GNL*?_'D9T=OG:LY-AI.6*`/B$$4R&#!M>2LJ!`J57*68H[8-J)I0"^-$*\!6W:/"X;8Y]SK'?XP^ M6V\W9[WG5?[<@$JT_MK(8?)>>7YZ%M MOV9C>(-Q<%*`4W=I=1#7G!/;GI\_G]'YQNLE/9]*<4*/3R_GS!CTC0.,K[,V MI\94`<2Q%3DSH-;R7LGJF%)R<"P^VO9&-HI!&$O-D?'4`#$S>7Y,N#5\D[%JDA2=6#WO-N;:'A[@&:7!_<7$[7;!.(JG!0<[%,3DT#C:1WMI< M'4<)$'?'XLV`7!ZUKL8 MKF>WUES-_;$HY=S>"67C`&/IJ\_SSZ&:YQ)QD/-@3`Z-(TRDMS:/ MQE$"Q+.Q>+-P9_8>#2&\E#P=FY.^_6T-XQ'&\RD`4MT#`B%2_KWOPX_WMKW[ M1R<,G2CL[H,`ZZOR4C=.[3!V[F08\.:&VDSYG\RU]`D8S=^\-!YVPP'%B#?I-OIK%7HOHN3E]" M@P]?W&D+^PZ8_,M?19'L](W,K''WZG(\[/6G,]2_^3*P_FC^S6!WO-DO7>]^ MX@?$OW>B*'#G^\B>;QS+'^%P[GL1?B^8Y_W`BQPL!MC(P'2JT@-51)WV6C,= M=60V'6_9-*`EI"E9.I,)U_Q19]0#?HTT2>GZVZT3+%Q[,R79RP;FG?%8\U\0 MDR)]&X?K*+X!^@HL-PSW3B<([-=)X"_W"ZBT0,"]Y$4PB#)DT%N(WD/I36C+ MFI(D=0\=%H^XEEM*VCA[;A_W.PKBJ]#/>XFS[;.]NR%.KNN'T'DABWWY&RA0 MI:_BTM^'^!KZ4Z'%GQOU#8!O1LA?T4N)88,:U%YUN76=$)QZE06^!;R5RBT-P[X2[@(_##$[WGE`J>$ MIXS+7\!1^_3QZ2447X-^[O'.">P(.Z;^R\[Q0NA8PF)?_@X*5*=`R&ZC]'YC M;R6>X1GB]]_0>SD1H/!F#G3INR&_$9F>3-^/[X&_EX'WA`<-9`(MEM_,*$H@ MI?P-\8@/0ZX6>'1EG_:50E48=^42$SYJ^)2Y\PM6CM!:FH? MT`C^;1W`?([QV\7#5-?;8Z4.0#YS5G[@9%.U3GCM>GY`![UQ=^)AVBF7>*!V M[41K?WG`!+`9ZU5*8)63[J_G$V[0T^H,&H^R-\MKK=!DM[2Z9SWTX^D0(,7<522D:O`N+TY1XW0;DV#>0/ M@6.'3L^)_QUXG<7"W^,H-746COM$_!)XX)>1*!6Q2QFEKS2]@X+L5O-ODH1\ M+\(I`O30L$Q4E7=WQ.&0[V>7T)^$%&!6S-=O$C@[VUWVG)43!,XRR:FQ==`< MNXEOW95UJ/+Z95BG_1*/*@Y(IGYX%S/(QF;-]TBJ:R/37S+BJKSG')>#RXTO MI]/O++SG2#5@OKL/(YS[!#@@^*';/+X9\JJ\XSR;S`DOGVQOX<0S+;/];K=Q MG:")Y+]KAVL\VGARE\[R[/5+Z.#15S;]TUE$[E,#2R*4Y$H-&R39'8\I"`E9 MX[9$KG0RV!TC=T&0NTMHT/P5_2F!\9]11MD@ MCHG&."Z0?TAL>+(W!`03)W#)K/EI<@D\3ZDF66+B4H%AU@-]B\SV3ON=61_] MJ=>/?_T97T/=SNP2_;.]W?U[_).LCKOM#/LCN#74\7J37,)N.2_1V<9?/$`N MA1'(*%L.PR/-)H.3!BAM@?Y.VB#:Z+^!5PSE@BX-I!-_XRY>&WEMDO)*5Q1) ML#G,K1^E"P,/I>R[V_R2/ MC.?SZ(I=K!/V2NPM*)_IK]'YHW4Q\JP7I4JP)3VC1=F2;FU>A^,)_Q"-5^A8 M%CH(([>.Q*&#/)0*1(0_PO+H?U@HHK+BRY^3/T;H_!%9Z`*-/(3%&PZOS=PB M]2*MAVYO?M>],QI=15VU@RNG@B9L;>884$0NLAY0%_7FZ`[_UF3? MW!F^_'0UBR93H\'%TE8[O`I*:`(8EHN(8'1&;CZA*S2+T`1-#488_CES7^C/ M<;Q!\\VZOK_<74Y?+O$-8[%6KK=6U)6HHP%_Y"\L*?F+7*=:8(]W?8\N=^@2 M35_P_^$F!J.17-D-)U])_>7%]&SRV/MJ+`+9NFKW=3D5-'FZ'1IBQ_854Y!'UT%?#L35Y?EC=7B^CR;`W5CO%6SNT"JIJ1]:I!KKR?R(5W2(L%P-L MB#&%[QN.JCN24UX$X0Q?)'\'V,F^](Q&%U=E[2AC:Z(+;7?Q>`#+1S-ZCZI` MHN0+ZID.NUEDK2`UAK[,QNXC$"CI4WIN=@ MJ^[-[FU!CTR[C1X?S!YR,I35#JZ\#IK0M4)=1`0C*AD1T>]HM#F]_!H\S'H7 M=W>+1V,1)E2YQ3'FL2:M#"^G>#2)5KP;Y+V1<"?Z8BK>(PJ(^;6#QC8Y#MQB(E`)K@K`JR'HW>"1)*/ZG=_=ZYSU;H\WG M=P)'EMXMHK&@3BN.D8XHR`\,QU>$-4$6&FW0YW>#1N\6__UZ^_BXNSZ/W@L4 M"TJWB,-37=H`H8=NR<571)1`U^@\>D?XZ]U'PQ7]/OCL/UVL+B&74>C6NT44 M%M1IQ1MB+=!PE7QV)1_%+E;H\N'=8'$Q&I(F1/VSSRMZ]?-=]YT`DJM\BZAD MZ]0&-!=HA(9Q:XK.,_1YE=S]3%8&O!N,7BQOI\/=M]?5Q?SBG2`SIW*+>#S6 MI!4'>;'$L7J*ACN$E4`7M8%JD+9AMHM`C"O31L@ M7**K%X2U0%0-=+E&,]1]?3'M`B6R#8>7=1Z'$3H7L?&N;K=OYJ:.`H6U@XREAZYU-18Z3T-N M/&6S\=`5(AH8CK9E;[Z)R/?*^?!VMC#W\PI;5^T8RZF@"5Y+1,32S\IS-$2W M:+8P^@,*N7*%_[Z=34?>L/?P;#:N"JIJA]6I!KJ/WV8D:WR9K(V&%DM;[>@J**$)8*\/&%,D[[]Z1-\PRJAT-%D; MCK";,"+KM_0:'XT38U&L*->T3,L+N[.']\V M#T01\M_DFZ;^8`JNT1E%?O(]L:"+D"EYW"/T_R;HF[9NH%M+;A>+T6X]PM>W MEYIZ@26W1B<4V"E80[S%!6%JA,G1B-S?HDMM77"Y7@TOJ1$NK;LYO0R9K580 M7:,C6!P5^@*3XV3P,O9)2V2ANWE\&S8;%#W!_")8[4:SIV^/^`9DX74EH36Z MX)27_,N?(T*(\3][0M\>20.P>NVE.EOS^3V9MZ`7SI_H/P]X3##7]/Y%\FMT M!9>M@DD0'G1.)[EX_A3_>"!CIKFV'@K(IZ&(C,VBV^5T<4E^:>HQ>TVQ=4\^PY-;HD0([A9[XABQ2 M>+H+-_2/U\GS%M^87FGJ!J;@&OU0Y"??$4\($\=_ MOR),GNR$O-+6"^2W^W)]0R_<[%ZCZR?(:G,51-?H"19'!:.@?[HOV!1NDLN$ M![I^`J[I)APM7<>+.B):QZ+W\%E7FL447&?85^"G-.Z[3I:21&E)C=X#^@R; M4AT=*,])1:[H1,"*U'T[WSU\A:U?5E%\29=4X9H=&WB@%>98Z"J>(5G%=>D0 M9H.^@E<"*WV2;]/P_@%?BR]LI^%"9^\PI=?MG")3Q;[!@9VPB-=KQ5>W^,I" M;\],=_@ORWO8T:21W"=3RI`)<`T5ZO81A[-J1TUW]`IAE.3%<4M:>`,V%RY] MI!G]]?A$?[LO=)K.FD'.=-50H6Y_<3BK]M<,)7R2/W&>D$Q'6F@&.P56^DB3 M!UJ.M+=^(X-=*QSI["F6\+I]5."IVCN3A[10*N813P%8(1KI[9;SVU=\98FA M\3J[(^J<0XXL*XJOVS4,KJJ=$0O'I*C5^*S MK-G/M;TE4T.?NW?G-X^+5_KE`;"[ZFE1TFQO0W1-?F\1MO@ ML5;RX3EAVTI7XC^GE_2O[G)]2W/4Y06YT4)OBG0!ZE"NB*I]2BZ1^F;Q)P>>]Y\@L<[D)5(Z^@`U(\%UE4-DPXTNHBP0I@767^*N;7298_; MJ_O@6QSGB5J7:\@)E7I:`'4;@WG%CGO<(LP*?4LSF+@C+]?`DRVR#_:,_R8) M\C;8+*VG^V?(19)U=`#JMP+KBKWV''^H23@AP@IX&:7L$SV]Z=U=QA#\+ MIV/0U4IU]0#J.";[BIWW@,[BCZ$X=[E*TYBS$(\HQL#KFJ1AN>V2?WK/Q/C) M?_/[WJX-R^/H`65]+/95+7!+9F7(_=YS[#-CAJBW`^W"@;?PMXYEO[`?Z=OZ MA::_S[??@BV^1_^`'$I4E5_29978IET5$R-,+?YVNGZ)QP;/.+AA/K1-/%B` M'2>4/,SG[6MD4;E#DL;BN\NO]*:^;A*I4*^GN)P5.XOPP2/SN'N&\<0G8496 M(I!6.COL9D93H8N';]\^!V^/D#F(NN1ZW9-GJ-@K-^0S-DT++QYPCO@-$2;` MF4;)$SR^W3XMK-'S[OX>N&:;LN!Z79'CI]83CV\(4Y-*X80>OJQ9B>X>$3@G MOY[H&)_\>1G1V^?Z>J1$BWK=(V*NUE<>[9YYO"!TERR))I/^EU&ZL4!GW\WQ M'Z//UMO-6>]Y!?D%6U5NO?XY9:?6(_-XRR7ZC*PW[-/.<,ZV`OY87:+]]OS\ M.:[U=;VD:U8T!A6F['J=462IUB%;=([.G[."8YA)O/I&;VB)J/3MS6)VL[JZ MOK_1UR4,R?4Z),]0K3NBN!^VZ(84YKI9H2MR*NR-SKYX>(B_T`7W%Q>WTP7T MVH!JTNOU"8NI6K\\/*0?&8-[=$$7;DP7#2P!*'D0*[B>]2Z&Z]FM!;E\74UJ MO;XX9J:8`UL!NDY.L1J2PL>WR()=N%ZB^M/SZS*=L+C!]Y[GGT-]O<"17J\W M6$S5>H5P.$R[X)A.N:#/8:%GCB\,\2]\,;V$_V]NAPZ^\O\!4$L#!!0````( M`!QGKT3N(PFS6RD``#5C`P`5`!P`8WED:2TR,#$T,#,S,5]P&UL550) M``/8\713V/%T4W5X"P`!!"4.```$.0$``.U=77/;N))]WZK]#][BW]]LD?_F?__GW__M'__Q]NU9QULL'=MP373V8XF1[S\;&)U=NS0# M^:WKF:L%1`L?WOW[OGY^1=SGV6SST%_?'=V]O9M7.[]KCV_G9'V_/*> M/MA5AY$1D-_/+"-`O[W_]-N'/__VEU_/KF[&;]__[?W[HP(ZWG*+[=D\./M/ M\[_8S?SOLWY_\,O9N>.<#6E*_VR(?(37R/HE*LBQWV;8C-_?',FUF6#G%P_/WOWZ_OW'=_M_;CIC\+&O[4CZ^QS96J)\GWX].G3 MN_#I&Z*-L[.=/K#GH"&:GM&__QQ>)S*:VPFV[-":@;'Q7&^Q?4?3O8N!<.Y: MEVY@!]MK=^KA1:A%THZPX&"[)/#R;6(J%/\VQVCZ^QMS:]E$0Q_^_/[C3C]_ MHH7^(2STW5&3J)_?/O^0]0-_A3]_,>(V`[1YHV-R0$=/9ZFV%L4-(F7%6KED_J] M)4UN.&_./&PA_/N;7T\UB8_,7V;>^IV%[)TUR(>T$1HA./E&F9!P8OW7:V MCO\,8)0AEE=(@)GA&&F20TUR31` M+<$1B&V*3TV98HP-ZE08;1<3STF9@/DL4GWR&5"5IP1@J_K#^V8)Y!#-;+JT M<(-;8Y%&O2A)@E"FD@`U`%L[/9L!^$. M:=#,P^P>PDR1Z!_)%$`-P12&8X.3%\,%QREOL?#<4>"9CZ,Y$<^_6P6AZY_, M;.Q!2R)#<@0390!M,+&H'/LUMGZ.VKCKXT.T]'!`V0B1:Y5V8L@D3=J,G12V MM3CB<>S4V`)\U[I[SUD17>'=*,`V$"=-PC+I-*!-DA&(8XO&5NB[9GU'CO/5 M]9[=$3)\ST76M>^O$&;:)"=MPC:\M*!MQ!608ZO&EO&[Y@U6$\XYGI'>\ MN,\3-CE^#MH."4$XNF]LW1Y[$P[4L4=^28]:.:E2;I1T*J#6X`K%V8YK;'V? M;-C.SY-O%48ZIEV.T[7",@G!.+:)U_S_>)>1A-3P>.H)APO#H8[I#TV,:CGVX(##D6RI+?F1%G4;SVV]H!#(9/H M`P[Z@(,^X*`/.+3_@$-Y8YS[/@I\S@3'?AAO"B`L8U0;(/(4 M">W`29,P1SJ-,JMPH.-QA:EIYBUOF([AS\]=B_ZY?%K9:\,A[?7/@XZ!\=9V M9_>&L\KLVA3)$V_A2.51;$@>]CQIF6N:ZD_H>*;IK4A+A\A$I-5D\+Y%021G MNO]))(V[H2@I7".*)01'(:[=-6F8A[>W*&TKUJ/(-HE'<&V1E``<8QA@M#1L MZW*S1*Z/2,^_"^8()Z1*F:1`CLA2,CG@&E!*WIK.8)XP'EIKZH7Q[]P]``#P4)85K0K&$-1WJK(A$BLBCB#1"-H>P[Y"63A%Y9/5W$G-; M$C8C\`+#"5-6=P[TE-'46R(<;`>.L;N60RC4DJYFLC.;3-+]^"E("G!-(!:M MIA.C)RP-/)?(L#)IBZY=TO@9OG$,;` M<&FLZ+G9JX\SWJVG?1AX")9]@13(@M`8\J)6M9\ MQYSH(.H^;F[5<]KI)UK+VZ5O&Q/;L0,;^60P#T^KS3V'-,NG`WNPY;BYBF:+ M-SYDLP%U4E6&D@&`RP;J"*51=IVA/=U4.C"UUS8F=E.Q$*?=D*A%P M,_%$J^L<[4F6PBLR:6?$RAI+G.Y@+TXZ^";C"5C7B=OR5NM&7&N(ULA=*+5==[VA)7WR@^\!<)=M*2G>CB]*R?5_NX4.Q5P8W&%J^N$ M[@G]:H7&WA`YA/U:`P/SA\/\A''_XB<$;C:1B'6=XSU]1!P;F]RY3"IM:GQD MIX5N0K&@.2=^%5@QW'?*M5].JLARO%3`;<85CF,M&%X3MJ%R;=0^\TA8YF1/ MV*\*_2/';O+DZN7W%/]JT+/S"`&8=ALUN%-08K#L:1, M"H6;"C)&8@K%L8Y"#\Q17`/FN5K.X_W,EWH,W"A9<3@64>AI.;]><@6%; MUV['6-J!D=XDSTFU/P3&3@7<3%SA.-92Z&D)(TO04VJ1J]QV9P,JCFTB?_\L M:C\=X%=XZ:S\Z.)E9B*KH*RCFSKERP*.CQ,5Q3D1K]#K,T2!8;O(NC2P2_?" MB%RKQ2IT6771U#;M-.>1SQ#A02(#<*/+B,RQK,J3,H=6AAX1^BH"C.;(]>TU MNG9-;X'ZGD\/_MQ-Q\8FNUM5)O=A#ZM0;N``**P,#AH4>IJR@N:N97+7,-#- MQA*IZG7J1X6>IAO;]7`8T3]`1/?ID9KW.+)GYC%P:V;%X?0RI?>K@'JUQA[U9GEN0/1#FC+CV+':0KF]N52AP#%3E>HJ'S44 M>K?R_#Y\QZ4PN>3)S';YN_*%KQP9L;^L@6A!@U!7\3,P=.6XF]8;,HBZS.<<7&5S0HF3#=Y'(SU?!G*S)7P[,C6E87F*F03.) M6V'(K(C@@ANQ&AQ&698Q7C*AP'!1PA89+18-7+0B5F/Y[T603"TP70O>B)`K M)#B2K<&=T"129@W5EJE,*!RX MH$69UC(GL9Q4/&/!GKZX0H&+3E3@A3X%7N73QI?XE'E]S]_K]0'O=JSWS2[M M^4V7TX"_-UVENN`RB79P'+LYJ?8A9-BIU#M66NN^S5.\]MAJCZWVV&J/[6OV MV$8W_WF!X'F/]Z!]_AHW9%X#%*U62%..YR"L(]2 MAU,JM,C8IFO7$ZD;4YW(^YSQN2_ M>Z[,(&(,>4Q93NIF:X0G7GHD+.7XE&0.+`,)TW`X!'1#<62JWEBE+KS*DPJ6 MO?*2\>D%=*OQ):O><$JCL1_I032-B:8OP&9,R5!YH&B%%T[#>/$$F]/,S5+& MD\ALQT^`QQ[5]./E9DD'TT>2QIXT=*[B&B-L*A09ZYUOJ#7SE[" MKRG;2*3<1U3DIX1M,:&,\$*DD_%\;?ND/3T/=[W5))BNG#@P=\QP=#)1^#-TY*&GC!TDW:5+;`7B.V)4OD M/(X_*YD3MJT+Z0!>"/:,C'GA2N?5<+REC_!Y:]E)=.GUDZ_ST0"TO(2B\".[T[;-^0&7: M-9D3%28OV=$+L)G)E)E,'GV>2,JJ=\]5AH$/Z4%6+RPBQ4]U3)H8J=IA;ZZ, MG'ZJT+/#E4MVM)4=95MB.H&#0&Z(J('+$,S_4OT-3# M45C`L;%!?CIR&:'^R5)VP81N4##WK,.(ER9E"FI.W%!HIF:@5*)1Y?],P?3W M"HE&@PNR_,WN_>6D2N`PFPHT9AA"00R53W>8]2 MZ(J[1<%A'"D13[)T_IBH%,X/%"`E%`$O:']"")&E159LA85JZ,4JG7"<0-(] M0B+LF;M[XY&Y'6/#]0TSVC`-OSD[NUC_6NT(0QQVFAG1=!<4D;62;+KNX_5I M8W4#Q77#!H#WV@&&[)Q`]!(I#R=LN2F!XD`H7.6A914Z->-7)\0!SCB>Z;QD M\3U<7C*@9N:+!>]%`>FV7AB^;9+1IVL[JR`39D4R-<=NZ=3*S)>+.X81,Z)R M;*G01?F=3"9STK;S-<+&#-VN%A.$[Z:9."2V3MPMF!]M[B:H#W8@*1 M#$'AN4FS8>&S2=6'_6AM/"$I$^B@0CJHD`XJI(,* MO>:@0K$^`S,P7VW_ZR+IV]T?PSLW`7N_>I\,YFU:Z@(-?NV@!ZHW- M7'>4406XX$8MWYXX`8Y5;U\PCJRI,^O!`>W3K3*BHA"^8V^(3/+==E!"]K%W MVJC05'7[EU?77%U+\5R_&2ID<)P0$:DKB(;TA4Q62O:%3`/$A#,>E[R%XS'+E%LG!!P,BB M,HA\46PSS M%PG!JP>$PK.-65D'&"T-V^I&4L77B%PK/`EW[ON(==WEA$*X$)(JI/78DE-5 M]:!3&5F./_(.C"T==F/Q]RH]>KV[]&16H*S<64ZFK-9#L9#B./YKI=>QTP+% MG8H=?E(Z/1<=Z?2M1T!&`=5[A%3&W,L*W"'+5K*4Q%VTI.^,SQ]<>!FX&,ED M:#U(LBJH`24JKXM++R9+[XB6W@EMZQ*[B&HJ#^"CT`G-D7MWA_B$77:)`L38 M$A70KEUVH2H`!CHTMJ&?M.?A^?3*>%51/;TOH1,VGAC0I@6VK`A M@U\O5P$UK(I4WNR.A"4BFD\K&R.B-#(^!MN!8[@T)@&-0K`\?@]H"B;R&5.8 MD7:T82=O.5[X:J@! M)6KOI$MJJS0O*H"LX5 M!H5^WG#01%880FF('#KT#0PR^7;1),-A))(>CN#PDT(;,V3`Z^6)#R_TY7%[ M:8BM\!`&LB(_DL"V_,0,ZS(2_P3V9:F`8V&%OM(A6D92-AW99+N7R@I M2-I2VXK%KYXO*@VE*:VITG-[Z3F]K?@IHIJ?*3XG%9JLP.D?N@I?&P[M0P.$ M;1ID,;GKD$)3F:QQ[)DB68&RPV+B_TPQ*B^G4V0&=]/+C3DWW!D:$C7=N6Q] MI#!3)FM\\;-(5J"8*28^O+B7[):>DZ$3XRT9)>\-)_N"R2)YA.-#.@]0(TL* M?-*(L`R'&=(.',")M%D;.O[XM0P^_D@3]W8AA`I=`48NW31S5>CI'*V62R?4 MB^'$D2&NW:F'%SNC<")Z%,L57U.7S`44(])"=9=W<^!H:=CHG$>K0_ MM7/T2)U1"F+-2\L$+WCD48QUID683],AQ*.G[;)+2C*.:6(/7DVQGFZ]`/EC M+UI)&LZ^V_MW>&:XT;U/NM'E.;85?J$1KOR[Z>"H)1T-C!6`7/H\%@Z/)8.CZ7#8[WF\%B-$*0XR'\C9"P*ZM\`D0*W MH*U9P>)07HUS>X901(*1/7/MJ6W28X^-4O>3FJ.4F9_4\W\DS-_"9E!I&`Q>]CI6#3S@^-V'(&`D39E M/LDV>!^UGU'S/,WS-,_3/$_S/,WSJC=&&8]B*=]AN[V$+?4'[@+GULDATS4H M)8OIQFA6J%FA9H6:%6I6J%DA$+2K\?YQ>$#\MD(.2XA>+LB M)GN:[&FRI\D>$+2W8W.V*`G9VZ@H>8E-5XQX@*.6!00'QC?C=^MNFZ&8PNJ4 MLDIARS21U$12$TE-)#61U$02"-I;021EV,4^&J4$$8E#4^:2"'`,42P>,%(8 MOG=\B$QDKRGL;A%]5=\`HZ5A6Y>;)7+]6DEBH>K5!H\LTE)-(C6)U"12DTA- M(C6)!()V-5O/9>A%'*NQ##.)0B\69Q7@6&0Q\8&Q2NZ[GYMQ/1:J7BFK+-12 MS2HUJ]2L4K-*S2HUJP2"]E:X)LNPD<,+E8L3F?WKE8N2$'`DM)CXP$@HC3\> MX)5):[IVB2@S4G6M%V/R:E1*-?,:I]FE9I>:76IVJ=FE9I=`T*[&9RG)&^)W MVTJRC.B=ME(,`1P/S!42&/6[)K6X,YO`:7=ENZD3C_FU*C[XF-]`30,U#=0T M4--`30,U#02"]E8X&0M0CL-KTJ5)RO[MZ9($`QR#E!(6&(OLK/S`6R#<14O/ MM^N-<C(XFGLX&".\Z*))4&MH'G9% M:N/PL-ND.:#F@)H#:@ZH.:#F@$#0W@I?H9A+Q`81$X[(*"*R`(XI\D0"YO<; M(H=\M`8&#K9C;+B^$6Y\-[2+7*1VI:2P2$,U4]1,43-%S10U4]1,$0C:6\$4 M2U"1R$IE2,S.?,4)"#BB64AX8.RSXRT6=K";$EVKXX6O`40N?0E@,P2T8`,4 M7VHIU%9-0S4-U314TU!-0S4-!8+V5M#0KRLZ`ZQ;>>!2W33$XS.?V,$`<*9RS%UI7R0KDF:HZH.:+FB)HC:HZH.2(0M+>"(Q8B'L?CD#19.1J=)(D&.!XI*3`P M3CFR9ZX]M4WZUFK3]%9AHP>>8R>:'?]0AZ.Q6`/4>A^+M57334TW-=W4=%/3 M34TW@:"]%73SPO!M_VZ:FF*WN__S^&:Q3)'1)#.I-R23<$:CR!:#7-^"(#( M_ZTA,AW#]\,%9*@XZU\K/PQUUD6^B>VPU2D3E&;%P=J!F+JX&<*2F8_AS MZA8B?R[)$+(V'+K^$W.:0GGBNQU2>8#:65)@MG'_JO*.-]TZ]G`.1\U+MK_; MS4D&U&I\L=B&^IO*X=A;(AQL!P[UX;D61=F2"G:]6!HVII\R([!TCOV@FY\# MJ"6EA&4;]>\5QLKJ$"X53<8M6SA?9%GY M?$!M7$!PCK45NHV&9'QQ5XA,&M[,M6G#Q%:63K\?A?/2`[6JA*`<:RKT0?4\ MC.R9VUD1WN>:B=<\D;DD_.H<.Z"Y??G49C,-CX9 MA_`,X?Q^G)?TJ`MSDP*UDU@\CBF4NI6B@'EY;B5QLG3(P)98BR\6QU(*_4H= M;T'T-B=,W%ZC7<-EV%'1;(=7O;$YEB[E;*JJ3P:&.[/)0OK<]U'@ M]VS"`U"?"&(QEZC2Z?>]-"\]4*-*",JQID*'TBUZ/CH^@3V7?#1W1_-D^F_9 M[/&IRZ+9@9J^N!HX)QP4.I\$+Y[*'<,+9LQ_85=+[%Y$=([%@1]\#P_0J3OV M'E7?@D/O44OUD7=]Y%T?>=='WO61=WWD'0C:6W'DG7OP8F3.D;5RT-TT,0^3 MQ[X=.QB[MK_T?,/AWL6LJ?2\\RXE2U>/(2;9K5R)P&Z"[D]Q,4XVUT:#)2I5 M_$:TW/9IRJLIKZ:\FO)JRJLI+Q"TMX+R'FC3?I+=;:#OY.'&H2N8+3:<;#;U MYF2R3WFQQ1-)X[0R/(5Z.'UZBRAW'F"T-&PK.KM8/\TLT0BEM+-$>S4-U314 MTU!-0S4-U304"-IKIJ&<^2LU=_K,R5/$,,L7$%FG1`'JK<=DG654(1[2&N>? M7+=MDV[.$HU0RC]+M%?S3\T_-?_4_%/S3\T_@:"]%6Y0[E1;>#._\/X\>/HI M(ZJX=RG814^>@F]V,UVV;L5[ZK+-U)Q2@WMY,&EI*&6!!X8FDZ*T"PL/.%_2ER"^AYF4\YG44 MG8)1)44#QU,-<=>65O*Y619,B=G&^R8)WR%T;PK=UZ$2YX;LB9:K`@6B6J=@;$- MV4S/PW=+A`T:BZ*/#%\:#A64F75PG%`F>`B=I#`VN#ZI6XOZ"*]1;^5:#81X M$=6F>'W);YA>2>J5I%Y)ZI6D7DGJE200M*M>21Y/EQ>&0X9#N=V0`CDSE#(_ MIWI#Y1!'">%S7D'2.#_L>*21;H##JH:V_]CD)D6!RI6RQP+MU&12DTE-)C69 MU&12DTD@:%=-)CL8679`I\V[ZG),7?6Y))&OFZU$D&C%S1Z00,$[:H7-.G)\]J=>G@1ZN1BNW\8OC53ELB>7F2&OYY0I'J;Y]#6 M4]15Y:MG*X%*W_.KA`F_N%(0813W4\"#I29X[[$M)E,U`*H&-S\97&IZ?VW5 M*(D'/;IHOR3K1DR:N'<#G;M6WW-GX5VKW0VKB^T5\F;86,YMTW#.,3)D1Z*Z M*F)L"U=<$7@X5J_:G-?\UN2@.?@4Y-ZGUD6!83OEG3)EZVO`$5.V:=KYHITO MVOFBG2_:^:*=+T#0KL;YK1Q&2^3:@ZA5`B^Q1AC*S^ MSMI1L%X/O@6KEXNOM7+T07UU8?S5'VO!^!I15>/ M[%)!IQI#]K3S;?EBCDFMZ#YX>JS?U<*KL#9L9RI\->#.JKIZ='\"B^[D4GOX M^3M^''6O'A[,IP9=+*QJ&_"N)*I]%7@7J;V&G:'W+8']"UV"+[HTV4VP&3O^ MN$'P\RMOH`LP*G^%'8%E@AJZ`]R=TJ0ZZ'*&_.D^;!_.@WV!W$#&N@4G`:\PI[!,T4-W0/N[FU2)5?6_;"__+&=7DVN M&NP4K&H;Z`J):E]A!TBJO0;8P]W>32K"^KKI3OQ+>S8//L]'G6V#T.=5W0#\ M,U6_PBZ057\-W0#N?F]2&:$:9N3#;(!?:.+MYR6='1OL#GE-:*!;<)OP"KL' MWQPU=!.XF\=)I3R%'T;C#?F\&SJV]Y;38"<1-Z"!+L)IP"OL(#Q3U-`]VK+[ MW!E>A(JXI2>^W;Y#QPOKN<'N(6Y``]V#TX!7V#UXIJCAEA?<76KZBT\E?S1' M]R;1SL)]6=1^]HA;8VV'C[(UO@K$+E_IO MH8LJK0WHS$I?#=;9*J\![G!WE^DO5G?B!/3$R:1_/S+KW506U%<;R-/UO1I\ M9Q1=`[3A[AS37[Z2[_>CX:W;[SX^UX]L=G6U`3M5W:O!=5K--<`:[BYPZ+MZ M[!-V]O7IQXBN1C:#>>W(YM98&[BS-;X:?#.470/$X>[DTE^^^(,PIV5FY?;R?XHRFUZ[ZQT?@E4L/.W$!<<1<`.MRD2R+QZZ#V] M.(]4+/IO\*,`+/B9)3#!R-Q"0+!4`#LTI4B:,*K)O6G>+N>WY/?%YP)@X.:5 MP$(V;PNAP%``[-",(F$^SZ?]S^$89XT?)N'/:4=OV>P2>&!F;R$DV&J`'=90 M),_D"D^7MZ/UCR?R(+V6*IY1`@FIC"W$0%ITV.'_1)*,)Y,9W=$-?^BMPS^/ M(WLS*0"$W#(D,,$OHX7P$"@$=L@\D5"8GEH,Z`92<&\-S<_T4P&0B+)+X(.9 MO8708*L!=K@YD3STWVX.?'9?OL[G%/;T7[\`-'++D,`'OXP6@D2@$-BAVT1" M_1@O^^,^^='OW(0+[@((X>:50$8V;PL1P5``\'!F(FG6#[X3?MD.GA?DP?!K M`2SP,TN`@9&YA6A@J0!X."^1./2SO;GY%O[P;;D-;M;I]QB5S2X!"6;V%H*" MK0;@H:V$OI>;W:68(`P_W7W\4F1-PL\LX[K*9FXA(%@JJ#'44^UG8_JV,;$= M.ZCG3<*BTAL])2-JB#XJHX_*Z*,R^JB,/BJCC\H`0;N:HS)'DR3'S_8UW,F= MTM<+]I:/W[.OU#NEB'@P*E.$>ALRF60Y=<`^/I,KTX^A/WLDO^U^6`Q]LRA( M^"7(8H110ELAPE(&[&,TN2(-E^3;V'U&TM[MT\M1A8KO&+:"ABN M6F`?M\F5:Q1^>EJ'G^U->'1D/$H?MCBU&%G4\(II*VJX:H%]-"=7KL%C^$+D M[OR%[A&._=NB>.$6((N4;`%MQ0A#%;"/Z.1*U+O?DE\L`OCMZ($*UTOOH)U2 MA"Q"6$6T%2-,=<`^RI,K$_F\I*(,W-O=DV]7]^G7*9]6B"Q2V(6T%2L>06OW+IY4=;*E3\?"\!A][X2H;=;P7;IWVQFMOO/;&:V^\ M]L9K;SP0M*OQQF=G3C:)6MS34XQ?.@^];T_F-KQ#D3'#R27M[56^)/6&99+4 MDY0#VU,O*]JW_LTX?/(UO)@7RI:)I5E-805QQ"FLY5#BJ0BV5U]6.O)U^#G\ MUK'F]Z'OV;JB#TH"*K>\@ICBE]=R6`D4!=OS+RO@P^.#^]P?WTPW:_*D))S8 MA13$4*J0E@,GK1+8'G_I4?8J_#C;10Y^"$?9SKQW7W9>RRFNZ,S&*Z[E6.*K M"?9.@:Q\\_OOX7P$BH+]BZ#K(C4(=ZY M-Y=/777X82H']F5C6=&>R7>Z)EU@QQJO9\_IL#8GEU,0/=ER6HX=AF)@ M7SZ6%>SQ(KP6]?!U1_PN_.%=)I)!)6451!"[K):CB*,@X)>7I?O(HD/_=)_I MX$K_36;=9=F!2%16T<&(65;+H<114(T7GVL_@W'MDJ=H;&QJ/78A4TNC)RUD M&J0/5^C#%?IPA3YC$S.65(AL`]1Y`CU9;$-QJ$D?>J$)D^M[^'#8F#)+48.+_QB MV@D9@5I@'Y;(D>O;*/0>7CW^^/$%OSREW6PE<\MA)).[G=#(*@'V(8<<<9Y> M[M?F^/9Y.9M1WTXQ0'`RR^$AG;F=<,BH`/8AAAQI7"K#A'Y:AWN;].OG('S< M*P8-F9+D<"(LJ9V@$2L']H&%'-$FY,OME_'+MXON\S1]I[%47CF4I/*V$Q=I M!<`^6)`CS*+7>[X(.=2-%5[K+L@V^/GE$,'(WTY4L!0!^^!`CD!!*,SBFSGZ M-OUZ,_M6#!>\W'*HR.1N)R:R2H!]$"!'G,?'W0%B/+NZNA^:K,LD)Y0@APQF M">U$!UL9L#?\^$9]CBSKYZT5 M[Q9_(\^>)U_2OND32I"#!+.$=D*#K0PE&_#1$_J_B>$C\LO_`U!+`P04```` M"``<9Z]$1[^*Q101``!PPP``$0`<`&-Y9&DM,C`Q-#`S,S$N>'-D550)``/8 M\713V/%T4W5X"P`!!"4.```$.0$``.U=6W/BN!)^/U7G/_CD:;9J",ED9G>;SCVCXOKRZL+!MB:HQOVZ,?%#`Y+OU\P/E1M734=&_RX6`'_ MXK]__OM??_RG5&)JCN6:AFIK@'ET/>#["]4##&=C`I16=[29!6S(C"%T;\OE MQ6)QJ6U)EEL*G%AFF%)IP[<7R'/+('DNKW!&4)T'5(C2&5V%X/;J^^WUU]MO M7YAF6RE=_79UM<.@YK@KSQB-(?-)^R5:S,\,SXN73,4T&0F7]!D)^,";`_UR MS6CIZ[>^-@:6RD#5&P$HJ!;P755#9MC5:#7P=(/H\.7J^NO5S9F(MRT\\$QCKSA.V1#)KF;HMI*-UXVTK/4.MR6WI7A6SG(W!2U'=N>6=$BZ]`KPY4+RJA0"94" MGJ%MZ5XFVB.NLDE(CM>^LY)E`0*P8_/$A-=749B8AY-'[FGA=@D:(VSH2 M(@/ELV3Q=.O4#2)O`E15-7$#E<<`P!U@]I+I0'Q!UI>1RF"-1*TCR!V>JU<4 MMLY4*WQ%J+&,W&)912Y02(""B(8*&XX!-)`!8B#9+T/'YR8Y/LRG/<:_%'C% MX,6A"8L%ME;=0>DPAX[-5QHVLH(^VJR`<.DT&$ZH==HL4Q'JJ%1;E-@6*\A< MCUUG%%#%0%53_7'#=!;^#DC/:71XOB6'IU:16TR#[_PL.KDX)`0'`E]Q&H:- M^C%#-;>6]3O>2+6-)Z)+S;%]QS1T\E)5?C>+P!(!)QLC&ZV`-!5-0U_I M1:^J@.XDOQTZ2;4BG0[M:$HZC+\? MPMCL<$(3#RPU5BK@2P_?&[;>-VFGWQ.U4]*KRP_M=D7Z"^?)7%/@&ERM(BBH MBZ]U'@0%NX6()ANUHJ_/XA<5WP#X[G1EPAG,(*2?TT&C: MD8IVFVG%#K5M)L MA-P([U6GP_LE'G2(0[$O'&)5I(<:625Q`H:\B19.11^?9;B&JCTR4&\<+&RR MC]HO\Z&C'`I><6@=+#0YU)>O5TVD2R\P3M^"9SYT+.#5@>OX1MH%;SPU'<]0 M%*M2[Y%MQ(;4:3.U!S3=;K-2`6?ZY=38\:`"\`F=`4RY=HHFI0,9BE;)K8ZD ME!16:C-\IU($)--#*`%D`:"+*IH#*9YJ^RH9&C/WOFGX4<'^$@I822Q/=C+% M"II3,8I4$>0*&7B+T3;+7,JR#!C$$6T=S8IP]!C8.':<%?J4+.GHAP)?M4Z[ MS2ED`_LSGG;AB#,KX'#S9S*QYMEFAX119.@-RP+,QL_640W,T M)1WB4-@+[SA(/30L/PCU`KXL,VA\F$=1E]FGSA0&=#`C`E[D`)!2>2R0S++2 MU="G1Y21#'^2O4].P(B.;"B^179_!33^DK$7[P=6'V1.0*O>X+B7A/I?A9$X M^;Y`/OV4&HSPIX26.!X>/S/O323@0\<]%,Z2V28>?E$W+:)9-QIB"WC3PSL; M^&`Z0X\LWEM(N^4?2TV',A2VDA^J,MM]P&BR>%^B&&TS;`.#D6JV50B!%YKO MIMP73L2)#G$H9K4W10YFR)S"-8/S',4N\O$/\6P2WO`PSY8EW1="\2YY9EFJ MMV*<(;-3$?-<$[/AS'S:/!6GZ8_E&`K><7Q+MU@SI#O%44YZ,9^"N@MG>=OC M"2E<)`$;JF/8O7B.SM5^RP$T=0-4P=W'.RH&.;2@@^#:Q'T'U<"EHAR)]P3R]P"LC7E%?VZ.!1BM/1>YK*!2WLT]3 MP)>U*T[Z+3UJ;YR6"1WH4,PMXAM_!>`9`:>=8J)AG(2.#FLH6/9\".K#HHG_ MPY&/"WPQ8VES`^/?B.)R:9F;(M"`N);:,Q\&,_(_,ZII M7I3/5_-]&!,HC@@B%*]OV>1$;U,=`#.ARJALA,H\YI`3;0^;>0*E$4F$TKLW M`D7I_D?Y\`+.=S(JV'CKE\-;I7E'8TPHY#@M]*&KH23 M2M=?2C?7EZCJM;AII7BV?#HI-G19I(B^TS5A_1L"7/&W;(I'WPV;I/Y=2B$@ MQ')\QP:X_O6UTF23)+L8NQ?2CE35W;O$-D8((D`D81F8T-^DE)Y9I7.+S;6Z M.C`2BW-(@Q]>+0`)0GBKU$+LTFU>7BV,#UT/<[Q.(\F6B#R5GLFSR1!QT7$2 M*7;(UL]9K$&]._D5ODIX401:7]Q-)$(S`LJ-R)6!#SU56U\WBL<=Z@7*S\6# M`91?:=#? M42PR-S>Z'<)2<_P][6+RST8_'0Q20G>H87R1O"A9!VCNC2`B79^MJQ;>OGE: MLWKN,&FE\J(JY\),&MW"3?A(%8U6)O*>/*!'*.4?QXZ^N(SI$ M9Y^C(NDOA"(*IB,[1\43W8&S'@1>*'F6ZM$O"`D4BR]SCBI1OE1-U(G)/T=5 MHEV*;$JODKM@J/PYJBH!_)M/H`V\$?#B-:07.T?%#KI`/[(/Q#D)^L]$Q.=H M!/RS4/K,!)UA?08:GF/MG);$@U^<_BGISEYUQSR;RC>\=_* M2%&LSM%`T3\]X@??4T:JT@X_]H'G*`O\KV,#&7L%3KDC3T)CJC0%6UEZ.R8\ M165K(R,+(T/@X]GOS;[F0&DX,T^9U.J#?JU_5/.&ZGKWUETNQX)A@RI*GM_+ M4)2.:M^(VG9CB3K0#$LUWY.-T:-L+,DC2L+*/RGM4R^F&E M'\OD]1'DAR0Z@1;/S6%K@Z\<=73S1.!$%?YQX*@)E6)[@(.7-N\ MB=U07YP(@KC*WWU,U\>:3C2YIR%K6/:3==0H341M[]["2B-HWF0:9]KW/>OI MN/O%T17N=B8NOH#@G9E9KP],B(,C`[XG:\=;GD;6M6M>_1>T^6 M!)NO3Q;'M>YA5>_?N*L)C_K#^^FCC(>?I3@^JGTC:GO_)N[Z+KPW;:D53'./ M:N!07>Y80.E6*Z'F$71G=\*) M)G]K/.1;Q&5UI3\@R>.$JD>3GM=/TY1AIU0Z4.B7(&M#`8C M/'4E"8TY^9B@^<`@H?(4^GRU=@^O^R&>`L&>+FDM_)30!M&D^5(?_P7M=6$_ MW8_'&%/\QR>T`84^7X9X5%Q>X5&B7VN3\3NA`2+H\J7XO.^;Y&4E+BQ\GN,^ MH>91A/E2'3\;RW:7)'3=%6S/^PF5CR;-U1#0;0?Q34B._]4G=TG[_BC"L]-\ MYUZ!F-[[GDQ7A_A$>L.=_-P_DIV-_/S<_T4]'B5_-,%1<))@2;Z6Q@I1U#DT M@N2B-\6>N&0XP_EXTGNK?U?J-[E1;D?7_[K=(7\/EO&('257I M\FV%Y-R3T!?196^;[[6,SBU"GU0?]"JUR%M-'_?(T*@W#R+P;\`KK^;I3_KV M@E?:P^4E$<6RRJ]YQKV?Q..G0?I0 M)SDN[D$S6(C*[B&C&,.;7&U+H?>8]!+XFU M:HV%#/:(Y)+?1K3`:W8TKEJ>J2OST:*5P201//)KD$F5!'3Z]T%76?6ECIVE M/XGAD].VL[!J^*.^P"Z/_P:CNIO%5:+YG)E5MC]%$Q/I&2_)`+KH/7H6RB,O MNZ-R1OI\6>'.6D&%B,[C01(O:G^2S.2&H+#(ERVZ,AD/FI/'QSOO:=I*;H(P M9;XTGS[UYIHB+-S1Z."0?EK"?.EM8Z$'9.^'S!'Q:PL&6\#)C4#GDB^+#/#A MGCOEJ5NM+X;MY#8XI,N7UE:CL0@.RK=U$MI-T?:C:/.E/2326UU-[@[OVZ-N MJ-GL2=IAP"\3=;XLH'AMN=[DQW)/&237?)_J_)8)+X@_ M7ZSTS=2UB_(6@SL_N?+1U/^H$8)?#@M^KP:]_A]02P$"'@,4````"``<9Z]$ MJT(+Q48X``"J?0$`$0`8```````!````I($`````8WED:2TR,#$T,#,S,2YX M;6Q55`4``]CQ=%-U>`L``00E#@``!#D!``!02P$"'@,4````"``<9Z]$J^'( MTA(,```VF```%0`8```````!````I(&1.```8WED:2TR,#$T,#,S,5]C86PN M>&UL550%``/8\713=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`'&>O1/,! M)FGI)P``!PT#`!4`&````````0```*2!\D0``&-Y9&DM,C`Q-#`S,S%?9&5F M+GAM;%54!0`#V/%T4W5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`!QGKT2N MY;P<$E@``"KH!``5`!@```````$```"D@2IM``!C>61I+3(P,30P,S,Q7VQA M8BYX;6Q55`4``]CQ=%-U>`L``00E#@``!#D!``!02P$"'@,4````"``<9Z]$ M[B,)LULI```U8P,`%0`8```````!````I(&+Q0``8WED:2TR,#$T,#,S,5]P M&UL550%``/8\713=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`'&>O M1$>_BL44$0``<,,``!$`&````````0```*2!->\``&-Y9&DM,C`Q-#`S,S$N M>'-D550%``/8\713=7@+``$$)0X```0Y`0``4$L%!@`````&``8`&@(``)0` $`0`````` ` end XML 15 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS EQUITY
3 Months Ended
Mar. 31, 2014
STOCKHOLDERS EQUITY [Text Block]

NOTE D – STOCKHOLDERS’ EQUITY

As a result of the reverse merger (see Note A item 6), the common stock of Cybrdi-Maryland has been cancelled and converted into shares of common stock of Certron at an exchange ratio of 1.566641609 per share. This resulted in the issuance of 47,328,263 shares of Carton’s common stock to the Cybrdi shareholders. As of March 31, 2014 and December 31, 2013, the Company had 120,225,323 shares issued and outstanding, respectively.

As of March 31, 2014, the balance sheet included total equity of $3,634,554, of which $984,522 was for non-controlling interest, representing 20% minority interest in Chaoying Biotech and 16.67% minority interest in SD Chaoying.

As of March 31, 2013, the balance sheet included total equity of $3,988,454, of which $1,034,733 was for non-controlling interest, representing 20% minority interest in Chaoying Biotech and 16.67% minority interest in SD Chaoying.

EXCEL 16 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\V,C%F9#$S8U\V.3,P7S0V,C9?86$S,U\V9#8P M8V0W8C8R,#DB#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I7 M;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U;6UA#I.86UE/@T*("`@(#QX.E=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-43T-+2$],1$524U]%455)5%E?3F%R#I.86UE/@T*("`@(#QX.E=O#I7;W)K M#I3='EL97-H965T($A2968],T0B5V]R:W-H965T3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V M,C%F9#$S8U\V.3,P7S0V,C9?86$S,U\V9#8P8V0W8C8R,#D-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-C(Q9F0Q,V-?-CDS,%\T-C(V7V%A,S-? M-F0V,&-D-V(V,C`Y+U=O'0O:'1M;#L@8VAA2!);F9O2`P.2P@,C`Q-#QB'0^)S$P+5$\'0^)V9A;'-E/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)V-Y9&D\'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO3QS<&%N M/CPO2!#;VUM;VX@4W1O8VLL(%-H87)E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!&:6QE2!796QL M($MN;W=N(%-E87-O;F5D($ES'0^)TYO/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)U$Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'!E;G-E'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPOF5D+"!N;R!S:&%R97,@:7-S=65D(&%N9"!O=71S=&%N9&EN9SPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAAF5D M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,#`L,#`P/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^ M)SQS<&%N/CPO2!P'0^)SQS<&%N/CPO'!E;G-E'0^)SQS<&%N/CPO'!E;G-E+"!N970\+W1D/@T*("`@("`@("`\=&0@8VQA M'!E;G-E+"!. M970\+W1D/@T*("`@("`@("`\=&0@8VQA&5S/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M/B@R-C@L,S4Q*3QS<&%N/CPO'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M/B@Q+#'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\V,C%F9#$S8U\V.3,P7S0V,C9?86$S,U\V9#8P8V0W8C8R M,#D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-C(Q9F0Q,V-?-CDS M,%\T-C(V7V%A,S-?-F0V,&-D-V(V,C`Y+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPOF%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M<#XT-"PW,#<\'0^)SQS<&%N/CPO'!E;G-E'0^)SQS<&%N/CPO6UE;G1S(&9O'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`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`R,#`P(&EN('1H92!096]P;&4G&-H86YG M92!O9B`Y.24@;V8@&ES=&EN9R!S:&%R96AO;&1E M6EN9R!":6]T M96-H(&1E96UE9"!T:&4@86-C;W5N=&EN9R!A8W%U:7)E6QE/3-$)V9O;G0M9F%M:6QY M.B!T:6UE6EN9R!":6]T96-H(&ES(&$@2!J;VEN="!V96YT=7)E(&)E='=E96X@4VAA86YX:2!#:&%O>6EN M9R!"96%U='D@)F%M<#L@0V]S;65T:6-S($=R;W5P($-O+BP@3'1D+B`H=&AE M("8C.#(R,#M#:&EN97-E(%!A65A2!B92!E>'1E;F1E9"!U<&]N(&UU='5A M;"!C;VYS96YT+B!4:&4@<')I;F-I<&%L(&%C=&EV:71I97,@;V8@0VAA;WEI M;F<@0FEO=&5C:"!A7,@86YD('1H M92!R96QA=&5D('-E2!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N+'1I;65S+'-EF4Z(#$P<'0[)SX-"@D)"0D) M36]S="!O9B!T:&4@0V]M<&%N>28C.#(Q-SMS(&%C=&EV:71I97,@87)E(&-O M;F1U8W1E9"!T:')O=6=H($-H86]Y:6YG($)I;W1E8V@L(&]F('=H:6-H(&ET M(&]W;G,@.#`E(&EN=&5R97-T+B9N8G-P.R!#:&%O>6EN9R!":6]T96-H+"!W M:71H(&ET2!P6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE M2`Q,"P@,C`P-2P@=&AE($-O;7!A;GD@8V]M<&QE M=&5D('1H92!M97)G97(@=VET:"!#>6)R9&D@36%R>6QA;F0@86YD(&-H86YG M960@:71S(&YA;64@=&\@0WEB2`R-BP@,C`P-RP@ M0VAA;WEI;F<@0FEO=&5C:"!E;G1E6EN9R8C.#(R,3LI(&9R;VT@=&AE($-H:6YE2!A;F0@37(N($)A M:2P@=&AE($-O;7!A;GDF(S@R,3<[&5C=71I=F4@;V9F:6-E MF5D(&EN('1H92!3:&%N M9&]N9R!P6EN9R!":6]T96-H(&9R;VT@=&AE($-H:6YE6QE/3-$)V9O;G0M M9F%M:6QY.B!T:6UE6EN9R!T;R!H879E(&$@2`R,#$Q+"!31"!#:&%O>6EN9R!E;F=A9V5D($1O M;F=S:&%N(%9I8W1O6EN9RP@=&\@;6%N86=E M(&%N9"!O<&5R871E('1H92!34$$@8G5S:6YE2X@4T0@0VAA;WEI;F<@:&%S(&YO="!C:&%R9V5D(&%N>2!F965S M(&9R;VT@5FEC=&]R:6$@86YD(&YO('=R:71T96X@86=R965M96YT('=A2!H87,@ M;F]T(&-O;6UE;F-E9"!C;VQL96-T:6YG(')E;G1A;"!A;F0@;6%N86=E;65N M="!F964@6EN9R!":6]T96-H(&EN=F5S=&5D("0Q-30L-S,R("AE<75I=F%L96YT M('1O(%)-0C$@;6EL;&EO;BD@=&\@6EN9R!#;&EN:6-A;"!0 M871H;VQO9WD@*"8C.#(R,#M)3U-#0U`F(S@R,C$[*2P@82!W:&]L;'DM;W=N M960@2!E2!R97-E87)C M:"!A;F0@8V]N2UR96QA=&5D(')E2!W:6QL(&-O M;G1I;G5E(&%S(&$@9V]I;F<@8V]N8V5R;BP@=VAI8V@@8V]N=&5M<&QA=&5S M('1H92!R96%L:7IA=&EO;B!O9B!A2!I=',@;&EA8FEL:71I97,@86YD('-U&-E M961E9"!C=7)R96YT(&%S2`D-"PR,S@L,3DV(&%N9"`D-"PP,3@L M,30Q(&%T($UA2!T;R!C M;VYT:6YU92!A2!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N+'1I;65S+'-EF4Z(#$P<'0[)SX-"@D)"0D)5&AE M($-O;7!A;GD@9FEN86YC97,@:71S(&]P97)A=&EO;G,@<')I;6%R:6QY('1H M'0@='=E M;'9E(&UO;G1H6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE&EM871E;'D@)#`N,R!M:6QL:6]N+B!(;W=E=F5R+"!T:&5R M92!I6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE&EM M871E;'D@)#`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`Q,"P@,C`P-2P@*'1H92`F M<75O=#M#;&]S:6YG($1A=&4F<75O=#LI('1H92!#;VUP86YY(&-L;W-E9"!O M;B!A;B!!9W)E96UE;G0@86YD(%!L86X@;V8@365R9V5R("AT:&4@)G%U;W0[ M06=R965M96YT)G%U;W0[*2!A;6]N9R!#97)T2`Y,RXX M)2!O9B!T:&4@:7-S=65D(&%N9"!O=71S=&%N9&EN9R!C;VUM;VX@6)R9&D@+2!-87)Y M;&%N9"P@=VET:"!#>6)R9&D@+4UA6)R9&DL($EN8RX\+W`^#0H)"0D)/'`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`@("`\=&%B;&4@8VQA2!F M:6YI6QE/3-$)V9O;G0M9F%M M:6QY.B!T:6UE2P@<&QA;G0@86YD(&5Q=6EP;65N="P@8V]N2!U65A M2X@5&AE("8C.#(R,#MC;VYS=')U8W1I;VX@:6X@ M<')O9W)E2`Q+"`R,#`R+"!W:71H('1H92!A9&]P=&EO;B!O9B!T:&4@ M86-C;W5N=&EN9R!G=6ED86YC92!F;W(@1V]O9'=I;&P@86YD($]T:&5R($EN M=&%N9VEB;&4@07-S971S+"!I;G1A;F=I8FQE(&%SF5D(&]N(&$@'!IF5D(&]V97(@:71S(&5S=&EM871E9"!L:69E(&]F M#0H@("`@("`Q,`T*("`@("`@>65A65A3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\V,C%F9#$S8U\V.3,P7S0V,C9?86$S,U\V9#8P8V0W8C8R M,#D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-C(Q9F0Q,V-?-CDS M,%\T-C(V7V%A,S-?-F0V,&-D-V(V,C`Y+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQP(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S+'-EF4Z(#$P<'0[)SX-"B`@("`@(#QS=')O;F<^3D]412!#("8C.#(Q,3L@3$E! M0DE,251)15,\+W-T6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6EN9R!" M96%U='D@)F%M<#L@0V]S;65T:6-S($=R;W5P($-O+BP@3'1D(&%N9"!T:&4@ M29A;7`[(S@R M,3<[3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\V,C%F9#$S8U\V.3,P7S0V,C9?86$S,U\V9#8P8V0W8C8R,#D-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-C(Q9F0Q,V-?-CDS,%\T-C(V7V%A M,S-?-F0V,&-D-V(V,C`Y+U=O'0O:'1M;#L@8VAA3H@=&EM97,@;F5W(')O;6%N+'1I;65S+'-EF4Z M(#$P<'0[)SX-"B`@("`@($%S(&$@2X- M"B`@("`\+W`^#0H@("`@/'`@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)V9O M;G0M9F%M:6QY.B!T:6UE2!O9B`D,RPV M,S0L-34T+"!O9B!W:&EC:"`D.3@T+#4R,@T*("`@("`@=V%S(&9O3H@=&EM97,@;F5W(')O;6%N+'1I;65S+'-EF4Z(#$P<'0[)SX-"B`@("`@($%S(&]F($UA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&5X=#XG/'`@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)V9O;G0M9F%M M:6QY.B!T:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE"`H)B,X,C(P.T5)5"8C.#(R,3LI(&]F M('1H92!04D,L('!R:6]R('1O(#(P,#2!S=6)J96-T('1O(&%N(&EN8V]M92!T87@@870@86X@ M969F96-T:79E(')A=&4@;V8-"B`@("`@(#,S)2`H#0H@("`@("`S,"4@"!A M9&IU65A65A<@T*("`@("`@-3`E('1A>"!R961U8W1I;VX@ M86YD('1A>"!H;VQI9&%Y(&9O28C.#(Q-SMS(&EN8V]M92!T87@@97AP M96YS92!I;F-L=61E&5S+B!4:&5R M92!W97)E(&YO(%4N4RX@8W5R2!T87@@8F5N969I="!I;B!T M:&4@9G5T=7)E('-I;F-E(&YO(')E=F5N=64@:7,@97AP96-T960@=&\@8F4@ M9V5N97)A=&5D(&EN('1H92!5+E,@87,@82!R97-U;'0@;V8@9&ES8V]N=&EN M=6EN9R!T:&4@52Y3+B!O<&5R871I;F<@8V]M<&%N>2!I;B!-87)Y;&%N9"!I M;B!/8W1O8F5R(#(P,#6EN9R!A;F0@0VAA;WEI;F<@0FEO=&5C:"P@'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQP(&%L:6=N/3-$:G5S=&EF>2!S='EL M93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S+'-EF4Z(#$P<'0[)SX-"B`@("`@(#QS=')O;F<^3D]412!&("8C M.#(Q,3L@0T].5$E.1T5.0TE%4R!!3D0@3$E424=!5$E/3B!,24%"24Q)5$E% M4SPO2!P7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A2!497AT($)L;V-K M73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQP(&%L:6=N/3-$ M:G5S=&EF>2!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M+'1I;65S+'-EF4Z(#$P<'0[)SX-"B`@("`\2!A8V-O=6YT:6YG('!R:6YC M:7!L97,@9V5N97)A;&QY(&%C8V5P=&5D(&EN('1H92!5;FET960@4W1A=&5S M(&]F($%M97)I8V$@9F]R(&%N;G5A;"!F:6YA;F-I86P@2!O9B!N;W)M86P@2!F;W(@=&AE(&9A:7(@<')E28C.#(Q-SMS($%N M;G5A;"!297!O6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#XG/'`@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T M:6UE2!* M=6YE(#(P,#0L('=E(&-O;F1U8W1E9"!B=7-I;F5S2!L;W-T(&ET2!C;VYC;'5D960@=&AA="!I=',@875D M:6\@86YD('9I9&5O=&%P92!B=7-I;F5S6QE/3-$)V9O;G0M M9F%M:6QY.B!T:6UE6)R9&DL($EN8RXL(&$@ M<')I=F%T96QY(&AE;&0@8V]M<&%N>2!I;F-O6)R9&D@36%R>6QA;F0@9&5E;65D('1H92!A8V-O=6YT:6YG(&%C M<75I6)R9&D@36%R>6QA M;F0N/"]P/@T*("`\<"!A;&EG;CTS1&IU6)R M9&D@36%R>6QA;F0@86-Q=6ER960@86X-"B`@("`X,"4@:6YT97)E2!#;RXL($QT9"X@*"8C M.#(R,#M#:&%O>6EN9R!":6]T96-H)B,X,C(Q.RDL(&$@2!J;VEN="!V96YT=7)E(&5S=&%B;&ES:&5D(&EN($IU;'D@,C`P M,"!I;B!T:&4@4&5O<&QE)W,@4F5P=6)L:6,@;V8@0VAI;F$@*"8C.#(R,#M0 M4D,F(S@R,C$[*2P@=&AR;W5G:"!T:&4@97AC:&%N9V4@;V8-"B`@("`Y.24@ M;V8@&ES=&EN9R!S:&%R96AO;&1E6EN9R!":6]T96-H(&1E96UE M9"!T:&4@86-C;W5N=&EN9R!A8W%U:7)E&D@0VAA;WEI;F<@0F5A=71Y M("9A;7`[($-O6EN9R!":6]T96-H(&%R92!R97-E87)C:"P@;6%N=69A8W1U2!S='EL93TS1"=F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S+'-EF4Z M(#$P<'0[)SX-"B`@("!/;B!&96)R=6%R>2`Q,"P@,C`P-2P@=&AE($-O;7!A M;GD@8V]M<&QE=&5D('1H92!M97)G97(@=VET:"!#>6)R9&D@36%R>6QA;F0@ M86YD(&-H86YG960@:71S(&YA;64@=&\@0WEB2`R M-BP@,C`P-RP@0VAA;WEI;F<@0FEO=&5C:"!E;G1E2!O=VYE6EN9R!I6EN9R!W87,@=')A;G-F97)R960@=&\@0VAA;WEI;F<@0FEO=&5C:"!F6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6EN9R!W:6QL('!R:6UA2!F;V-U2!3:&%N9&]N9R!!9&UI;FES=')A=&EO;B!F;W(@0VEV:6P@069F86ER6EN9R!H860@2!C;VUP;&5T960@=&AE(&-O;G-T'1E65T('1O(&)E(&-O;7!L971E9"P@8G5T('=H:6-H(&%R92!E M>'!E8W1E9"!T;R!B92!C;VUP;&5T960@:6X@,C`Q-"!P6EN9R!#;&EN:6-A;"!0871H;VQO9WD@ M*"8C.#(R,#M)3U-#0U`F(S@R,C$[*2P@82!W:&]L;'DM;W=N960@2!E2!R97-E87)C:"!A;F0@8V]N M2UR96QA=&5D(')E6EN9R!":6]T96-H(&AA6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE2!W:6QL(&-O;G1I;G5E(&%S(&$@9V]I;F<@8V]N8V5R;BP@=VAI8V@@8V]N M=&5M<&QA=&5S('1H92!R96%L:7IA=&EO;B!O9B!A2!I=',@;&EA8FEL:71I97,@86YD('-U M2!T;R!C;VYT:6YU M92!A6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE2!T:')O=6=H M('-H;W)T+71E2`D,RXP#0H@("`@;6EL;&EO;B`H97%U:79A;&5N="!T M;R!234(Q.0T*("`@(&UI;&QI;VXI(&]F(&-A<&ET86P@:7,@;F5E9&5D+B!4 M:&4@0V]M<&%N>2P@=&%K:6YG(&EN=&\@86-C;W5N="!T:&4@879A:6QA8FQE M(&)A;FMI;F<@9F%C:6QI=&EE2!P;W-I=&EO;BX@5&AE(&9O M;&QO=VEN9R!S971S(&9OF4Z(#$P M<'0[)R!W:61T:#TS1#$P,"4^#0H@("`@/'1R/@T*("`@("`@/'1D('9A;&EG M;CTS1'1O<"!W:61T:#TS1#4E/@T*("`@("`@("`\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0[)SX-"B`@("`@("`@("`\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S+'-EF4Z(#$P<'0[ M)SX-"B`@("`@("`@("`\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N+'1I;65S+'-E&EM871E;'D@)#`N,PT*("`@ M("`@("`@("`@;6EL;&EO;BX@2&]W979E6QE/3-$)V9O;G0M9F%M:6QY M.B!T:6UE2!H87,@;F]T M(&-O;6UE;F-E9"!C;VQL96-T:6YG(')E;G1A;"!A;F0@;6%N86=E;65N="!F M964@6QE/3-$)V9O M;G0M9F%M:6QY.B!T:6UE2!R97%U:7)E(&%D9&ET:6]N M86P@9G5N9',@86YD(&UA>2!S965K('1O(')A:7-E('-U8V@@9G5N9',@=&AR M;W5G:"!P=6)L:6,@86YD('!R:79A=&4@9FEN86YC:6YG'0@0FQO M8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'`@86QI9VX] M,T1J=7-T:69Y('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE2!F6QE M/3-$)V9O;G0M9F%M:6QY.B!T:6UEF5D('5P;VX@=&AE M(&1E;&EV97)Y(&]F(&=O;V1S('1O(&-U2!497AT M($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQP(&%L M:6=N/3-$:G5S=&EF>2!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N+'1I;65S+'-EF4Z(#$P<'0[)SX-"B`@("`\ M6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE M2!C;&]S960@;VX@86X@06=R965M96YT(&%N9"!0;&%N M(&]F($UE6)R9&D@+4UA6QA;F0L('=I=&@@0WEB6)R9&DM36%R>6QA;F0@:&%S(&)E96X@8V%N8V5L;&5D(&%N9"!C;VYV M97)T960@:6YT;R!T:&4@6)R9&DL($EN8RX-"B`@/"]P/@T*("`\<"!A;&EG;CTS1&IU2!A;65N9&5D(&ET'0@0FQO8VM=/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#XG/'`@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.B!T:6UE&5S M/"]S=')O;F<^#0H@(#PO<#X-"B`@/'`@86QI9VX],T1J=7-T:69Y('-T>6QE M/3-$)V9O;G0M9F%M:6QY.B!T:6UE&5S(&-U2!D=64@<&QU2!T;R!T:&4@9&EF9F5R96YC97,@8F5T=V5E;B!T:&4@8F%S M:7,@;V8@87-S971S(&%N9"!L:6%B:6QI=&EE"!A&5S(&%L2!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N+'1I;65S+'-EF4Z(#$P<'0[)SY4 M:&4@0V]M<&%N>2!H87,@861O<'1E9"!A;&P@3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V,C%F9#$S M8U\V.3,P7S0V,C9?86$S,U\V9#8P8V0W8C8R,#D-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO-C(Q9F0Q,V-?-CDS,%\T-C(V7V%A,S-?-F0V,&-D M-V(V,C`Y+U=O'0O:'1M;#L@8VAA2!/9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC M:65S(#(\+W1D/@T*("`@("`@("`\=&0@8VQA2!/9B!3:6=N M:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S(#0\+W1D/@T*("`@("`@("`\ M=&0@8VQA'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M2!/9B!3:6=N:69I8V%N="!!8V-O M=6YT:6YG(%!O;&EC:65S(#$T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XT+#(S."PQ.38\2!/9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S(#$U/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT+#`Q."PQ-#$\2!/9B!3:6=N:69I8V%N="!! M8V-O=6YT:6YG(%!O;&EC:65S(#$V/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XS+#`P,"PP,#`\2!/9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S(#$W M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!/9B!3:6=N:69I8V%N M="!!8V-O=6YT:6YG(%!O;&EC:65S(#(P/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M<#XS+C`P)3QS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V,C%F9#$S M8U\V.3,P7S0V,C9?86$S,U\V9#8P8V0W8C8R,#D-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO-C(Q9F0Q,V-?-CDS,%\T-C(V7V%A,S-?-F0V,&-D M-V(V,C`Y+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M2`Q/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XQ+C4V-C8T,38P.3QS<&%N/CPO2`R/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-RPS,C@L,C8S/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M2`X/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XS+#DX."PT-30\2`Q,3PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\V,C%F9#$S8U\V.3,P7S0V,C9?86$S,U\V M9#8P8V0W8C8R,#D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-C(Q M9F0Q,V-?-CDS,%\T-C(V7V%A,S-?-F0V,&-D-V(V,C`Y+U=O'0O:'1M;#L@8VAA"`R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M<#XS,"XP,"4\"`V/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,"XP,"4\"`Y/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XQ-2XP,"4\&UL/@T*+2TM+2TM/5].97AT4&%R=%\V G,C%F9#$S8U\V.3,P7S0V,C9?86$S,U\V9#8P8V0W8C8R,#DM+0T* ` end XML 17 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
LIABILITIES
3 Months Ended
Mar. 31, 2014
LIABILITIES [Text Block]

NOTE C – LIABILITIES

As of March 31, 2014, the balance sheet included total liabilities of $6,470,111, which consisted of current liabilities of $6,100,122 and construction payable of $369,989. Included in the current liabilities was a short-term loan of $160,865 (equivalent to RMB1.0 million) from Mr. Fengguo Liu, an unrelated party. The short-term loan is due on January 15, 2015 with an interest rate at 2% per month. Also included in the current liabilities was $3,015,609 of loans from related companies, including Xi’an Yanfeng Biotechnology Co., Ltd., Shaanxi Yanfeng Real Estate Co. Ltd, Shaanxi Chaoying Beauty & Cosmetics Group Co., Ltd and the stockholders who are also the Company&#8217;s officers. These entities were related to the Company through common ownership and principal officers. These loans are non-interest bearing and have no set repayment terms.

XML 18 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED BALANCE SHEETS (USD $)
Mar. 31, 2014
Dec. 31, 2013
CURRENT ASSETS    
Cash and equivalents $ 886,570 $ 203,921
Accounts receivable, net 50,235 6,409
Inventories 797,775 848,525
Other receivables, net and prepaid expenses 127,343 906,459
Advance to suppliers 3 4,536
TOTAL CURRENT ASSETS 1,861,926 1,969,850
PROPERTY, PLANT AND EQUIPMENT, NET 1,090,546 1,144,781
CONSTRUCTION IN PROGRESS 6,535,811 6,609,918
INTANGIBLE ASSETS, NET 616,382 628,193
TOTAL ASSETS 10,104,665 10,352,742
CURRENT LIABILITIES    
Short-term loan 1,447,783 1,308,858
Accounts payable 31,402 11,903
Accrued expenses 865,286 810,331
Deferred revenue 130,575 126,128
Customers deposits 157,971 165,066
Due to related parties 3,015,609 2,963,494
Deferred tax liabilities 10,421 10,598
Other payables 441,075 591,613
TOTAL CURRENT LIABILITIES 6,100,122 5,987,991
CONSTRUCTION PAYABLE 369,989 376,297
TOTAL LIABILITIES 6,470,111 6,364,288
EQUITY    
Preferred Stock, $1.00 per value, 500,000 shares authorized, no shares issued and outstanding 0 0
Common Stock, no par value, 150,000,000 shares authorized, and 120,225,323 shares issued and outstanding as of March 31, 2014 and December 31, 2013, respectively 4,313,614 4,313,614
Additional paid-in capital 172,308 172,308
Reserve funds 336,885 336,885
Accumulated deficit (3,758,942) (3,525,809)
Accumulated other comprehensive income 1,586,167 1,656,723
TOTAL STOCKHOLDERS' EQUITY 2,650,032 2,953,721
NONCONTROLLING INTEREST 984,522 1,034,733
TOTAL EQUITY 3,634,554 3,988,454
TOTAL LIABILITIES AND EQUITY $ 10,104,665 $ 10,352,742
XML 19 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
3 Months Ended
Mar. 31, 2014
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Text Block]

NOTE A - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

1. Interim Financial Statements

The unaudited consolidated financial statements of Cybrdi Inc. and subsidiaries have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and pursuant to the requirements for reporting on Form 10-Q. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. However, the information included in these interim financial statements reflects all adjustments (consisting solely of normal recurring adjustments) which are, in the opinion of management, necessary for the fair presentation of the consolidated financial position and the consolidated results of operations. Results shown for interim periods are not necessarily indicative of the results to be obtained for a full year. The consolidated balance sheet information as of December 31, 2013 was derived from the audited consolidated financial statements included in the Company’s Annual Report on Form 10-K. These interim financial statements should be read in conjunction with that report. Certain comparative amounts have been reclassified to conform to the current period's presentation.

The consolidated financial statements include the accounts of Cybrdi, Inc. and its wholly-owned subsidiaries and joint ventures. All material intercompany balances and transactions have been eliminated.

2. Description of Business

Cybrdi, Inc. was incorporated on August 1, 1966, under the laws of the State of California. From then to approximately June 2004, we conducted business in the distribution of magnetic media products, primarily blank audio and video cassettes. Due to continuing intense price competition and technological changes in the marketplace for its products, the Company lost its remaining significant customers and disposed of or wrote off its remaining inventory. As a result of these occurrences, the Company concluded that its audio and videotape businesses were no longer viable and some of its product lines were obsolete.

In November 2004, we acquired all of the ownership interests in Cybrdi, Inc., a privately held company incorporated in the State of Maryland ("Cybrdi Maryland"). For financial statement reporting purposes, the transaction was treated as a reverse acquisition, with Cybrdi Maryland deemed the accounting acquirer and Certron Corporation deemed the accounting acquiree. Historical information of the surviving company is that of Cybrdi Maryland.

Cybrdi Maryland was established in 2001 to acquire an interest in biogenetic products commercialization and related services entities in Asia. On March 5, 2003, Cybrdi Maryland acquired an 80% interest in Shaanxi Chao Ying Biotechnology Co., Ltd. (“Chaoying Biotech”), a sino-foreign equity joint venture established in July 2000 in the People's Republic of China (“PRC”), through the exchange of 99% of shares to the existing shareholders of Chaoying Biotech. For financial statement reporting purposes, the merger was treated as a reverse acquisition, with Chaoying Biotech deemed the accounting acquirer and Cybrdi Maryland deemed the accounting acquiree.

Chaoying Biotech is a sino-foreign equity joint venture between Shaanxi Chaoying Beauty & Cosmetics Group Co., Ltd. (the “Chinese Partner”, a PRC corporation) and Immuno-Onco Genomics Inc. (the “Foreign Partner”, a USA corporation). The joint venture agreement has a 15 year operating period starting from its formation in July 2000 and it may be extended upon mutual consent. The principal activities of Chaoying Biotech are research, manufacture and sale of various high-quality tissue arrays and the related services in the PRC.

Most of the Company’s activities are conducted through Chaoying Biotech, of which it owns 80% interest.  Chaoying Biotech, with its principal operations located in China, aims to take advantage of China's abundant scientific talent, low wage rates, less stringent biogenetic regulation, and the huge genetic population as it introduces its growing list of tissue micro array products.

On February 10, 2005, the Company completed the merger with Cybrdi Maryland and changed its name to Cybrdi, Inc.On July 26, 2007, Chaoying Biotech entered into an acquisition agreement with the Chinese partner to acquire 83.33% equity ownership of Shandong Chaoying Culture and Entertainment Co., Ltd (“SD Chaoying”) from the Chinese partner for RMB15 million. The Chinese partner is a principal shareholder of the Company and Mr. Bai, the Company’s chief executive officer, chairman and a principal shareholder, is also a principal of the Chinese partner. SD Chaoying is a corporation organized in the Shandong province of P.R.China. On September 5, 2007, Shandong MOFCOM approved this acquisition and ownership of SD Chaoying was transferred to Chaoying Biotech from the Chinese Partner.

The business of SD Chaoying will primarily focus on culture and entertainment, including make-up, personal care, health club, gambling, saunas for massage and bath, karaoke, catering, and lodging. The Company plans for SD Chaoying to have a specific emphasis on casino gambling, but such operations have not been approved by Shandong Administration for Civil Affairs. At the end of 2010, SD Chaoying had substantially completed the construction of two residential buildings and had recognized revenue from sales of housing units from these buildings for 2010. The main structure of the commercial entertainment center has also been completed, with the exterior, rooftop, the surrounding supporting projects and the community landscaping yet to be completed, but which are expected to be completed in 2014 prior to the commencement of operations by merchant tenants if we can obtain an estimated $3.0 million to complete construction. In January 2011, SD Chaoying engaged Dongshan Victoria Spring Hotel (“Victoria”), which is controlled by the wife of the General Manager of SD Chaoying, to manage and operate the SPA business at the completed section of the cultural and entertainment facility. SD Chaoying has not charged any fees from Victoria and no written agreement was signed. As of March 31, 2014, the Company has not commenced collecting rental and management fee revenue for the culture and entertainment center.

On April 29, 2011, Chaoying Biotech invested $154,732 (equivalent to RMB1 million) to restore the operation of the Institute of Shaanxi Chaoying Clinical Pathology (“IOSCCP”), a wholly-owned subsidiary established on July 31, 2003, whose main business includes pathology research and consulting, diagnostic clinical pathology and pathology-related research and development of new technologies, and basic training in pathology. Chaoying Biotech has been its sole shareholder.

3. Going Concern

The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred significant losses and has not demonstrated the ability to generate sufficient cash flows from operations to satisfy its liabilities and sustain operations. The Company had an accumulated deficit of $3,758,942 and $3,525,809 as of March 31, 2014 and December 31, 2013, including net losses of $266,613 and $178,315 for the three months ended March 31, 2014 and 2013, respectively. In addition, current liabilities exceeded current assets by $4,238,196 and $4,018,141 at March 31, 2014 and December 31, 2013, respectively. These matters raise substantial doubt about the Company’s ability to continue as a going concern.

The Company finances its operations primarily through short-term bank borrowings and advances from related parties and/or officers/shareholders. In order to complete the construction of SD Chaoying cultural and entertainment center, approximately $3.0 million (equivalent to RMB19 million) of capital is needed. The Company, taking into account the available banking facilities, internal financial resource, and support from related companies, believes it has sufficient working capital to meet its present obligation for at least the next twelve months. Management is taking actions to address the company's financial condition and deteriorating liquidity position. The following sets forth management’s plans for dealing with the adverse effects of the conditions:

(a) Sale of housing inventories: Proceeds to be received from the sale of the remaining housing of the two completed residential buildings are expected to amount to approximately $0.3 million. However, there is no assurance when such sales will occur.
   
(b) Rental and management fee revenue from the cultural and entertainment center: Annual rental revenue is estimated to be approximately $0.68 million per year. Management fee revenue will be charged to commercial tenants at 3% of annual gross revenue. As of March 31, 2014, the Company has not commenced collecting rental and management fee revenue for the culture and entertainment center.

As of March 31, 2014, the Company has not commenced collecting rental and management fee revenue for the culture and entertainment center.

The Company may require additional funds and may seek to raise such funds through public and private financings or from other sources. There is no assurance that the above management’s plans will be realized or the additional financing will be available or that, if available, such financing will be obtainable on terms favorable to the Company or that any additional financing will not be dilutive. The consolidated financial statements do not include any adjustments that might result from the outcome of those uncertainties.

4. Use of Estimates:

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.

5. Revenue Recognition

Revenue represents the invoiced value of goods sold recognized upon the delivery of goods to customers and service income is recognized when services are provided. Deferred revenue represents the undelivered portion of invoiced value of goods sold to customers. Sales transactions not meeting all the conditions of the full accrual method are accounted for using the deposit method of accounting. Under the deposit method, all costs are capitalized as incurred, and payments received from the buyer are recorded as customer deposits.

6. Reverse Merger

On February 10, 2005, (the "Closing Date") the Company closed on an Agreement and Plan of Merger (the "Agreement") among Certron Corporation (“Certron”), a California corporation, Certron Acquisition Corp., a Maryland corporation and a wholly-owned subsidiary of Certron ("Acquisition Sub"), and Cybrdi, Inc., a Maryland corporation (“Cybrdi – Maryland”) relating to the acquisition by Certron of all of the issued and outstanding capital stock of Cybrdi -Maryland in exchange for shares of common stock of Certron that will aggregate approximately 93.8% of the issued and outstanding common stock of Certron. Pursuant to the terms of the Agreement, at the Closing Date (a) Acquisition Sub has been merged with and into Cybrdi - Maryland, with Cybrdi -Maryland being the surviving corporation, (b) the common stock of Cybrdi-Maryland has been cancelled and converted into the right to receive shares of the common stock of Certron at an exchange ratio of 1.566641609 per share. This resulted in the issuance of 47,328,263 shares of the Carton’s common stock, and (c) each share of the common stock of Acquisition Sub has been converted in to and become one share of the common stock of Cybrdi-Maryland. The share exchange has been accounted for as a reverse merger under the purchase method of accounting. Accordingly, Cybrdi, Inc. will be treated as the continuing entity for accounting purposes and the historical financial statements presented will be those of Cybrdi, Inc.

In connection with the Agreement, on February 10, 2005, the Company amended its articles of incorporation to authorize the issuance of 150 million shares of common stock no par value and 500,000 shares of preferred stock, $1.00 par value per share, none of which are issued or outstanding.

Concurrent with the filing of the Articles of Merger, all of the Company then existing officers and directors tendered their resignation and Yanbiao Bai was appointed as its Chairman of the Board of Directors. Mr. Bai then nominated the balance of the Board of Directors.

7. Income Taxes

Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due plus deferred taxes related primarily to the differences between the basis of assets and liabilities for financial and income tax reporting. The deferred tax assets and liabilities represent the future tax return consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes also are recognized for operating losses that are available to offset future income taxes.

8. Recent Accounting Pronouncements

The Company has adopted all recently issued accounting pronouncements. The adoption of the accounting pronouncements, including those not yet effective, is not anticipated to have a material effect on the financial position or results of operations of the Company.

XML 20 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 21 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
ASSETS
3 Months Ended
Mar. 31, 2014
ASSETS [Text Block]

NOTE B – ASSETS

The March 31, 2014 consolidated balance sheet included total current assets of $1,861,926 and non-current assets of $8,242,739. Of these amounts, $886,570 in cash and equivalents is planned for funding current operations and for future business expansion.

Current assets also included accounts receivable, inventories, other receivables and prepaid expenses, and advance to suppliers. Inventories are mainly finished goods. Other components of inventories include raw materials and housing inventories. Inventories are stated at the lower of cost or market. Cost of raw materials is determined on the basis of first in first out method (“FIFO”). Finished goods are determined on the weighted average basis and are comprised of direct materials, direct labor, and an appropriate proportion of overhead.

Included in non-current assets are property, plant and equipment, construction-in-progress and intangible assets. Property, plant and equipment mainly consist of building, office equipment, motor vehicles, leasehold improvement and machinery used for product manufacturing located in the People’s Republic of China (“PRC”). Depreciation on property, plant and equipment is computed using the straight-line method over the estimated useful life of the assets. The majority of the assets have estimated useful lives of 10 years. Building and office equipment have estimated useful lives of 20 and 5 years, respectively. The “construction in progress” in the amount of $6,535,811 mainly consisted of land under development and construction of the entertainment, culture, and casino facility in Shandong Province, which will be transferred to fixed assets in SD Chaoying when construction is completed. For the $3.22 million land use rights, $2.5 million was classified under construction-in-progress for the commercial property and the remaining $0.62 million was classified under intangible assets subject to amortization. Intangible assets included a tissue chip patent at Chaoying Biotech and $0.62 million of land use rights being put in operation for the partial completed commercial property at SD Chaoying. Effective January 1, 2002, with the adoption of the accounting guidance for Goodwill and Other Intangible Assets, intangible assets with a definite life are amortized on a straight-line basis. The patent expired on April 30, 2013, which was amortized over its estimated life of 10 years. The land use rights classified in intangible asset is being amortized over its estimated life of 36.9 years through the maturity of the land use rights for commercial use on November 6, 2047.

XML 22 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)
Mar. 31, 2014
Dec. 31, 2013
Preferred Stock, Par Value Per Share $ 1.00 $ 1.00
Preferred Stock, Shares Authorized 500,000 500,000
Preferred Stock, Shares Issued 0 0
Preferred Stock, Shares Outstanding 0 0
Common Stock, No Par Value      
Common Stock, Shares Authorized 150,000,000 150,000,000
Common Stock, Shares, Issued 120,225,323 120,225,323
Common Stock, Shares, Outstanding 120,225,323 120,225,323
XML 23 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
INCOME TAX (Narrative) (Details) (USD $)
3 Months Ended
Mar. 31, 2014
Income Tax 1 33.00%
Income Tax 2 30.00%
Income Tax 3 3.00%
Income Tax 4 25.00%
Income Tax 5 33.00%
Income Tax 6 50.00%
Income Tax 7 50.00%
Income Tax 8 15.00%
Income Tax 9 15.00%
Income Tax 10 $ 116
Income Tax 11 $ 0
XML 24 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information
3 Months Ended
Mar. 31, 2014
May 09, 2014
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Mar. 31, 2014  
Trading Symbol cydi  
Entity Registrant Name Cybrdi, Inc.  
Entity Central Index Key 0000019002  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   120,225,323
Entity Current Reporting Status Yes  
Entity Voluntary Filers No  
Entity Well Known Seasoned Issuer No  
Document Fiscal Year Focus 2014  
Document Fiscal Period Focus Q1  
XML 25 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (USD $)
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Revenue    
Housing $ 80,650 $ 0
Commercial rental 0 0
Tissue array products 68,136 151,152
Total revenue 148,786 151,152
Cost of Sales    
Housing 47,145 0
Commercial rental - related party 26,299 16,696
Tissue array products 68,070 98,520
Total cost of sales 141,514 115,216
Gross Profit 7,272 35,936
Operating Expenses:    
Salaries and wages 50,988 53,913
Depreciation and amortization 11,422 33,445
Bad debt expense 0 6,630
Professional fees 38,575 40,107
Selling and distribution expenses 2,861 4,186
Other general and administrative expenses 123,538 27,592
Total Operating Expenses 227,384 165,873
Loss from Operations (220,112) (129,937)
Other Expense    
Interest expenses, net (47,472) (46,188)
Other expense, net (767) (2,048)
Total Other Expense, Net (48,239) (48,236)
Loss before Income Taxes (268,351) (178,173)
Less: Income Tax (Benefit) Expense (1,738) 142
Net loss (266,613) (178,315)
Less: Net loss attributable to the non-controlling interests (33,480) (31,493)
Net loss attributable to CYBRDI, INC. (233,133) (146,822)
Foreign currency translation loss (70,556) (37,094)
Comprehensive loss $ (303,689) $ (183,916)
Net Loss Per Common Share    
Basic and Diluted $ 0.00 $ 0.00
Weighted Average Number of Shares Outstanding    
Basic and Diluted 120,225,323 120,225,323
XML 26 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2014
Interim Financial Statements [Policy Text Block]

1. Interim Financial Statements

The unaudited consolidated financial statements of Cybrdi Inc. and subsidiaries have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and pursuant to the requirements for reporting on Form 10-Q. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. However, the information included in these interim financial statements reflects all adjustments (consisting solely of normal recurring adjustments) which are, in the opinion of management, necessary for the fair presentation of the consolidated financial position and the consolidated results of operations. Results shown for interim periods are not necessarily indicative of the results to be obtained for a full year. The consolidated balance sheet information as of December 31, 2013 was derived from the audited consolidated financial statements included in the Company’s Annual Report on Form 10-K. These interim financial statements should be read in conjunction with that report. Certain comparative amounts have been reclassified to conform to the current period's presentation.

The consolidated financial statements include the accounts of Cybrdi, Inc. and its wholly-owned subsidiaries and joint ventures. All material intercompany balances and transactions have been eliminated.

Description of Business [Policy Text Block]

2. Description of Business

Cybrdi, Inc. was incorporated on August 1, 1966, under the laws of the State of California. From then to approximately June 2004, we conducted business in the distribution of magnetic media products, primarily blank audio and video cassettes. Due to continuing intense price competition and technological changes in the marketplace for its products, the Company lost its remaining significant customers and disposed of or wrote off its remaining inventory. As a result of these occurrences, the Company concluded that its audio and videotape businesses were no longer viable and some of its product lines were obsolete.

In November 2004, we acquired all of the ownership interests in Cybrdi, Inc., a privately held company incorporated in the State of Maryland ("Cybrdi Maryland"). For financial statement reporting purposes, the transaction was treated as a reverse acquisition, with Cybrdi Maryland deemed the accounting acquirer and Certron Corporation deemed the accounting acquiree. Historical information of the surviving company is that of Cybrdi Maryland.

Cybrdi Maryland was established in 2001 to acquire an interest in biogenetic products commercialization and related services entities in Asia. On March 5, 2003, Cybrdi Maryland acquired an 80% interest in Shaanxi Chao Ying Biotechnology Co., Ltd. (“Chaoying Biotech”), a sino-foreign equity joint venture established in July 2000 in the People's Republic of China (“PRC”), through the exchange of 99% of shares to the existing shareholders of Chaoying Biotech. For financial statement reporting purposes, the merger was treated as a reverse acquisition, with Chaoying Biotech deemed the accounting acquirer and Cybrdi Maryland deemed the accounting acquiree.

Chaoying Biotech is a sino-foreign equity joint venture between Shaanxi Chaoying Beauty & Cosmetics Group Co., Ltd. (the “Chinese Partner”, a PRC corporation) and Immuno-Onco Genomics Inc. (the “Foreign Partner”, a USA corporation). The joint venture agreement has a 15 year operating period starting from its formation in July 2000 and it may be extended upon mutual consent. The principal activities of Chaoying Biotech are research, manufacture and sale of various high-quality tissue arrays and the related services in the PRC.

Most of the Company’s activities are conducted through Chaoying Biotech, of which it owns 80% interest.  Chaoying Biotech, with its principal operations located in China, aims to take advantage of China's abundant scientific talent, low wage rates, less stringent biogenetic regulation, and the huge genetic population as it introduces its growing list of tissue micro array products.

On February 10, 2005, the Company completed the merger with Cybrdi Maryland and changed its name to Cybrdi, Inc.On July 26, 2007, Chaoying Biotech entered into an acquisition agreement with the Chinese partner to acquire 83.33% equity ownership of Shandong Chaoying Culture and Entertainment Co., Ltd (“SD Chaoying”) from the Chinese partner for RMB15 million. The Chinese partner is a principal shareholder of the Company and Mr. Bai, the Company’s chief executive officer, chairman and a principal shareholder, is also a principal of the Chinese partner. SD Chaoying is a corporation organized in the Shandong province of P.R.China. On September 5, 2007, Shandong MOFCOM approved this acquisition and ownership of SD Chaoying was transferred to Chaoying Biotech from the Chinese Partner.

The business of SD Chaoying will primarily focus on culture and entertainment, including make-up, personal care, health club, gambling, saunas for massage and bath, karaoke, catering, and lodging. The Company plans for SD Chaoying to have a specific emphasis on casino gambling, but such operations have not been approved by Shandong Administration for Civil Affairs. At the end of 2010, SD Chaoying had substantially completed the construction of two residential buildings and had recognized revenue from sales of housing units from these buildings for 2010. The main structure of the commercial entertainment center has also been completed, with the exterior, rooftop, the surrounding supporting projects and the community landscaping yet to be completed, but which are expected to be completed in 2014 prior to the commencement of operations by merchant tenants if we can obtain an estimated $3.0 million to complete construction. In January 2011, SD Chaoying engaged Dongshan Victoria Spring Hotel (“Victoria”), which is controlled by the wife of the General Manager of SD Chaoying, to manage and operate the SPA business at the completed section of the cultural and entertainment facility. SD Chaoying has not charged any fees from Victoria and no written agreement was signed. As of March 31, 2014, the Company has not commenced collecting rental and management fee revenue for the culture and entertainment center.

On April 29, 2011, Chaoying Biotech invested $154,732 (equivalent to RMB1 million) to restore the operation of the Institute of Shaanxi Chaoying Clinical Pathology (“IOSCCP”), a wholly-owned subsidiary established on July 31, 2003, whose main business includes pathology research and consulting, diagnostic clinical pathology and pathology-related research and development of new technologies, and basic training in pathology. Chaoying Biotech has been its sole shareholder.

Going Concern [Policy Text Block]

3. Going Concern

The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred significant losses and has not demonstrated the ability to generate sufficient cash flows from operations to satisfy its liabilities and sustain operations. The Company had an accumulated deficit of $3,758,942 and $3,525,809 as of March 31, 2014 and December 31, 2013, including net losses of $266,613 and $178,315 for the three months ended March 31, 2014 and 2013, respectively. In addition, current liabilities exceeded current assets by $4,238,196 and $4,018,141 at March 31, 2014 and December 31, 2013, respectively. These matters raise substantial doubt about the Company’s ability to continue as a going concern.

The Company finances its operations primarily through short-term bank borrowings and advances from related parties and/or officers/shareholders. In order to complete the construction of SD Chaoying cultural and entertainment center, approximately $3.0 million (equivalent to RMB19 million) of capital is needed. The Company, taking into account the available banking facilities, internal financial resource, and support from related companies, believes it has sufficient working capital to meet its present obligation for at least the next twelve months. Management is taking actions to address the company's financial condition and deteriorating liquidity position. The following sets forth management’s plans for dealing with the adverse effects of the conditions:

(a) Sale of housing inventories: Proceeds to be received from the sale of the remaining housing of the two completed residential buildings are expected to amount to approximately $0.3 million. However, there is no assurance when such sales will occur.
   
(b) Rental and management fee revenue from the cultural and entertainment center: Annual rental revenue is estimated to be approximately $0.68 million per year. Management fee revenue will be charged to commercial tenants at 3% of annual gross revenue. As of March 31, 2014, the Company has not commenced collecting rental and management fee revenue for the culture and entertainment center.

As of March 31, 2014, the Company has not commenced collecting rental and management fee revenue for the culture and entertainment center.

The Company may require additional funds and may seek to raise such funds through public and private financings or from other sources. There is no assurance that the above management’s plans will be realized or the additional financing will be available or that, if available, such financing will be obtainable on terms favorable to the Company or that any additional financing will not be dilutive. The consolidated financial statements do not include any adjustments that might result from the outcome of those uncertainties.

Use of estimates [Policy Text Block]

4. Use of Estimates:

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.

Revenue recognition [Policy Text Block]

5. Revenue Recognition

Revenue represents the invoiced value of goods sold recognized upon the delivery of goods to customers and service income is recognized when services are provided. Deferred revenue represents the undelivered portion of invoiced value of goods sold to customers. Sales transactions not meeting all the conditions of the full accrual method are accounted for using the deposit method of accounting. Under the deposit method, all costs are capitalized as incurred, and payments received from the buyer are recorded as customer deposits.

Reverse Merger [Policy Text Block]

6. Reverse Merger

On February 10, 2005, (the "Closing Date") the Company closed on an Agreement and Plan of Merger (the "Agreement") among Certron Corporation (“Certron”), a California corporation, Certron Acquisition Corp., a Maryland corporation and a wholly-owned subsidiary of Certron ("Acquisition Sub"), and Cybrdi, Inc., a Maryland corporation (“Cybrdi – Maryland”) relating to the acquisition by Certron of all of the issued and outstanding capital stock of Cybrdi -Maryland in exchange for shares of common stock of Certron that will aggregate approximately 93.8% of the issued and outstanding common stock of Certron. Pursuant to the terms of the Agreement, at the Closing Date (a) Acquisition Sub has been merged with and into Cybrdi - Maryland, with Cybrdi -Maryland being the surviving corporation, (b) the common stock of Cybrdi-Maryland has been cancelled and converted into the right to receive shares of the common stock of Certron at an exchange ratio of 1.566641609 per share. This resulted in the issuance of 47,328,263 shares of the Carton’s common stock, and (c) each share of the common stock of Acquisition Sub has been converted in to and become one share of the common stock of Cybrdi-Maryland. The share exchange has been accounted for as a reverse merger under the purchase method of accounting. Accordingly, Cybrdi, Inc. will be treated as the continuing entity for accounting purposes and the historical financial statements presented will be those of Cybrdi, Inc.

In connection with the Agreement, on February 10, 2005, the Company amended its articles of incorporation to authorize the issuance of 150 million shares of common stock no par value and 500,000 shares of preferred stock, $1.00 par value per share, none of which are issued or outstanding.

Concurrent with the filing of the Articles of Merger, all of the Company then existing officers and directors tendered their resignation and Yanbiao Bai was appointed as its Chairman of the Board of Directors. Mr. Bai then nominated the balance of the Board of Directors.

Income taxes [Policy Text Block]

7. Income Taxes

Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due plus deferred taxes related primarily to the differences between the basis of assets and liabilities for financial and income tax reporting. The deferred tax assets and liabilities represent the future tax return consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes also are recognized for operating losses that are available to offset future income taxes.

Recent Accounting Pronouncements [Policy Text Block]

8. Recent Accounting Pronouncements

The Company has adopted all recently issued accounting pronouncements. The adoption of the accounting pronouncements, including those not yet effective, is not anticipated to have a material effect on the financial position or results of operations of the Company.

XML 27 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONTINGENCIES AND LITIGATION LIABILITIES
3 Months Ended
Mar. 31, 2014
CONTINGENCIES AND LITIGATION LIABILITIES [Text Block]

NOTE F – CONTINGENCIES AND LITIGATION LIABILITIES

During the three months ended March 31, 2014, there were no material developments in any previously reported litigation.

XML 28 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
LIABILITIES (Narrative) (Details)
3 Months Ended
Mar. 31, 2014
USD ($)
Mar. 31, 2014
CNY
Liabilities 1 $ 6,470,111  
Liabilities 2 6,100,122  
Liabilities 3 369,989  
Liabilities 4 160,865  
Liabilities 5   1,000,000
Liabilities 6 2.00% 2.00%
Liabilities 7 $ 3,015,609  
XML 29 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)
3 Months Ended
Mar. 31, 2014
USD ($)
Y
Mar. 31, 2014
CNY
Basis Of Presentation And Summary Of Significant Accounting Policies 1 80.00% 80.00%
Basis Of Presentation And Summary Of Significant Accounting Policies 2 99.00% 99.00%
Basis Of Presentation And Summary Of Significant Accounting Policies 3 15 15
Basis Of Presentation Andsummary Of Significant Accounting Policies 4 80.00% 80.00%
Basis Of Presentation And Summary Of Significant Accounting Policies 4 83.33% 83.33%
Basis Of Presentation And Summary Of Significant Accounting Policies 5   15,000,000
Basis Of Presentation And Summary Of Significant Accounting Policies 6 3,000,000  
Basis Of Presentation And Summary Of Significant Accounting Policies 7 154,732  
Basis Of Presentation And Summary Of Significant Accounting Policies 8   1,000,000
Basis Of Presentation Andsummary Of Significant Accounting Policies 10 3,758,942  
Basis Of Presentation Andsummary Of Significant Accounting Policies 11 3,525,809  
Basis Of Presentation Andsummary Of Significant Accounting Policies 12 266,613  
Basis Of Presentation Andsummary Of Significant Accounting Policies 13 178,315  
Basis Of Presentation Andsummary Of Significant Accounting Policies 14 4,238,196  
Basis Of Presentation Andsummary Of Significant Accounting Policies 15 4,018,141  
Basis Of Presentation Andsummary Of Significant Accounting Policies 16 3,000,000  
Basis Of Presentation Andsummary Of Significant Accounting Policies 17   19,000,000
Basis Of Presentation Andsummary Of Significant Accounting Policies 18 300,000  
Basis Of Presentation Andsummary Of Significant Accounting Policies 19 680,000  
Basis Of Presentation Andsummary Of Significant Accounting Policies 20 3.00% 3.00%
Basis Of Presentation And Summary Of Significant Accounting Policies 22 93.80% 93.80%
Basis Of Presentation And Summary Of Significant Accounting Policies 23 1.566641609 1.566641609
Basis Of Presentation And Summary Of Significant Accounting Policies 24 47,328,263 47,328,263
Basis Of Presentation And Summary Of Significant Accounting Policies 25 150,000,000 150,000,000
Basis Of Presentation And Summary Of Significant Accounting Policies 26 500,000 500,000
Basis Of Presentation And Summary Of Significant Accounting Policies 27 $ 1.00  
XML 30 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
ASSETS (Narrative) (Details) (USD $)
3 Months Ended
Mar. 31, 2014
Y
Assets 1 $ 1,861,926
Assets 2 8,242,739
Assets 3 886,570
Assets 4 10
Assets 5 20
Assets 6 5
Assets 7 6,535,811
Assets 8 3,220,000
Assets 9 2,500,000
Assets 10 620,000
Assets 11 $ 620,000
Assets 12 10
Assets 13 36.9
XML 31 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS EQUITY (Narrative) (Details) (USD $)
3 Months Ended
Mar. 31, 2014
Stockholders Equity 1 1.566641609
Stockholders Equity 2 47,328,263
Stockholders Equity 3 120,225,323
Stockholders Equity 4 $ 3,634,554
Stockholders Equity 5 984,522
Stockholders Equity 6 20.00%
Stockholders Equity 7 16.67%
Stockholders Equity 8 3,988,454
Stockholders Equity 9 $ 1,034,733
Stockholders Equity 10 20.00%
Stockholders Equity 11 16.67%
XML 32 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss attributable to Cybrdi Inc. $ (233,133) $ (146,822)
Adjustments to Reconcile Net Loss to Cash Provided by operating activities:    
Depreciation and amortization 44,707 55,881
Bad debt expense 0 6,630
Minority interest (33,480) (31,493)
Changes in Operating Assets and Liabilities:    
Accounts receivable (44,753) (15,067)
Inventories 37,206 4,262
Other receivable and prepaid expenses 782,725 6,552
Accounts payable and other current liabilities 96,421 92,845
Deferred revenue 6,683 0
Advance to suppliers (4,409) 24,307
Net Cash used in Operating Activities 651,967 (2,905)
CASH FLOWS FROM INVESTING ACTIVITIES    
Advance for loan to affiliated companies (4,249) 0
Purchase of property, plant, and equipment (7,702) (7,601)
Payments for construction in progress (37,970) (279)
Net Cash used in Investing Activities (49,921) (7,880)
CASH FLOWS FROM FINANCING ACTIVTIES    
Proceeds from loans from related companies 78,950 10,668
Loan from shareholders/officers 17,877 8,998
Net cash provided by Financing Activities 96,827 19,666
NET INCREASE IN CASH & CASH EQUIVALENTS 698,873 8,881
EFFECT OF EXCHANGE RATE CHANGE ON CASH & CASH EQUIVALENTS (16,224) 15,074
CASH & CASH EQUIVALENTS, BEGINNING BALANCE 203,921 956,235
CASH & CASH EQUIVALENTS, ENDING BALANCE 886,570 980,190
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION    
Interest paid 39,328 45,799
Income taxes paid $ 113 $ 153
XML 33 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
INCOME TAX
3 Months Ended
Mar. 31, 2014
INCOME TAX [Text Block]

NOTE E – INCOME TAXES

Under the Enterprise Income Tax (“EIT”) of the PRC, prior to 2007, Chinese enterprises are generally subject to an income tax at an effective rate of 33% ( 30% statutory income taxes plus 3% local income taxes) on income reported in the statutory financial statements after appropriate tax adjustments, unless the enterprise is located in a specially designated region for which more favorable effective tax rates are applicable. Beginning on January 1, 2008, the new EIT law has replaced the existing laws for Domestic Enterprises (“DEs”) and Foreign Invested Enterprises (“FIEs”). The new standard EIT rate of 25% will replace the 33% rate previously applicable to both DES and FIEs. The two year tax exemption, six year 50% tax reduction and tax holiday for production-oriented FIEs will be eliminated. According to the Western Developing Plan implemented by the PRC Government, Chaoying Biotech is entitled to a 50% reduction in EIT of preferential policy, but not less than 15%. As a result, Chaoying Biotech’s effective EIT tax rate has been 15% since 2008.

The Company’s income tax expense includes U.S. and PRC income taxes. There were no U.S. current taxes for the three months ended March 31, 2014 according to net loss incurred in the U.S. entity, which will not be anticipated to have any tax benefit in the future since no revenue is expected to be generated in the U.S as a result of discontinuing the U.S. operating company in Maryland in October 2007. There were $116 and $0 of PRC current income taxes accrued for the three months ended March 31, 2014 in SD Chaoying and Chaoying Biotech, respectively.

XML 34 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 7 183 1 false 0 0 false 6 false false R1.htm 101 - Document - Document and Entity Information Sheet http://www.cybrdi.com/taxonomy/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 102 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.cybrdi.com/taxonomy/role/BalanceSheet CONSOLIDATED BALANCE SHEETS false false R3.htm 103 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.cybrdi.com/taxonomy/role/BalanceSheetParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) false false R4.htm 104 - Statement - CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME Sheet http://www.cybrdi.com/taxonomy/role/IncomeStatement CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME false false R5.htm 105 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.cybrdi.com/taxonomy/role/CashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS false false R6.htm 109 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.cybrdi.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES false false R7.htm 110 - Disclosure - ASSETS Sheet http://www.cybrdi.com/taxonomy/role/NotesToFinancialStatementsAssetsTextBlock ASSETS false false R8.htm 111 - Disclosure - LIABILITIES Sheet http://www.cybrdi.com/taxonomy/role/NotesToFinancialStatementsLiabilitiesTextBlock LIABILITIES false false R9.htm 112 - Disclosure - STOCKHOLDERS EQUITY Sheet http://www.cybrdi.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock STOCKHOLDERS EQUITY false false R10.htm 123 - Disclosure - INCOME TAX Sheet http://www.cybrdi.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock INCOME TAX false false R11.htm 127 - Disclosure - CONTINGENCIES AND LITIGATION LIABILITIES Sheet http://www.cybrdi.com/taxonomy/role/NotesToFinancialStatementsLegalMattersAndContingenciesTextBlock CONTINGENCIES AND LITIGATION LIABILITIES false false R12.htm 128 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.cybrdi.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies Summary of Significant Accounting Policies (Policies) false false R13.htm 138 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details) Sheet http://www.cybrdi.com/taxonomy/role/DisclosureSignificantAccountingPoliciesTextBlockDetails BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details) false false R14.htm 139 - Disclosure - ASSETS (Narrative) (Details) Sheet http://www.cybrdi.com/taxonomy/role/DisclosureAssetsTextBlockDetails ASSETS (Narrative) (Details) false false R15.htm 140 - Disclosure - LIABILITIES (Narrative) (Details) Sheet http://www.cybrdi.com/taxonomy/role/DisclosureLiabilitiesTextBlockDetails LIABILITIES (Narrative) (Details) false false R16.htm 141 - Disclosure - STOCKHOLDERS EQUITY (Narrative) (Details) Sheet http://www.cybrdi.com/taxonomy/role/DisclosureStockholdersEquityNoteDisclosureTextBlockDetails STOCKHOLDERS EQUITY (Narrative) (Details) false false R17.htm 142 - Disclosure - INCOME TAX (Narrative) (Details) Sheet http://www.cybrdi.com/taxonomy/role/DisclosureIncomeTaxDisclosureTextBlockDetails INCOME TAX (Narrative) (Details) false false All Reports Book All Reports 'Monetary' elements on report '138 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)' had a mix of different decimal attribute values. Process Flow-Through: 102 - Statement - CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Mar. 31, 2013' Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: 103 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Process Flow-Through: 104 - Statement - CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME Process Flow-Through: 105 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS cydi-20140331.xml cydi-20140331.xsd cydi-20140331_cal.xml cydi-20140331_def.xml cydi-20140331_lab.xml cydi-20140331_pre.xml true true